>HK732433.1 Sequence 1199 from patent US 9045754
GTGCCTTTAAAA
>HK732432.1 Sequence 1198 from patent US 9045754
ATCCTCTTGATA
>HK732431.1 Sequence 1197 from patent US 9045754
GTCTTCAAAAGG
>HK732430.1 Sequence 1196 from patent US 9045754
CTTCAAAAGGAT
>HK732428.1 Sequence 1194 from patent US 9045754
GTCATAATGTCT
>HK732427.1 Sequence 1193 from patent US 9045754
TCTGGAGTCACA
>HK732426.1 Sequence 1192 from patent US 9045754
AGTAGTTGTACT
>HK732420.1 Sequence 1186 from patent US 9045754
TGGACTTGGCGG
>HK732417.1 Sequence 1183 from patent US 9045754
GATTTCCTGATC
>HK732415.1 Sequence 1181 from patent US 9045754
TTGAGCATCTTG
>HK732414.1 Sequence 1180 from patent US 9045754
CACACAGGCAAT
>HK732413.1 Sequence 1179 from patent US 9045754
TAATCCAGGTGA
>HK732412.1 Sequence 1178 from patent US 9045754
TATGCACAAATC
>HK732411.1 Sequence 1177 from patent US 9045754
CTTTGTCAAGAT
>HK732410.1 Sequence 1176 from patent US 9045754
TCATCAAAAGGT
>HK732409.1 Sequence 1175 from patent US 9045754
ATCTTGTGAAAC
>HK732408.1 Sequence 1174 from patent US 9045754
TCTGCAGTTAAA
>HK732407.1 Sequence 1173 from patent US 9045754
GTCAGAATATCT
>HK732406.1 Sequence 1172 from patent US 9045754
CATAGATTGTAT
>HK732405.1 Sequence 1171 from patent US 9045754
CACCTTCAAGTC
>HK732404.1 Sequence 1170 from patent US 9045754
TTCTGCAGGATG
>HK732403.1 Sequence 1169 from patent US 9045754
TGGATAAATATC
>HK732401.1 Sequence 1167 from patent US 9045754
ACAGGTCAAGTC
>HK732399.1 Sequence 1165 from patent US 9045754
TTTCTGCAGGAA
>HK732398.1 Sequence 1164 from patent US 9045754
TGGCCCTGGACC
>HK732395.1 Sequence 1161 from patent US 9045754
CATGGCTGCAGC
>HK732394.1 Sequence 1160 from patent US 9045754
ATGGCTGCTGCG
>HK732393.1 Sequence 1159 from patent US 9045754
AGAGAGCAACTC
>HK732392.1 Sequence 1158 from patent US 9045754
TGCTCACAGGCG
>HK732391.1 Sequence 1157 from patent US 9045754
CCTGAAACTGCA
>HK732390.1 Sequence 1156 from patent US 9045754
GTTAGAACAGAC
>HK732389.1 Sequence 1155 from patent US 9045754
GGACCGCAGCCG
>HK732388.1 Sequence 1154 from patent US 9045754
TGGCCTCACAGC
>HK732387.1 Sequence 1153 from patent US 9045754
AGAGAGCTGAGC
>HK732386.1 Sequence 1152 from patent US 9045754
ACAAAGAGTCCC
>HK732385.1 Sequence 1151 from patent US 9045754
TCTGACTGGGAA
>HK732384.1 Sequence 1150 from patent US 9045754
TGCTGCACATCC
>HK732383.1 Sequence 1149 from patent US 9045754
TCTGGATCAGAG
>HK732382.1 Sequence 1148 from patent US 9045754
GTTTAGTGCACA
>HK732381.1 Sequence 1147 from patent US 9045754
GCACAAATTTTC
>HK732380.1 Sequence 1146 from patent US 9045754
TTCTTAAAGGTG
>HK732378.1 Sequence 1144 from patent US 9045754
GTGAAACATTTT
>HK732377.1 Sequence 1143 from patent US 9045754
GAAGCTGCTGGT
>HK732376.1 Sequence 1142 from patent US 9045754
CAGTTTATTCAA
>HK732375.1 Sequence 1141 from patent US 9045754
ACAATTATGGCA
>HK732374.1 Sequence 1140 from patent US 9045754
GTATTCAAGTAA
>HK732373.1 Sequence 1139 from patent US 9045754
GAAATTGAGGAA
>HK732372.1 Sequence 1138 from patent US 9045754
TGAAGTTAATTC
>HK732364.1 Sequence 1130 from patent US 9045754
AAAGTCAGGCCA
>HK732363.1 Sequence 1129 from patent US 9045754
TGCGAGTTGTTG
>HK732362.1 Sequence 1128 from patent US 9045754
CAGTGGACCACA
>HK732356.1 Sequence 1122 from patent US 9045754
GGGTCTTTCCTC
>HK732355.1 Sequence 1121 from patent US 9045754
CTTGTCCATCAG
>HK732354.1 Sequence 1120 from patent US 9045754
TGACTCTCGGAC
>HK732353.1 Sequence 1119 from patent US 9045754
CTCGGACTTTGA
>HK732352.1 Sequence 1118 from patent US 9045754
AATGCAGGATCT
>HK732351.1 Sequence 1117 from patent US 9045754
GATCTCTCGAGT
>HK732350.1 Sequence 1116 from patent US 9045754
CCAACTCCAACT
>HK732349.1 Sequence 1115 from patent US 9045754
GTTGTTCCCTCT
>HK732347.1 Sequence 1113 from patent US 9045754
CTCACCTTCATG
>HK732346.1 Sequence 1112 from patent US 9045754
AGTTGTTGTTCC
>HK732345.1 Sequence 1111 from patent US 9045754
GTTGTTGTTCCC
>HK732344.1 Sequence 1110 from patent US 9045754
GCGCTAGGCCGC
>HK732343.1 Sequence 1109 from patent US 9045754
CGAGTTGTTGTT
>HK732342.1 Sequence 1108 from patent US 9045754
GAGTTGTTGTTC
>HK732341.1 Sequence 1107 from patent US 9045754
TTGTTGTTCCCT
>HK732332.1 Sequence 1098 from patent US 9045754
CAGCCTACCAGT
>HK732312.1 Sequence 1078 from patent US 9045754
GTGCGCTCCCAT
>HK732311.1 Sequence 1077 from patent US 9045754
GTTGAGCATGAC
>HK732309.1 Sequence 1074 from patent US 9045754
TTTATAAAACTG
>HK732308.1 Sequence 1073 from patent US 9045754
TAAAAACAACAA
>HK732306.1 Sequence 1071 from patent US 9045754
GCTGACATCTCG
>HK732305.1 Sequence 1070 from patent US 9045754
GGGCTTCTTCCA
>HK732304.1 Sequence 1069 from patent US 9045754
TGGGTGGCCGGG
>HK732302.1 Sequence 1067 from patent US 9045754
ACAGCCAGGTAG
>HK732298.1 Sequence 1063 from patent US 9045754
CCCTGAAGGTTC
>HK732297.1 Sequence 1062 from patent US 9045754
TGTGAGGCTCCA
>HK732296.1 Sequence 1061 from patent US 9045754
GCGCGAGCCCGA
>HK732294.1 Sequence 1059 from patent US 9045754
CAGGCCATGTGG
>HK732293.1 Sequence 1058 from patent US 9045754
TTGACCAGGAAG
>HK732290.1 Sequence 1055 from patent US 9045754
CACCCACTGGTG
>HK732285.1 Sequence 1050 from patent US 9045754
CCCTCTACACCA
>HK732282.1 Sequence 1047 from patent US 9045754
CTTCCACTGATC
>HK732279.1 Sequence 1044 from patent US 9045754
CCTTCCACTGAT
>HK732278.1 Sequence 1043 from patent US 9045754
AGGAAGGGCTTC
>HK732277.1 Sequence 1042 from patent US 9045754
AGGGCTTCCAGT
>HK732276.1 Sequence 1041 from patent US 9045754
AACTTCAGTGTC
>HK732275.1 Sequence 1040 from patent US 9045754
AAGGGCCCTGGG
>HK732271.1 Sequence 1036 from patent US 9045754
AGCTCCTTCCAC
>HK732264.1 Sequence 1029 from patent US 9045754
TTCCACTGATCC
>HK732261.1 Sequence 1026 from patent US 9045754
TCCACTGATCCT
>HK732258.1 Sequence 1023 from patent US 9045754
CGTTTGGGTGGC
>HK732256.1 Sequence 1021 from patent US 9045754
CTCCTTCCACTG
>HK732253.1 Sequence 1018 from patent US 9045754
CTGCAACATGAT
>HK732251.1 Sequence 1016 from patent US 9045754
GGAGAAGCGCAG
>HK732249.1 Sequence 1014 from patent US 9045754
TTGTCGATCTGC
>HK732248.1 Sequence 1013 from patent US 9045754
GCCAGACAGAAG
>HK732247.1 Sequence 1012 from patent US 9045754
TTGTTCTTAGGA
>HK732243.1 Sequence 1008 from patent US 9045754
TCGGACTTTGAA
>HK732241.1 Sequence 1006 from patent US 9045754
GCTCCTTCCACT
>HK732240.1 Sequence 1005 from patent US 9045754
ACACCATCTCCC
>HK732239.1 Sequence 1004 from patent US 9045754
GTTCCCTCTACA
>HK732237.1 Sequence 1002 from patent US 9045754
CGGTTTTTGTTC
>HK732236.1 Sequence 1001 from patent US 9045754
TCCTTCCACTGA
>HK732235.1 Sequence 1000 from patent US 9045754
CCCCAGCAGCGG
>HK732232.1 Sequence 997 from patent US 9045754
TTGATATAGTCA
>HK732231.1 Sequence 996 from patent US 9045754
ATCTTCAGAGAT
>HK732229.1 Sequence 994 from patent US 9045754
TATAGCTCCTCT
>HK732228.1 Sequence 993 from patent US 9045754
CTACACCAGGTC
>HK732227.1 Sequence 992 from patent US 9045754
CGGGTACTATGG
>HK732225.1 Sequence 990 from patent US 9045754
TCCCAAACAAAT
>HK732223.1 Sequence 988 from patent US 9045754
GTATGCACTGCT
>HK732222.1 Sequence 987 from patent US 9045754
CAGAGAAGGTCT
>HK732221.1 Sequence 986 from patent US 9045754
TTCTGCTCCCAC
>HK732220.1 Sequence 985 from patent US 9045754
CTCCCACACCAT
>HK732219.1 Sequence 984 from patent US 9045754
TCATTCCCCACT
>HK732217.1 Sequence 982 from patent US 9045754
CCTCTACACCAG
>HK732213.1 Sequence 978 from patent US 9045754
CCATTTTTATCA
>HK732212.1 Sequence 977 from patent US 9045754
TAGTCATTATCT
>HK732210.1 Sequence 975 from patent US 9045754
GGCTGACATTCA
>HK732208.1 Sequence 973 from patent US 9045754
TACACCAGGTCA
>HK732206.1 Sequence 971 from patent US 9045754
TGGCTTCATGTC
>HK732204.1 Sequence 969 from patent US 9045754
CTCTACACCAGG
>HK732203.1 Sequence 968 from patent US 9045754
GTTCTTAGGAAG
>HK732201.1 Sequence 966 from patent US 9045754
GAGGTGGGAAAA
>HK732200.1 Sequence 965 from patent US 9045754
ATGTCATTAAAC
>HK732199.1 Sequence 964 from patent US 9045754
ACCCAGTCAGGG
>HK732198.1 Sequence 963 from patent US 9045754
AGGTAGGAGAAG
>HK732196.1 Sequence 961 from patent US 9045754
TCTACACCAGGT
>HK732191.1 Sequence 956 from patent US 9045754
TCCCTCTACACC
>HK732190.1 Sequence 955 from patent US 9045754
TTCCCTCTACAC
>HK732186.1 Sequence 951 from patent US 9045754
CAAGTAGGATGT
>HK732185.1 Sequence 950 from patent US 9045754
CGACACGGGAAC
>HK732184.1 Sequence 949 from patent US 9045754
TTAACGAGCCTT
>HK732169.1 Sequence 934 from patent US 9045754
TTTCCTCTTGTC
>HK732164.1 Sequence 929 from patent US 9045754
TTGTTCCCTCTA
>HK732163.1 Sequence 928 from patent US 9045754
CCCGCCACCACC
>HK732157.1 Sequence 922 from patent US 9045754
GCTTACGATTGT
>HK732156.1 Sequence 921 from patent US 9045754
CCATGGCGGGAC
>HK732155.1 Sequence 920 from patent US 9045754
GTAAGAGGCAGG
>HK732150.1 Sequence 915 from patent US 9045754
CCGTTGGACCCC
>HK732144.1 Sequence 909 from patent US 9045754
TCAGCCAGACAG
>HK732143.1 Sequence 908 from patent US 9045754
ATGTCAACCGGC
>HK732142.1 Sequence 907 from patent US 9045754
CAAAAGGATCCC
>HK732141.1 Sequence 906 from patent US 9045754
TGGATGATTGGC
>HK732136.1 Sequence 901 from patent US 9045754
TGTTCCCTCTAC
>HK732133.1 Sequence 898 from patent US 9045754
CTGGTAAATAGC
>HK732127.1 Sequence 892 from patent US 9045754
GACTCCAAAGTC
>HK732126.1 Sequence 891 from patent US 9045754
TTCTTGATGTCC
>HK732124.1 Sequence 889 from patent US 9045754
CCGACTGTGGTC
>HK732123.1 Sequence 888 from patent US 9045754
GACTGTGGTCAA
>HK732122.1 Sequence 887 from patent US 9045754
TTTAATCCGACT
>HK732121.1 Sequence 886 from patent US 9045754
TTGTCGATCTCC
>HK732120.1 Sequence 885 from patent US 9045754
TTCCCAGCCTTG
>HK732119.1 Sequence 884 from patent US 9045754
TTAATCCGACTG
>HK732118.1 Sequence 883 from patent US 9045754
TGTGGTCAAAAG
>HK732117.1 Sequence 882 from patent US 9045754
TGTCGATCTCCT
>HK732116.1 Sequence 881 from patent US 9045754
TGGTCAAAAGGG
>HK732115.1 Sequence 880 from patent US 9045754
TGCACTGACGAG
>HK732114.1 Sequence 879 from patent US 9045754
TGCAATTTAATC
>HK732113.1 Sequence 878 from patent US 9045754
TGATCCTGCACT
>HK732112.1 Sequence 877 from patent US 9045754
TCGATCTCCTCG
>HK732111.1 Sequence 876 from patent US 9045754
TCCTGCACTGAC
>HK732110.1 Sequence 875 from patent US 9045754
TCCGACTGTGGT
>HK732109.1 Sequence 874 from patent US 9045754
TCCCAGCCTTGT
>HK732106.1 Sequence 871 from patent US 9045754
TAATCCGACTGT
>HK732105.1 Sequence 870 from patent US 9045754
GTTCCCAGCCTT
>HK732104.1 Sequence 869 from patent US 9045754
GTGGTCAAAAGG
>HK732103.1 Sequence 868 from patent US 9045754
GTCGATCTCCTC
>HK732101.1 Sequence 866 from patent US 9045754
GGTCAAAAGGGC
>HK732100.1 Sequence 865 from patent US 9045754
GCCTTGTCGATC
>HK732099.1 Sequence 864 from patent US 9045754
GCCGCCCAGTTC
>HK732098.1 Sequence 863 from patent US 9045754
GCCCAGTTCCCA
>HK732097.1 Sequence 862 from patent US 9045754
GCACTGACGAGT
>HK732096.1 Sequence 861 from patent US 9045754
GCAATTTAATCC
>HK732095.1 Sequence 860 from patent US 9045754
GATCCTGCACTG
>HK732094.1 Sequence 859 from patent US 9045754
CTTGTCGATCTC
>HK732093.1 Sequence 858 from patent US 9045754
CTGTGGTCAAAA
>HK732092.1 Sequence 857 from patent US 9045754
CTGCACTGACGA
>HK732091.1 Sequence 856 from patent US 9045754
CTGATCCTGCAC
>HK732090.1 Sequence 855 from patent US 9045754
CGCCCAGTTCCC
>HK732089.1 Sequence 854 from patent US 9045754
CGACTGTGGTCA
>HK732088.1 Sequence 853 from patent US 9045754
CCTTGTCGATCT
>HK732086.1 Sequence 851 from patent US 9045754
CCTGCACTGACG
>HK732085.1 Sequence 850 from patent US 9045754
CCGCCCAGTTCC
>HK732084.1 Sequence 849 from patent US 9045754
CCCAGTTCCCAG
>HK732083.1 Sequence 848 from patent US 9045754
CCCAGCCTTGTC
>HK732082.1 Sequence 847 from patent US 9045754
CCAGTTCCCAGC
>HK732081.1 Sequence 846 from patent US 9045754
CCAGCCTTGTCG
>HK732080.1 Sequence 845 from patent US 9045754
CCACTGATCCTG
>HK732079.1 Sequence 844 from patent US 9045754
CAGTTCCCAGCC
>HK732078.1 Sequence 843 from patent US 9045754
CAGCCTTGTCGA
>HK732077.1 Sequence 842 from patent US 9045754
CACTGATCCTGC
>HK732076.1 Sequence 841 from patent US 9045754
CACTGACGAGTC
>HK732075.1 Sequence 840 from patent US 9045754
CAATTTAATCCG
>HK732074.1 Sequence 839 from patent US 9045754
ATTTAATCCGAC
>HK732073.1 Sequence 838 from patent US 9045754
ATCCTGCACTGA
>HK732072.1 Sequence 837 from patent US 9045754
ATCCGACTGTGG
>HK732071.1 Sequence 836 from patent US 9045754
AGTTCCCAGCCT
>HK732070.1 Sequence 835 from patent US 9045754
AGCCTTGTCGAT
>HK732069.1 Sequence 834 from patent US 9045754
AGCCGCCCAGTT
>HK732068.1 Sequence 833 from patent US 9045754
ACTGTGGTCAAA
>HK732067.1 Sequence 832 from patent US 9045754
ACTGATCCTGCA
>HK732065.1 Sequence 830 from patent US 9045754
AATTTAATCCGA
>HK732064.1 Sequence 829 from patent US 9045754
AATCCGACTGTG
>HK732013.1 Sequence 777 from patent US 9045754
GTTCACCTCCAG
>HK732012.1 Sequence 776 from patent US 9045754
AGCTTCACCAGG
>HK732011.1 Sequence 775 from patent US 9045754
GCCTCCATGTAC
>HK732002.1 Sequence 766 from patent US 9045754
GGTACAGGTCGA
>HK731997.1 Sequence 761 from patent US 9045754
CTTGGAGTAGGG
>HK731989.1 Sequence 753 from patent US 9045754
GGACCCATCGGC
>HK731977.1 Sequence 741 from patent US 9045754
CAGGGTGACTGC
>HK731976.1 Sequence 740 from patent US 9045754
CCAGGCATGGAG
>HK731973.1 Sequence 737 from patent US 9045754
CCACTCCCATTC
>HK731972.1 Sequence 736 from patent US 9045754
TGACAGGGCAGA
>HK731971.1 Sequence 735 from patent US 9045754
GACAGGGCAGAT
>HK731970.1 Sequence 734 from patent US 9045754
CCAGACATCAGG
>HK731965.1 Sequence 729 from patent US 9045754
CCAGGCCCATGA
>HK731954.1 Sequence 718 from patent US 9045754
CTGGTGGTCAGC
>HK731935.1 Sequence 699 from patent US 9045754
TCACCAGCTGGA
>HK731930.1 Sequence 694 from patent US 9045754
CTGCAGGCCACT
>HK731928.1 Sequence 692 from patent US 9045754
TGAGCCAGGTGA
>HK731925.1 Sequence 689 from patent US 9045754
AGAGGATGCTGG
>HK731924.1 Sequence 688 from patent US 9045754
CAGACCCCTCGC
>HK731919.1 Sequence 683 from patent US 9045754
CCCGGAGTAGGC
>HK731690.1 Sequence 408 from patent US 9045754
CGCCCTTCAGCA
>HK731612.1 Sequence 300 from patent US 9045754
GGGCATTGAGGT
>HK731611.1 Sequence 299 from patent US 9045754
GGCATTGAGGTT
>HK731610.1 Sequence 298 from patent US 9045754
GCATTGAGGTTG
>HK731609.1 Sequence 297 from patent US 9045754
CATTGAGGTTGA
>HK731608.1 Sequence 296 from patent US 9045754
ATTGAGGTTGAC
>HK731607.1 Sequence 295 from patent US 9045754
GCCGGAGACTGA
>HK731606.1 Sequence 293 from patent US 9045754
GCACACAGCTGC
>HK731604.1 Sequence 291 from patent US 9045754
CACACAGCTGCC
>HK731603.1 Sequence 290 from patent US 9045754
ACACAGCTGCCC
>HK731602.1 Sequence 289 from patent US 9045754
CACAGCTGCCCG
>HK731601.1 Sequence 288 from patent US 9045754
CCATGGTGAAGA
>HK731600.1 Sequence 287 from patent US 9045754
GCCAGCATGAGT
>HK731599.1 Sequence 285 from patent US 9045754
CCAGCATGAGTC
>HK731598.1 Sequence 284 from patent US 9045754
CAGCATGAGTCC
>HK731597.1 Sequence 283 from patent US 9045754
GGGCATGAGCTT
>HK731596.1 Sequence 281 from patent US 9045754
GGCATGAGCTTC
>HK731594.1 Sequence 279 from patent US 9045754
GCATGAGCTTCA
>HK731593.1 Sequence 278 from patent US 9045754
CATGAGCTTCAC
>HK731592.1 Sequence 277 from patent US 9045754
GAGCAGCCCACC
>HK731591.1 Sequence 276 from patent US 9045754
AGCAGCCCACCT
>HK731590.1 Sequence 275 from patent US 9045754
GCAGCCCACCTC
>HK731589.1 Sequence 274 from patent US 9045754
CCTGGCATGACC
>HK731588.1 Sequence 272 from patent US 9045754
CTGGCATGACCA
>HK731587.1 Sequence 271 from patent US 9045754
TGGCATGACCAT
>HK731586.1 Sequence 270 from patent US 9045754
GGCATGACCATG
>HK731585.1 Sequence 269 from patent US 9045754
GCATGACCATGA
>HK731584.1 Sequence 268 from patent US 9045754
CATGACCATGAG
>HK731583.1 Sequence 267 from patent US 9045754
CAGCTTCAGGTA
>HK731582.1 Sequence 266 from patent US 9045754
GGACACCGTCAG
>HK731581.1 Sequence 265 from patent US 9045754
GTATTTGTCGAA
>HK731580.1 Sequence 264 from patent US 9045754
GACGAAGGTCTG
>HK731579.1 Sequence 263 from patent US 9045754
GCCAGCCCTCCT
>HK731578.1 Sequence 262 from patent US 9045754
CCAGCCCTCCTG
>HK731577.1 Sequence 261 from patent US 9045754
CAGCCCTCCTGT
>HK731576.1 Sequence 260 from patent US 9045754
AGCCCTCCTGTC
>HK731575.1 Sequence 259 from patent US 9045754
GCCCTCCTGTCA
>HK731574.1 Sequence 258 from patent US 9045754
CCCTCCTGTCAC
>HK731573.1 Sequence 257 from patent US 9045754
ATCATGGTGATG
>HK731572.1 Sequence 256 from patent US 9045754
TCATGGTGATGC
>HK731571.1 Sequence 254 from patent US 9045754
CATGGTGATGCC
>HK731570.1 Sequence 253 from patent US 9045754
ATGGTGATGCCC
>HK731569.1 Sequence 252 from patent US 9045754
TGGTGATGCCCA
>HK731568.1 Sequence 251 from patent US 9045754
ATGTTCCAGCCC
>HK731567.1 Sequence 246 from patent US 9045754
TGTTCCAGCCCA
>HK731565.1 Sequence 243 from patent US 9045754
AGATCTTGGTGA
>HK731564.1 Sequence 242 from patent US 9045754
ACAGGTAGAGGC
>HK731563.1 Sequence 241 from patent US 9045754
AGAGCGCATTCC
>HK731562.1 Sequence 240 from patent US 9045754
CCAAGCCACTTG
>HK731561.1 Sequence 239 from patent US 9045754
GCCAGGCCCACA
>HK731560.1 Sequence 238 from patent US 9045754
CCAGGCCCACAA
>HK731559.1 Sequence 237 from patent US 9045754
CAGGCCCACAAA
>HK731558.1 Sequence 236 from patent US 9045754
CTGCCGATGTTG
>HK731557.1 Sequence 235 from patent US 9045754
TGCCGATGTTGC
>HK731556.1 Sequence 234 from patent US 9045754
GCCGATGTTGCT
>HK731555.1 Sequence 233 from patent US 9045754
CCGATGTTGCTG
>HK731554.1 Sequence 232 from patent US 9045754
CGATGTTGCTGG
>HK731553.1 Sequence 230 from patent US 9045754
GATGTTGCTGGC
>HK731552.1 Sequence 229 from patent US 9045754
ACCGGCCACCAC
>HK731551.1 Sequence 228 from patent US 9045754
CCGGCCACCACA
>HK731550.1 Sequence 226 from patent US 9045754
TAGCCGCCCACA
>HK731549.1 Sequence 225 from patent US 9045754
ACCACAAGCCAA
>HK731548.1 Sequence 224 from patent US 9045754
CCAATGACCAGC
>HK731547.1 Sequence 223 from patent US 9045754
CAATGACCAGCA
>HK731546.1 Sequence 222 from patent US 9045754
AATGACCAGCAG
>HK731545.1 Sequence 221 from patent US 9045754
ATGACCAGCAGG
>HK731544.1 Sequence 219 from patent US 9045754
TGACCAGCAGGA
>HK731543.1 Sequence 218 from patent US 9045754
GACCAGCAGGAA
>HK731542.1 Sequence 217 from patent US 9045754
ACCAGCAGGAAA
>HK731541.1 Sequence 216 from patent US 9045754
CCAGCAGGAAAT
>HK731540.1 Sequence 215 from patent US 9045754
CAGCAGGAAATA
>HK731539.1 Sequence 214 from patent US 9045754
TGTCAGCAGGAT
>HK730699.1 Sequence 75 from patent US 9045554
TAGTCCGGTGAT
>HK730698.1 Sequence 74 from patent US 9045554
CTCGTAGTCCGG
>HK730696.1 Sequence 72 from patent US 9045554
GGTCTCGTAGTA
>HK730695.1 Sequence 71 from patent US 9045554
GCCGCGGTCTCA
>HK730692.1 Sequence 59 from patent US 9045554
GGTCTCRTAGTC
>HK730189.1 Sequence 11 from patent US 9045521
AAATTCTAACAT
>HK730187.1 Sequence 9 from patent US 9045521
AAACGCCTCCAT
>HK730186.1 Sequence 8 from patent US 9045521
AGGTTCAAACAT
>HK730184.1 Sequence 6 from patent US 9045521
CAGTTCAAACAT
>HK730183.1 Sequence 5 from patent US 9045521
TTGATGAAACAT
>HK730181.1 Sequence 3 from patent US 9045521
AGGTTCAAACAT
>HK730179.1 Sequence 1 from patent US 9045521
CTCTCTCTCTCT
>HK730109.1 Sequence 2 from patent US 9044729
CAGGAAACAGCT
>HK730108.1 Sequence 1 from patent US 9044729
GTTTTCCCAGTC
>HK729954.1 Sequence 23 from patent US 9044493
GGTCTGGAGAGG
>HK729953.1 Sequence 22 from patent US 9044493
TGGAGAGGTTCT
>HK729952.1 Sequence 21 from patent US 9044493
CCTGGTCTGGAG
>HK729951.1 Sequence 20 from patent US 9044493
CAGCTCTGCCTA
>HK729950.1 Sequence 19 from patent US 9044493
GGCCAGCTCTGC
>HK728831.1 Sequence 204 from patent US 9044445
CCANNNNNNTGG
>HK727710.1 Sequence 2005 from patent US 9040774
CGGCGAGCACAA
>HK727709.1 Sequence 2004 from patent US 9040774
CGGCGAGCACAA
>HK727708.1 Sequence 2003 from patent US 9040774
AGGCGAGCACAA
>HK727707.1 Sequence 2002 from patent US 9040774
GAGGAGGCACAA
>HK727427.1 Sequence 1722 from patent US 9040774
AAGCCAAACACA
>HK727178.1 Sequence 1473 from patent US 9040774
CAGGCAACAGGC
>HK727140.1 Sequence 1435 from patent US 9040774
CAGGCAACAGGC
>HK726919.1 Sequence 1214 from patent US 9040774
AAGCCCCCCGCA
>HK726912.1 Sequence 1207 from patent US 9040774
GCGCCCCCCGCA
>HK726876.1 Sequence 1171 from patent US 9040774
CCGCCCCCCGCA
>HK726856.1 Sequence 1151 from patent US 9040774
CCGCCCCCCGCA
>HK724859.1 Sequence 84 from patent US 9040493
GATTCAAACCCA
>HK724858.1 Sequence 83 from patent US 9040493
AGATTCAAACCC
>HK724857.1 Sequence 82 from patent US 9040493
CAGATTCAAACC
>HK724856.1 Sequence 81 from patent US 9040493
TCAGATTCAAAC
>HK724848.1 Sequence 73 from patent US 9040493
TGTGGATCTGGC
>HK724847.1 Sequence 72 from patent US 9040493
ATGTGGATCTGG
>HK724846.1 Sequence 71 from patent US 9040493
CATGTGGATCTG
>HK724845.1 Sequence 70 from patent US 9040493
ACATGTGGATCT
>HK724844.1 Sequence 69 from patent US 9040493
TACATGTGGATC
>HK724824.1 Sequence 49 from patent US 9040493
GGTGTGTCTTCA
>HK724823.1 Sequence 48 from patent US 9040493
AGGTGTGTCTTC
>HK724822.1 Sequence 47 from patent US 9040493
CAGGTGTGTCTT
>HK724821.1 Sequence 46 from patent US 9040493
GCAGGTGTGTCT
>HK724820.1 Sequence 45 from patent US 9040493
CGCAGGTGTGTC
>HK724808.1 Sequence 33 from patent US 9040493
TTGGTGCAGTCT
>HK724807.1 Sequence 32 from patent US 9040493
CTTGGTGCAGTC
>HK724805.1 Sequence 30 from patent US 9040493
TCCTTGGTGCAG
>HK724804.1 Sequence 29 from patent US 9040493
CTCCTTGGTGCA
>HK724790.1 Sequence 15 from patent US 9040493
CTGGTGCTTGGC
>HK724789.1 Sequence 14 from patent US 9040493
TCTGGTGCTTGG
>HK724788.1 Sequence 13 from patent US 9040493
TTCTGGTGCTTG
>HK724783.1 Sequence 8 from patent US 9040493
CAGCATGTACTG
>HK724782.1 Sequence 7 from patent US 9040493
CCAGCATGTACT
>HK724781.1 Sequence 6 from patent US 9040493
ACCAGCATGTAC
>HK719606.1 Sequence 350 from patent US 9034839
GCAGGTTCTCAC
>HK719601.1 Sequence 345 from patent US 9034839
TGATTGGTACGT
>HK719434.1 Sequence 174 from patent US 9034839
CTAACATATGAA
>HK719363.1 Sequence 102 from patent US 9034839
TGCCTACTGGCC
>HK719274.1 Sequence 11 from patent US 9034839
GATTGGCAGCTT
>HK719199.1 Sequence 32 from patent US 9034837
CATTGTCACACT
>HK719196.1 Sequence 29 from patent US 9034837
ATTGTCACACTC
>HK719097.1 Sequence 151 from patent US 9034798
GTCCNNNNCTAC
>HK717096.1 Sequence 587 from patent US 9034642
GGGGGGGGGGGG
>HK715055.1 Sequence 10 from patent US 9034598
CATATGGGATCC
>HK715054.1 Sequence 9 from patent US 9034598
CTCGAGTAATGA
>HK715047.1 Sequence 2 from patent US 9034598
TAATGACTCGAG
>HK715041.1 Sequence 45 from patent US 9034597
CCAAGGCCTTAA
>HK714347.1 Sequence 10 from patent US 9034321
CATATGGGATCC
>HK714346.1 Sequence 9 from patent US 9034321
CTCGAGTAATGA
>HK714339.1 Sequence 2 from patent US 9034321
TAATGACTCGAG
>HK714257.1 Sequence 10 from patent US 9034320
CATATGGGATCC
>HK714256.1 Sequence 9 from patent US 9034320
CTCGAGTAATGA
>HK714249.1 Sequence 2 from patent US 9034320
TAATGACTCGAG
>HK700611.1 Sequence 70 from patent US 9029516
GATCCTGCCCGG
>HK700498.1 Sequence 10 from patent US 9029506
CATATGGGATCC
>HK700497.1 Sequence 9 from patent US 9029506
CTCGAGTAATGA
>HK700490.1 Sequence 2 from patent US 9029506
TAATGACTCGAG
>HK697941.1 Sequence 6 from patent US 9029335
GCGTTTTTTGCT
>HK697940.1 Sequence 5 from patent US 9029335
AGCAAAAAACGC
>HK695356.1 Sequence 155 from patent US 9028845
TCGAACGTTCGA
>HK695348.1 Sequence 147 from patent US 9028845
TCGATTCGAGCG
>HK695312.1 Sequence 111 from patent US 9028845
TCGTAACGTTCG
>HK695310.1 Sequence 109 from patent US 9028845
TCGGAACGTTCG
>HK695305.1 Sequence 104 from patent US 9028845
CTGAACGTTCAG
>HK692240.1 Sequence 136 from patent US 9028798
ATGTGTTGGAGT
>HK692236.1 Sequence 132 from patent US 9028798
ATGCCTAAGCGT
>HK692235.1 Sequence 131 from patent US 9028798
ATGCCTAAGCGT
>HK692234.1 Sequence 130 from patent US 9028798
ATGCCTAAGCGT
>HK692233.1 Sequence 129 from patent US 9028798
CCACACAGGCAT
>HK692231.1 Sequence 127 from patent US 9028798
GGGCGGGGGAGG
>HK692230.1 Sequence 126 from patent US 9028798
GGGCGGGGGAGG
>HK692229.1 Sequence 125 from patent US 9028798
GGGCGGGGGAGG
>HK692227.1 Sequence 123 from patent US 9028798
AAAGGTGGGCGG
>HK692226.1 Sequence 122 from patent US 9028798
AAAGGTGGGCGG
>HK692225.1 Sequence 121 from patent US 9028798
ACGCCCCAACAA
>HK692216.1 Sequence 112 from patent US 9028798
CCAACCAAGCAA
>HK692215.1 Sequence 111 from patent US 9028798
CCACCTACATAA
>HK692214.1 Sequence 110 from patent US 9028798
CCACCTACATAA
>HK692211.1 Sequence 107 from patent US 9028798
ACGCCTACTCTG
>HK692210.1 Sequence 106 from patent US 9028798
ACGCCTACTCTG
>HK692209.1 Sequence 105 from patent US 9028798
ACGCCTACTCTG
>HK692206.1 Sequence 102 from patent US 9028798
TTGCATGGGCTG
>HK692205.1 Sequence 101 from patent US 9028798
TTGCATGGGCTG
>HK692204.1 Sequence 100 from patent US 9028798
TTGCATGGGCTG
>HK692203.1 Sequence 99 from patent US 9028798
TTGCATGGGCTG
>HK692202.1 Sequence 98 from patent US 9028798
TTGCGTGGCCAG
>HK692201.1 Sequence 97 from patent US 9028798
TTGCGTGGCCAG
>HK692200.1 Sequence 96 from patent US 9028798
TTGCGTGGCCAG
>HK692199.1 Sequence 95 from patent US 9028798
TTGCGTGGCCAG
>HK692198.1 Sequence 94 from patent US 9028798
CCACCCCTGCAC
>HK692197.1 Sequence 93 from patent US 9028798
CCACCCCTGCAC
>HK692196.1 Sequence 92 from patent US 9028798
CTGCCCACACCT
>HK692194.1 Sequence 90 from patent US 9028798
CTTCCCACGCTC
>HK692191.1 Sequence 87 from patent US 9028798
TGGCGGGGGGGG
>HK692190.1 Sequence 86 from patent US 9028798
TGGCGGGGGGGG
>HK692188.1 Sequence 84 from patent US 9028798
CCTGCCACGCCA
>HK692187.1 Sequence 83 from patent US 9028798
CCTGCCACGCCA
>HK692180.1 Sequence 76 from patent US 9028798
TTACGTGGGTGC
>HK692179.1 Sequence 75 from patent US 9028798
TTACGTGGGTGC
>HK692178.1 Sequence 74 from patent US 9028798
TTACGTGGGTGC
>HK692175.1 Sequence 71 from patent US 9028798
GAGGGTGGGTGT
>HK692174.1 Sequence 70 from patent US 9028798
GAGGGTGGGTGT
>HK692173.1 Sequence 69 from patent US 9028798
GAGGGTGGGTGT
>HK692170.1 Sequence 66 from patent US 9028798
ACACACACTCAT
>HK692169.1 Sequence 65 from patent US 9028798
ACACACACTCAT
>HK692163.1 Sequence 59 from patent US 9028798
TTGTTGGGGCGG
>HK692162.1 Sequence 58 from patent US 9028798
CCTCCCTCTCAA
>HK692161.1 Sequence 57 from patent US 9028798
CCTCCCACACAC
>HK692160.1 Sequence 56 from patent US 9028798
CCTCCCACACAC
>HK692159.1 Sequence 55 from patent US 9028798
CCTCCCACACAC
>HK692158.1 Sequence 54 from patent US 9028798
CCTCCCACACAC
>HK692155.1 Sequence 51 from patent US 9028798
ACACTCCCGCAC
>HK692154.1 Sequence 50 from patent US 9028798
ACACTCCCGCAC
>HK692153.1 Sequence 49 from patent US 9028798
ACACCCACACTG
>HK692152.1 Sequence 48 from patent US 9028798
ACACCCACACTG
>HK692150.1 Sequence 46 from patent US 9028798
CCAACCACACAA
>HK692147.1 Sequence 43 from patent US 9028798
GTGCATAGGCTG
>HK692146.1 Sequence 42 from patent US 9028798
GTGCATAGGCTG
>HK692141.1 Sequence 37 from patent US 9028798
TTGCGTAGGCGG
>HK692140.1 Sequence 36 from patent US 9028798
TTGCGTAGGCGG
>HK692139.1 Sequence 35 from patent US 9028798
TTGCGTAGGCGG
>HK692138.1 Sequence 34 from patent US 9028798
TTGCGTAGGCGG
>HK692135.1 Sequence 31 from patent US 9028798
GCGCGTGGGCGG
>HK692134.1 Sequence 30 from patent US 9028798
GCGCGTGGGCGG
>HK692133.1 Sequence 29 from patent US 9028798
GCGCGTGGGCGG
>HK692132.1 Sequence 28 from patent US 9028798
GCGCGTGGGCGG
>HK692131.1 Sequence 27 from patent US 9028798
ACGCCCGCGCGT
>HK692130.1 Sequence 26 from patent US 9028798
ACGCCCGCGCGT
>HK692129.1 Sequence 25 from patent US 9028798
ACGCCCGCGCGT
>HK692128.1 Sequence 24 from patent US 9028798
ACGCCCGCGCGT
>HK692126.1 Sequence 22 from patent US 9028798
ACAGCCACGCGG
>HK692125.1 Sequence 21 from patent US 9028798
GAGCGTAGGCGG
>HK692124.1 Sequence 20 from patent US 9028798
GAGCGTAGGCGG
>HK692123.1 Sequence 19 from patent US 9028798
GAGCGTAGGCGG
>HK692122.1 Sequence 18 from patent US 9028798
GAGCGTAGGCGG
>HK692119.1 Sequence 15 from patent US 9028798
CCACCGCCGCCT
>HK692118.1 Sequence 14 from patent US 9028798
CCACCGCCGCCA
>HK692117.1 Sequence 13 from patent US 9028798
CAGCGCGGGCGG
>HK692116.1 Sequence 12 from patent US 9028798
CAGCGCGGGCGG
>HK692115.1 Sequence 11 from patent US 9028798
CAGCGCGGGCGG
>HK692114.1 Sequence 10 from patent US 9028798
CAGCGCGGGCGG
>HZ427187.1 JP 2014221072-A/26: SEQUENCING BY A COMBINATION OF MONONUCLEOTIDE SPECIFIC DIGESTION AND MASS SPECTROMETRY
CACGAAGACGGT
>HZ427186.1 JP 2014221072-A/25: SEQUENCING BY A COMBINATION OF MONONUCLEOTIDE SPECIFIC DIGESTION AND MASS SPECTROMETRY
ACCCACACAAAT
>HZ423834.1 JP 2014169323-A/26: Microemulsions with Adsorbed Macromolecules and Microparticles
ATTGACGTCAAT
>HZ423608.1 JP 2014166187-A/42: Generation of Tumor-Free Embryonic Stem-Like Pluripotent Cells Using Inducible Recombinant RNA Agents
GATATCCTGCAG
>HZ423568.1 JP 2014166187-A/2: Generation of Tumor-Free Embryonic Stem-Like Pluripotent Cells Using Inducible Recombinant RNA Agents
GCCTGGCTTAGC
>HZ423567.1 JP 2014166187-A/1: Generation of Tumor-Free Embryonic Stem-Like Pluripotent Cells Using Inducible Recombinant RNA Agents
GCTAAGCCAGGC
>HZ421615.1 JP 2014111650-A/1: A METHOD FOR PRODUCING INFLUENZA HEMAGGLUTININ MULTIVALENT VACCINES
AGCAAAAGCAGG
>HZ421551.1 JP 2014138597-A/17: SINGLE MOLECULE ARRAYS FOR GENETIC AND CHEMICAL ANALYSIS
ACATTAACGGAC
>HZ419810.1 JP 2014132901-A/586: GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HAEMOPHILUS INFLUENZAE
GGGGGGGGGGGG
>HZ418767.1 JP 2014097072-A/85: Compositions of asymmetric interfering RNA and uses thereof
CTGATATTGATG
>HZ418766.1 JP 2014097072-A/84: Compositions of asymmetric interfering RNA and uses thereof
TGATATTGATGG
>HZ417935.1 JP 2014113163-A/4: Compositions and methods related to mRNA translational enhancer elements
RMSCSGCNGMWR
>HZ400281.1 JP 2015178507-A/13: Human Notch3 Based Fusion Proteins As Decoy Inhibitors Of Notch3 Signaling
CCGCGGCTCCTC
>HZ400280.1 JP 2015178507-A/12: Human Notch3 Based Fusion Proteins As Decoy Inhibitors Of Notch3 Signaling
GAGGAGCCGCGG
>HZ391580.1 JP 2015157813-A/22: Methods and means for treating DNA repeat instability associated genetic disorders
CCTGCCTGCCTG
>HZ391579.1 JP 2015157813-A/21: Methods and means for treating DNA repeat instability associated genetic disorders
CGGCGGCGGCGG
>HZ391578.1 JP 2015157813-A/20: Methods and means for treating DNA repeat instability associated genetic disorders
CTGCTGCTGCTG
>HZ391577.1 JP 2015157813-A/19: Methods and means for treating DNA repeat instability associated genetic disorders
GCGGCGGCGGCG
>HZ391576.1 JP 2015157813-A/18: Methods and means for treating DNA repeat instability associated genetic disorders
CAGCAGCAGCAG
>HZ409700.1 JP 2015528002-A/2297: CHIRAL CONTROL
CCAGGTAAGTAT
>HZ409998.1 JP 2015525567-A/87: HIGH-THROUGHPUT DNA FRAGMENT ASSEMBLY
CTAACTAATNAG
>HZ409996.1 JP 2015525567-A/85: HIGH-THROUGHPUT DNA FRAGMENT ASSEMBLY
CTAACTAATNAG
>HZ407528.1 JP 2015528002-A/125: CHIRAL CONTROL
CAGTCTGCTTCG
>HZ407511.1 JP 2015528002-A/108: CHIRAL CONTROL
CAGTCTGCTTCG
>HZ407472.1 JP 2015528002-A/69: CHIRAL CONTROL
TCAGCGTGCGCC
>HZ406947.1 JP 2015525081-A/12: INHIBITORS OF THE MIR-15 FAMILY OF MICRO-RNAS
TGCCGTGCTGCT
>HZ406946.1 JP 2015525081-A/11: INHIBITORS OF THE MIR-15 FAMILY OF MICRO-RNAS
TGCTGTGCTGCT
>HZ406945.1 JP 2015525081-A/10: INHIBITORS OF THE MIR-15 FAMILY OF MICRO-RNAS
TGACGTGCTGCT
>HZ406944.1 JP 2015525081-A/9: INHIBITORS OF THE MIR-15 FAMILY OF MICRO-RNAS
TGATGTGCTGCT
>HZ406943.1 JP 2015525081-A/8: INHIBITORS OF THE MIR-15 FAMILY OF MICRO-RNAS
TTCCGTGCTGCT
>HZ406942.1 JP 2015525081-A/7: INHIBITORS OF THE MIR-15 FAMILY OF MICRO-RNAS
TTCTGTGCTGCT
>HZ406941.1 JP 2015525081-A/6: INHIBITORS OF THE MIR-15 FAMILY OF MICRO-RNAS
TTACGTGCTGCT
>HZ406940.1 JP 2015525081-A/5: INHIBITORS OF THE MIR-15 FAMILY OF MICRO-RNAS
TTATGTGCTGCT
>HZ405799.1 WO 2015156275-A/15: Method of Screening for ATP11C or CDC50A Inhibitor
CTTAGATGAGAC
>HZ403330.1 JP 2015157855-A/120: ANTAGONISTS OF IL-6 TO PREVENT OR TREAT CACHEXIA, WEAKNESS, FATIGUE, AND/OR FEVER
GCCTATGACTTG
>HZ402993.1 JP 2015187132-A/120: ANTIBODIES TO IL-6 AND USE THEREOF
GCCTATGACTTG
>LG053855.1 KR 1020150044901-A/49: ENGINEERING T-CELL RECEPTORS
CTCGAGATCTGA
>LG053838.1 KR 1020150059168-A/752: STEM CELL MICROPARTICLES
GTGCCCTTCTTC
>LG053833.1 KR 1020150059168-A/747: STEM CELL MICROPARTICLES
GGGTCCGGTGCG
>LG053034.1 KR 1020150036642-A/2300: CHIRAL CONTROL
CCAGGTAAGTAT
>LG050806.1 KR 1020150036642-A/69: CHIRAL CONTROL
TCAGCGTGCGCC
>LG050862.1 KR 1020150036642-A/125: CHIRAL CONTROL
CAGTCTGCTTCG
>LG050845.1 KR 1020150036642-A/108: CHIRAL CONTROL
CAGTCTGCTTCG
>LG006142.1 KR 1020150004822-A/752: STEM CELL MICROPARTICLES
GTGCCCTTCTTC
>LG006137.1 KR 1020150004822-A/747: STEM CELL MICROPARTICLES
GGGTCCGGTGCG
>LG049294.1 KR 1020150030260-A/30: DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES
AAAAACTCAGGT
>LG049278.1 KR 1020150030260-A/14: DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES
GGAATGAACAGG
>LG047897.1 KR 1020150032306-A/87: HIGH-THROUGHPUT DNA FRAGMENT ASSEMBLY
CTAACTAATNAG
>LG047895.1 KR 1020150032306-A/85: HIGH-THROUGHPUT DNA FRAGMENT ASSEMBLY
CTAACTAATNAG
>LG047716.1 KR 1020150036140-A/12: Inhibitors of the MIR-15 Family of Micro-RNAs
TGCCGTGCTGCT
>LG047715.1 KR 1020150036140-A/11: Inhibitors of the MIR-15 Family of Micro-RNAs
TGCTGTGCTGCT
>LG047714.1 KR 1020150036140-A/10: Inhibitors of the MIR-15 Family of Micro-RNAs
TGACGTGCTGCT
>LG047713.1 KR 1020150036140-A/9: Inhibitors of the MIR-15 Family of Micro-RNAs
TGATGTGCTGCT
>LG047712.1 KR 1020150036140-A/8: Inhibitors of the MIR-15 Family of Micro-RNAs
TTCCGTGCTGCT
>LG047711.1 KR 1020150036140-A/7: Inhibitors of the MIR-15 Family of Micro-RNAs
TTCTGTGCTGCT
>LG047710.1 KR 1020150036140-A/6: Inhibitors of the MIR-15 Family of Micro-RNAs
TTACGTGCTGCT
>LG047709.1 KR 1020150036140-A/5: Inhibitors of the MIR-15 Family of Micro-RNAs
TTATGTGCTGCT
>LG046977.1 KR 1020150013357-A/20: NUCLEIC ACIDS
CTACNNNNNNAG
>LG024479.1 KR 1020150004414-A/2741: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTCTTGTCTTT
>LG024478.1 KR 1020150004414-A/2740: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAGACAAGACA
>LG024477.1 KR 1020150004414-A/2739: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCTTGTCTTTG
>LG024476.1 KR 1020150004414-A/2738: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAAGACAAGAC
>LG024475.1 KR 1020150004414-A/2737: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTGTCTTTGC
>LG024474.1 KR 1020150004414-A/2736: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAAAGACAAGA
>LG024473.1 KR 1020150004414-A/2735: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGTCTTTGCT
>LG024472.1 KR 1020150004414-A/2734: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCAAAGACAAG
>LG024471.1 KR 1020150004414-A/2733: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTCTTTGCTG
>LG024470.1 KR 1020150004414-A/2732: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGCAAAGACAA
>LG024469.1 KR 1020150004414-A/2731: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTCTTTGCTGA
>LG024468.1 KR 1020150004414-A/2730: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAGCAAAGACA
>LG024467.1 KR 1020150004414-A/2729: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCTTTGCTGAT
>LG024466.1 KR 1020150004414-A/2728: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCAGCAAAGAC
>LG024465.1 KR 1020150004414-A/2727: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTTGCTGATG
>LG024464.1 KR 1020150004414-A/2726: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATCAGCAAAGA
>LG024463.1 KR 1020150004414-A/2725: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTTGCTGATGT
>LG024462.1 KR 1020150004414-A/2724: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACATCAGCAAAG
>LG024461.1 KR 1020150004414-A/2723: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGCTGATGTT
>LG024460.1 KR 1020150004414-A/2722: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACATCAGCAAA
>LG024459.1 KR 1020150004414-A/2721: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCTGATGTTT
>LG024458.1 KR 1020150004414-A/2720: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAACATCAGCAA
>LG024457.1 KR 1020150004414-A/2719: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCTGATGTTTC
>LG024456.1 KR 1020150004414-A/2718: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAACATCAGCA
>LG024455.1 KR 1020150004414-A/2717: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTGATGTTTCA
>LG024454.1 KR 1020150004414-A/2716: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAAACATCAGC
>LG024453.1 KR 1020150004414-A/2715: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGATGTTTCAA
>LG024452.1 KR 1020150004414-A/2714: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGAAACATCAG
>LG024451.1 KR 1020150004414-A/2713: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGATGTTTCAAT
>LG024450.1 KR 1020150004414-A/2712: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTGAAACATCA
>LG024449.1 KR 1020150004414-A/2711: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATGTTTCAATA
>LG024448.1 KR 1020150004414-A/2710: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTGAAACATC
>LG024447.1 KR 1020150004414-A/2709: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGTTTCAATAA
>LG024446.1 KR 1020150004414-A/2708: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATTGAAACAT
>LG024445.1 KR 1020150004414-A/2707: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTTTCAATAAA
>LG024444.1 KR 1020150004414-A/2706: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTATTGAAACA
>LG024443.1 KR 1020150004414-A/2705: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTTCAATAAAA
>LG024442.1 KR 1020150004414-A/2704: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTTATTGAAAC
>LG024441.1 KR 1020150004414-A/2703: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTCAATAAAAG
>LG024440.1 KR 1020150004414-A/2702: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTTTATTGAAA
>LG024439.1 KR 1020150004414-A/2701: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCAATAAAAGG
>LG024438.1 KR 1020150004414-A/2700: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTTTTATTGAA
>LG024437.1 KR 1020150004414-A/2699: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAATAAAAGGA
>LG024436.1 KR 1020150004414-A/2698: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTTTTATTGA
>LG024435.1 KR 1020150004414-A/2697: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAATAAAAGGAA
>LG024434.1 KR 1020150004414-A/2696: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCCTTTTATTG
>LG024433.1 KR 1020150004414-A/2695: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATAAAAGGAAT
>LG024432.1 KR 1020150004414-A/2694: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCCTTTTATT
>LG024431.1 KR 1020150004414-A/2693: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAAAAGGAATT
>LG024430.1 KR 1020150004414-A/2692: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTCCTTTTAT
>LG024429.1 KR 1020150004414-A/2691: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAAAGGAATTC
>LG024428.1 KR 1020150004414-A/2690: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATTCCTTTTA
>LG024427.1 KR 1020150004414-A/2689: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAAGGAATTCC
>LG024426.1 KR 1020150004414-A/2688: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAATTCCTTTT
>LG024425.1 KR 1020150004414-A/2687: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAGGAATTCCA
>LG024424.1 KR 1020150004414-A/2686: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGAATTCCTTT
>LG024423.1 KR 1020150004414-A/2685: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGGAATTCCAT
>LG024422.1 KR 1020150004414-A/2684: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGGAATTCCTT
>LG024421.1 KR 1020150004414-A/2683: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGAATTCCATA
>LG024420.1 KR 1020150004414-A/2682: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATGGAATTCCT
>LG024419.1 KR 1020150004414-A/2681: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAATTCCATAA
>LG024418.1 KR 1020150004414-A/2680: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATGGAATTCC
>LG024417.1 KR 1020150004414-A/2679: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATTCCATAAC
>LG024416.1 KR 1020150004414-A/2678: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTATGGAATTC
>LG024415.1 KR 1020150004414-A/2677: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTCCATAACT
>LG024414.1 KR 1020150004414-A/2676: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTTATGGAATT
>LG024413.1 KR 1020150004414-A/2675: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCCATAACTT
>LG024412.1 KR 1020150004414-A/2674: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGTTATGGAAT
>LG024411.1 KR 1020150004414-A/2673: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCCATAACTTC
>LG024410.1 KR 1020150004414-A/2672: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAGTTATGGAA
>LG024409.1 KR 1020150004414-A/2671: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCATAACTTCT
>LG024408.1 KR 1020150004414-A/2670: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAAGTTATGGA
>LG024407.1 KR 1020150004414-A/2669: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCATAACTTCTT
>LG024406.1 KR 1020150004414-A/2668: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGAAGTTATGG
>LG024405.1 KR 1020150004414-A/2667: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATAACTTCTTG
>LG024404.1 KR 1020150004414-A/2666: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGAAGTTATG
>LG024403.1 KR 1020150004414-A/2665: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAACTTCTTGC
>LG024402.1 KR 1020150004414-A/2664: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAAGAAGTTAT
>LG024401.1 KR 1020150004414-A/2663: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAACTTCTTGCT
>LG024400.1 KR 1020150004414-A/2662: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCAAGAAGTTA
>LG024399.1 KR 1020150004414-A/2661: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACTTCTTGCTA
>LG024398.1 KR 1020150004414-A/2660: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGCAAGAAGTT
>LG024397.1 KR 1020150004414-A/2659: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTTCTTGCTAA
>LG024396.1 KR 1020150004414-A/2658: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAGCAAGAAGT
>LG024395.1 KR 1020150004414-A/2657: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTCTTGCTAAG
>LG024394.1 KR 1020150004414-A/2656: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTAGCAAGAAG
>LG024393.1 KR 1020150004414-A/2655: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTTGCTAAGT
>LG024392.1 KR 1020150004414-A/2654: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTTAGCAAGAA
>LG024391.1 KR 1020150004414-A/2653: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTGCTAAGTC
>LG024390.1 KR 1020150004414-A/2652: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACTTAGCAAGA
>LG024389.1 KR 1020150004414-A/2651: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGCTAAGTCC
>LG024388.1 KR 1020150004414-A/2650: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGACTTAGCAAG
>LG024387.1 KR 1020150004414-A/2649: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCTAAGTCCT
>LG024386.1 KR 1020150004414-A/2648: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGACTTAGCAA
>LG024385.1 KR 1020150004414-A/2647: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCTAAGTCCTG
>LG024384.1 KR 1020150004414-A/2646: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGGACTTAGCA
>LG024383.1 KR 1020150004414-A/2645: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTAAGTCCTGA
>LG024382.1 KR 1020150004414-A/2644: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAGGACTTAGC
>LG024381.1 KR 1020150004414-A/2643: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAAGTCCTGAG
>LG024380.1 KR 1020150004414-A/2642: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCAGGACTTAG
>LG024379.1 KR 1020150004414-A/2641: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAGTCCTGAGC
>LG024378.1 KR 1020150004414-A/2640: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTCAGGACTTA
>LG024377.1 KR 1020150004414-A/2639: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGTCCTGAGCC
>LG024376.1 KR 1020150004414-A/2638: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCTCAGGACTT
>LG024375.1 KR 1020150004414-A/2637: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTCCTGAGCCT
>LG024374.1 KR 1020150004414-A/2636: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGCTCAGGACT
>LG024373.1 KR 1020150004414-A/2635: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCCTGAGCCTG
>LG024372.1 KR 1020150004414-A/2634: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGGCTCAGGAC
>LG024371.1 KR 1020150004414-A/2633: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTGAGCCTGT
>LG024370.1 KR 1020150004414-A/2632: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGGCTCAGGA
>LG024369.1 KR 1020150004414-A/2631: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTGAGCCTGTT
>LG024368.1 KR 1020150004414-A/2630: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACAGGCTCAGG
>LG024367.1 KR 1020150004414-A/2629: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGAGCCTGTTT
>LG024366.1 KR 1020150004414-A/2628: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAACAGGCTCAG
>LG024365.1 KR 1020150004414-A/2627: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAGCCTGTTTT
>LG024364.1 KR 1020150004414-A/2626: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAACAGGCTCA
>LG024363.1 KR 1020150004414-A/2625: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGCCTGTTTTG
>LG024362.1 KR 1020150004414-A/2624: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAAACAGGCTC
>LG024361.1 KR 1020150004414-A/2623: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCCTGTTTTGT
>LG024360.1 KR 1020150004414-A/2622: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAAAACAGGCT
>LG024359.1 KR 1020150004414-A/2621: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCTGTTTTGTG
>LG024358.1 KR 1020150004414-A/2620: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACAAAACAGGC
>LG024357.1 KR 1020150004414-A/2619: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTGTTTTGTGT
>LG024356.1 KR 1020150004414-A/2618: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACACAAAACAGG
>LG024355.1 KR 1020150004414-A/2617: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTTTTGTGTC
>LG024354.1 KR 1020150004414-A/2616: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACACAAAACAG
>LG024353.1 KR 1020150004414-A/2615: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTTTTGTGTCT
>LG024352.1 KR 1020150004414-A/2614: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGACACAAAACA
>LG024351.1 KR 1020150004414-A/2613: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTTTGTGTCTA
>LG024350.1 KR 1020150004414-A/2612: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGACACAAAAC
>LG024349.1 KR 1020150004414-A/2611: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTTGTGTCTAC
>LG024348.1 KR 1020150004414-A/2610: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAGACACAAAA
>LG024347.1 KR 1020150004414-A/2609: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGTGTCTACT
>LG024346.1 KR 1020150004414-A/2608: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTAGACACAAA
>LG024345.1 KR 1020150004414-A/2607: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTGTCTACTG
>LG024344.1 KR 1020150004414-A/2606: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGTAGACACAA
>LG024343.1 KR 1020150004414-A/2605: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTGTCTACTGT
>LG024342.1 KR 1020150004414-A/2604: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGTAGACACA
>LG024341.1 KR 1020150004414-A/2603: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGTCTACTGTT
>LG024340.1 KR 1020150004414-A/2602: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACAGTAGACAC
>LG024339.1 KR 1020150004414-A/2601: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTCTACTGTTC
>LG024338.1 KR 1020150004414-A/2600: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAACAGTAGACA
>LG024337.1 KR 1020150004414-A/2599: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCTACTGTTCT
>LG024336.1 KR 1020150004414-A/2598: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAACAGTAGAC
>LG024335.1 KR 1020150004414-A/2597: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTACTGTTCTA
>LG024334.1 KR 1020150004414-A/2596: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGAACAGTAGA
>LG024333.1 KR 1020150004414-A/2595: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTACTGTTCTAG
>LG024332.1 KR 1020150004414-A/2594: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAGAACAGTAG
>LG024331.1 KR 1020150004414-A/2593: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTGTTCTAGA
>LG024330.1 KR 1020150004414-A/2592: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTAGAACAGTA
>LG024329.1 KR 1020150004414-A/2591: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTGTTCTAGAA
>LG024328.1 KR 1020150004414-A/2590: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTAGAACAGT
>LG024327.1 KR 1020150004414-A/2589: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTTCTAGAAG
>LG024326.1 KR 1020150004414-A/2588: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTCTAGAACAG
>LG024325.1 KR 1020150004414-A/2587: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTTCTAGAAGG
>LG024324.1 KR 1020150004414-A/2586: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTTCTAGAACA
>LG024323.1 KR 1020150004414-A/2585: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTCTAGAAGGC
>LG024322.1 KR 1020150004414-A/2584: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCTTCTAGAAC
>LG024321.1 KR 1020150004414-A/2583: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTAGAAGGCA
>LG024320.1 KR 1020150004414-A/2582: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCCTTCTAGAA
>LG024319.1 KR 1020150004414-A/2581: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTAGAAGGCAA
>LG024318.1 KR 1020150004414-A/2580: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCCTTCTAGA
>LG024317.1 KR 1020150004414-A/2579: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAGAAGGCAAA
>LG024316.1 KR 1020150004414-A/2578: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGCCTTCTAG
>LG024315.1 KR 1020150004414-A/2577: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGAAGGCAAAT
>LG024314.1 KR 1020150004414-A/2576: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTGCCTTCTA
>LG024313.1 KR 1020150004414-A/2575: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAAGGCAAATC
>LG024312.1 KR 1020150004414-A/2574: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATTTGCCTTCT
>LG024311.1 KR 1020150004414-A/2573: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAGGCAAATCA
>LG024310.1 KR 1020150004414-A/2572: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGATTTGCCTTC
>LG024309.1 KR 1020150004414-A/2571: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGGCAAATCAC
>LG024308.1 KR 1020150004414-A/2570: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGATTTGCCTT
>LG024307.1 KR 1020150004414-A/2569: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGCAAATCACA
>LG024306.1 KR 1020150004414-A/2568: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTGATTTGCCT
>LG024305.1 KR 1020150004414-A/2567: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCAAATCACAT
>LG024304.1 KR 1020150004414-A/2566: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGTGATTTGCC
>LG024303.1 KR 1020150004414-A/2565: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAAATCACATT
>LG024302.1 KR 1020150004414-A/2564: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATGTGATTTGC
>LG024301.1 KR 1020150004414-A/2563: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAATCACATTT
>LG024300.1 KR 1020150004414-A/2562: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATGTGATTTG
>LG024299.1 KR 1020150004414-A/2561: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATCACATTTA
>LG024298.1 KR 1020150004414-A/2560: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAATGTGATTT
>LG024297.1 KR 1020150004414-A/2559: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATCACATTTAT
>LG024296.1 KR 1020150004414-A/2558: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAAATGTGATT
>LG024295.1 KR 1020150004414-A/2557: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCACATTTATT
>LG024294.1 KR 1020150004414-A/2556: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATAAATGTGAT
>LG024293.1 KR 1020150004414-A/2555: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCACATTTATTT
>LG024292.1 KR 1020150004414-A/2554: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATAAATGTGA
>LG024291.1 KR 1020150004414-A/2553: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACATTTATTTC
>LG024290.1 KR 1020150004414-A/2552: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAATAAATGTG
>LG024289.1 KR 1020150004414-A/2551: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACATTTATTTCC
>LG024288.1 KR 1020150004414-A/2550: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAAATAAATGT
>LG024287.1 KR 1020150004414-A/2549: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATTTATTTCCT
>LG024286.1 KR 1020150004414-A/2548: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGAAATAAATG
>LG024285.1 KR 1020150004414-A/2547: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTATTTCCTA
>LG024284.1 KR 1020150004414-A/2546: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGGAAATAAAT
>LG024283.1 KR 1020150004414-A/2545: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTATTTCCTAC
>LG024282.1 KR 1020150004414-A/2544: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAGGAAATAAA
>LG024281.1 KR 1020150004414-A/2543: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATTTCCTACT
>LG024280.1 KR 1020150004414-A/2542: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTAGGAAATAA
>LG024279.1 KR 1020150004414-A/2541: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTTCCTACTA
>LG024278.1 KR 1020150004414-A/2540: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGTAGGAAATA
>LG024277.1 KR 1020150004414-A/2539: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTCCTACTAG
>LG024276.1 KR 1020150004414-A/2538: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAGTAGGAAAT
>LG024275.1 KR 1020150004414-A/2537: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTCCTACTAGG
>LG024274.1 KR 1020150004414-A/2536: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTAGTAGGAAA
>LG024273.1 KR 1020150004414-A/2535: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCCTACTAGGA
>LG024272.1 KR 1020150004414-A/2534: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTAGTAGGAA
>LG024271.1 KR 1020150004414-A/2533: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTACTAGGAC
>LG024270.1 KR 1020150004414-A/2532: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCCTAGTAGGA
>LG024269.1 KR 1020150004414-A/2531: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTACTAGGACC
>LG024268.1 KR 1020150004414-A/2530: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTCCTAGTAGG
>LG024267.1 KR 1020150004414-A/2529: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTACTAGGACCA
>LG024266.1 KR 1020150004414-A/2528: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGTCCTAGTAG
>LG024265.1 KR 1020150004414-A/2527: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTAGGACCAT
>LG024264.1 KR 1020150004414-A/2526: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGGTCCTAGTA
>LG024263.1 KR 1020150004414-A/2525: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTAGGACCATA
>LG024262.1 KR 1020150004414-A/2524: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATGGTCCTAGT
>LG024261.1 KR 1020150004414-A/2523: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAGGACCATAG
>LG024260.1 KR 1020150004414-A/2522: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTATGGTCCTAG
>LG024259.1 KR 1020150004414-A/2521: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGGACCATAGG
>LG024258.1 KR 1020150004414-A/2520: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTATGGTCCTA
>LG024257.1 KR 1020150004414-A/2519: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGACCATAGGT
>LG024256.1 KR 1020150004414-A/2518: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCTATGGTCCT
>LG024255.1 KR 1020150004414-A/2517: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGACCATAGGTA
>LG024254.1 KR 1020150004414-A/2516: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACCTATGGTCC
>LG024253.1 KR 1020150004414-A/2515: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACCATAGGTAC
>LG024252.1 KR 1020150004414-A/2514: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTACCTATGGTC
>LG024251.1 KR 1020150004414-A/2513: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCATAGGTACA
>LG024250.1 KR 1020150004414-A/2512: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTACCTATGGT
>LG024249.1 KR 1020150004414-A/2511: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCATAGGTACAT
>LG024248.1 KR 1020150004414-A/2510: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGTACCTATGG
>LG024247.1 KR 1020150004414-A/2509: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATAGGTACATC
>LG024246.1 KR 1020150004414-A/2508: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATGTACCTATG
>LG024245.1 KR 1020150004414-A/2507: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAGGTACATCT
>LG024244.1 KR 1020150004414-A/2506: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGATGTACCTAT
>LG024243.1 KR 1020150004414-A/2505: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGGTACATCTT
>LG024242.1 KR 1020150004414-A/2504: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGATGTACCTA
>LG024241.1 KR 1020150004414-A/2503: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGTACATCTTC
>LG024240.1 KR 1020150004414-A/2502: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAGATGTACCT
>LG024239.1 KR 1020150004414-A/2501: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTACATCTTCA
>LG024238.1 KR 1020150004414-A/2500: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAAGATGTACC
>LG024237.1 KR 1020150004414-A/2499: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTACATCTTCAG
>LG024236.1 KR 1020150004414-A/2498: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGAAGATGTAC
>LG024235.1 KR 1020150004414-A/2497: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACATCTTCAGA
>LG024234.1 KR 1020150004414-A/2496: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTGAAGATGTA
>LG024233.1 KR 1020150004414-A/2495: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACATCTTCAGAG
>LG024232.1 KR 1020150004414-A/2494: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTGAAGATGT
>LG024231.1 KR 1020150004414-A/2493: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATCTTCAGAGT
>LG024230.1 KR 1020150004414-A/2492: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTCTGAAGATG
>LG024229.1 KR 1020150004414-A/2491: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCTTCAGAGTC
>LG024228.1 KR 1020150004414-A/2490: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACTCTGAAGAT
>LG024227.1 KR 1020150004414-A/2489: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTCAGAGTCC
>LG024226.1 KR 1020150004414-A/2488: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGACTCTGAAGA
>LG024225.1 KR 1020150004414-A/2487: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTCAGAGTCCT
>LG024224.1 KR 1020150004414-A/2486: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGACTCTGAAG
>LG024223.1 KR 1020150004414-A/2485: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCAGAGTCCTT
>LG024222.1 KR 1020150004414-A/2484: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGGACTCTGAA
>LG024221.1 KR 1020150004414-A/2483: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAGAGTCCTTA
>LG024220.1 KR 1020150004414-A/2482: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAGGACTCTGA
>LG024219.1 KR 1020150004414-A/2481: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGAGTCCTTAA
>LG024218.1 KR 1020150004414-A/2480: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAAGGACTCTG
>LG024217.1 KR 1020150004414-A/2479: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGTCCTTAAC
>LG024216.1 KR 1020150004414-A/2478: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTAAGGACTCT
>LG024215.1 KR 1020150004414-A/2477: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGTCCTTAACT
>LG024214.1 KR 1020150004414-A/2476: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTTAAGGACTC
>LG024213.1 KR 1020150004414-A/2475: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTCCTTAACTC
>LG024212.1 KR 1020150004414-A/2474: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGTTAAGGACT
>LG024211.1 KR 1020150004414-A/2473: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCCTTAACTCT
>LG024210.1 KR 1020150004414-A/2472: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGTTAAGGAC
>LG024209.1 KR 1020150004414-A/2471: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTTAACTCTT
>LG024208.1 KR 1020150004414-A/2470: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGAGTTAAGGA
>LG024207.1 KR 1020150004414-A/2469: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTTAACTCTTT
>LG024206.1 KR 1020150004414-A/2468: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAGAGTTAAGG
>LG024205.1 KR 1020150004414-A/2467: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTAACTCTTTT
>LG024204.1 KR 1020150004414-A/2466: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAAGAGTTAAG
>LG024203.1 KR 1020150004414-A/2465: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAACTCTTTTA
>LG024202.1 KR 1020150004414-A/2464: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAAAGAGTTAA
>LG024201.1 KR 1020150004414-A/2463: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAACTCTTTTAA
>LG024200.1 KR 1020150004414-A/2462: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAAAAGAGTTA
>LG024199.1 KR 1020150004414-A/2461: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACTCTTTTAAT
>LG024198.1 KR 1020150004414-A/2460: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTAAAAGAGTT
>LG024197.1 KR 1020150004414-A/2459: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTCTTTTAATT
>LG024196.1 KR 1020150004414-A/2458: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTAAAAGAGT
>LG024195.1 KR 1020150004414-A/2457: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTTTTAATTT
>LG024194.1 KR 1020150004414-A/2456: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATTAAAAGAG
>LG024193.1 KR 1020150004414-A/2455: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTTTAATTTG
>LG024192.1 KR 1020150004414-A/2454: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAATTAAAAGA
>LG024191.1 KR 1020150004414-A/2453: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTTTAATTTGT
>LG024190.1 KR 1020150004414-A/2452: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAAATTAAAAG
>LG024189.1 KR 1020150004414-A/2451: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTTAATTTGTT
>LG024188.1 KR 1020150004414-A/2450: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACAAATTAAAA
>LG024187.1 KR 1020150004414-A/2449: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTAATTTGTTC
>LG024186.1 KR 1020150004414-A/2448: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAACAAATTAAA
>LG024185.1 KR 1020150004414-A/2447: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAATTTGTTCT
>LG024184.1 KR 1020150004414-A/2446: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAACAAATTAA
>LG024183.1 KR 1020150004414-A/2445: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAATTTGTTCTC
>LG024182.1 KR 1020150004414-A/2444: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGAACAAATTA
>LG024181.1 KR 1020150004414-A/2443: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTTGTTCTCT
>LG024180.1 KR 1020150004414-A/2442: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGAACAAATT
>LG024179.1 KR 1020150004414-A/2441: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTGTTCTCTA
>LG024178.1 KR 1020150004414-A/2440: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGAGAACAAAT
>LG024177.1 KR 1020150004414-A/2439: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGTTCTCTAT
>LG024176.1 KR 1020150004414-A/2438: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAGAGAACAAA
>LG024175.1 KR 1020150004414-A/2437: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTTCTCTATA
>LG024174.1 KR 1020150004414-A/2436: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATAGAGAACAA
>LG024173.1 KR 1020150004414-A/2435: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTTCTCTATAA
>LG024172.1 KR 1020150004414-A/2434: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATAGAGAACA
>LG024171.1 KR 1020150004414-A/2433: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTCTCTATAAT
>LG024170.1 KR 1020150004414-A/2432: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTATAGAGAAC
>LG024169.1 KR 1020150004414-A/2431: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTCTATAATG
>LG024168.1 KR 1020150004414-A/2430: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATTATAGAGAA
>LG024167.1 KR 1020150004414-A/2429: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTCTATAATGG
>LG024166.1 KR 1020150004414-A/2428: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCATTATAGAGA
>LG024165.1 KR 1020150004414-A/2427: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTATAATGGT
>LG024164.1 KR 1020150004414-A/2426: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCATTATAGAG
>LG024163.1 KR 1020150004414-A/2425: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTATAATGGTG
>LG024162.1 KR 1020150004414-A/2424: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACCATTATAGA
>LG024161.1 KR 1020150004414-A/2423: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTATAATGGTGA
>LG024160.1 KR 1020150004414-A/2422: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCACCATTATAG
>LG024159.1 KR 1020150004414-A/2421: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATAATGGTGAA
>LG024158.1 KR 1020150004414-A/2420: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCACCATTATA
>LG024157.1 KR 1020150004414-A/2419: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAATGGTGAAT
>LG024156.1 KR 1020150004414-A/2418: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCACCATTAT
>LG024155.1 KR 1020150004414-A/2417: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAATGGTGAATA
>LG024154.1 KR 1020150004414-A/2416: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTCACCATTA
>LG024153.1 KR 1020150004414-A/2415: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATGGTGAATAT
>LG024152.1 KR 1020150004414-A/2414: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATTCACCATT
>LG024151.1 KR 1020150004414-A/2413: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGGTGAATATC
>LG024150.1 KR 1020150004414-A/2412: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATATTCACCAT
>LG024149.1 KR 1020150004414-A/2411: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGTGAATATCT
>LG024148.1 KR 1020150004414-A/2410: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGATATTCACCA
>LG024147.1 KR 1020150004414-A/2409: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTGAATATCTT
>LG024146.1 KR 1020150004414-A/2408: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGATATTCACC
>LG024145.1 KR 1020150004414-A/2407: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGAATATCTTC
>LG024144.1 KR 1020150004414-A/2406: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAGATATTCAC
>LG024143.1 KR 1020150004414-A/2405: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAATATCTTCA
>LG024142.1 KR 1020150004414-A/2404: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAAGATATTCA
>LG024141.1 KR 1020150004414-A/2403: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATATCTTCAA
>LG024140.1 KR 1020150004414-A/2402: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGAAGATATTC
>LG024139.1 KR 1020150004414-A/2401: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATATCTTCAAA
>LG024138.1 KR 1020150004414-A/2400: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGAAGATATT
>LG024137.1 KR 1020150004414-A/2399: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATCTTCAAAT
>LG024136.1 KR 1020150004414-A/2398: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTGAAGATAT
>LG024135.1 KR 1020150004414-A/2397: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATCTTCAAATG
>LG024134.1 KR 1020150004414-A/2396: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATTTGAAGATA
>LG024133.1 KR 1020150004414-A/2395: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCTTCAAATGA
>LG024132.1 KR 1020150004414-A/2394: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCATTTGAAGAT
>LG024131.1 KR 1020150004414-A/2393: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTCAAATGAT
>LG024130.1 KR 1020150004414-A/2392: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCATTTGAAGA
>LG024129.1 KR 1020150004414-A/2391: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTCAAATGATT
>LG024128.1 KR 1020150004414-A/2390: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATCATTTGAAG
>LG024127.1 KR 1020150004414-A/2389: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCAAATGATTT
>LG024126.1 KR 1020150004414-A/2388: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATCATTTGAA
>LG024125.1 KR 1020150004414-A/2387: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAAATGATTTA
>LG024124.1 KR 1020150004414-A/2386: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAATCATTTGA
>LG024123.1 KR 1020150004414-A/2385: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAATGATTTAG
>LG024122.1 KR 1020150004414-A/2384: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAAATCATTTG
>LG024121.1 KR 1020150004414-A/2383: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATGATTTAGT
>LG024120.1 KR 1020150004414-A/2382: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTAAATCATTT
>LG024119.1 KR 1020150004414-A/2381: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATGATTTAGTA
>LG024118.1 KR 1020150004414-A/2380: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTAAATCATT
>LG024117.1 KR 1020150004414-A/2379: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGATTTAGTAT
>LG024116.1 KR 1020150004414-A/2378: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATACTAAATCAT
>LG024115.1 KR 1020150004414-A/2377: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGATTTAGTATT
>LG024114.1 KR 1020150004414-A/2376: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATACTAAATCA
>LG024113.1 KR 1020150004414-A/2375: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATTTAGTATTA
>LG024112.1 KR 1020150004414-A/2374: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAATACTAAATC
>LG024111.1 KR 1020150004414-A/2373: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTAGTATTAT
>LG024110.1 KR 1020150004414-A/2372: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAATACTAAAT
>LG024109.1 KR 1020150004414-A/2371: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTAGTATTATT
>LG024108.1 KR 1020150004414-A/2370: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATAATACTAAA
>LG024107.1 KR 1020150004414-A/2369: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAGTATTATTT
>LG024106.1 KR 1020150004414-A/2368: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATAATACTAA
>LG024105.1 KR 1020150004414-A/2367: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGTATTATTTA
>LG024104.1 KR 1020150004414-A/2366: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAATAATACTA
>LG024103.1 KR 1020150004414-A/2365: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTATTATTTAT
>LG024102.1 KR 1020150004414-A/2364: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAAATAATACT
>LG024101.1 KR 1020150004414-A/2363: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTATTATTTATG
>LG024100.1 KR 1020150004414-A/2362: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATAAATAATAC
>LG024099.1 KR 1020150004414-A/2361: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTATTTATGG
>LG024098.1 KR 1020150004414-A/2360: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCATAAATAATA
>LG024097.1 KR 1020150004414-A/2359: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTATTTATGGC
>LG024096.1 KR 1020150004414-A/2358: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCATAAATAAT
>LG024095.1 KR 1020150004414-A/2357: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATTTATGGCA
>LG024094.1 KR 1020150004414-A/2356: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCCATAAATAA
>LG024093.1 KR 1020150004414-A/2355: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTTATGGCAA
>LG024092.1 KR 1020150004414-A/2354: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCCATAAATA
>LG024091.1 KR 1020150004414-A/2353: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTATGGCAAA
>LG024090.1 KR 1020150004414-A/2352: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGCCATAAAT
>LG024089.1 KR 1020150004414-A/2351: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTATGGCAAAT
>LG024088.1 KR 1020150004414-A/2350: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTGCCATAAA
>LG024087.1 KR 1020150004414-A/2349: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATGGCAAATA
>LG024086.1 KR 1020150004414-A/2348: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTTGCCATAA
>LG024085.1 KR 1020150004414-A/2347: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATGGCAAATAC
>LG024084.1 KR 1020150004414-A/2346: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTATTTGCCATA
>LG024083.1 KR 1020150004414-A/2345: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGGCAAATACA
>LG024082.1 KR 1020150004414-A/2344: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTATTTGCCAT
>LG024081.1 KR 1020150004414-A/2343: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGCAAATACAC
>LG024080.1 KR 1020150004414-A/2342: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGTATTTGCCA
>LG024079.1 KR 1020150004414-A/2341: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCAAATACACA
>LG024078.1 KR 1020150004414-A/2340: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTGTATTTGCC
>LG024077.1 KR 1020150004414-A/2339: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAAATACACAA
>LG024076.1 KR 1020150004414-A/2338: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTGTATTTGC
>LG024075.1 KR 1020150004414-A/2337: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAATACACAAA
>LG024074.1 KR 1020150004414-A/2336: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGTGTATTTG
>LG024073.1 KR 1020150004414-A/2335: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATACACAAAG
>LG024072.1 KR 1020150004414-A/2334: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTTGTGTATTT
>LG024071.1 KR 1020150004414-A/2333: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATACACAAAGA
>LG024070.1 KR 1020150004414-A/2332: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTTGTGTATT
>LG024069.1 KR 1020150004414-A/2331: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATACACAAAGAA
>LG024068.1 KR 1020150004414-A/2330: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTTTGTGTAT
>LG024067.1 KR 1020150004414-A/2329: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACACAAAGAAA
>LG024066.1 KR 1020150004414-A/2328: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTCTTTGTGTA
>LG024065.1 KR 1020150004414-A/2327: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACACAAAGAAAG
>LG024064.1 KR 1020150004414-A/2326: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTTCTTTGTGT
>LG024063.1 KR 1020150004414-A/2325: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACAAAGAAAGC
>LG024062.1 KR 1020150004414-A/2324: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTTTCTTTGTG
>LG024061.1 KR 1020150004414-A/2323: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAAAGAAAGCC
>LG024060.1 KR 1020150004414-A/2322: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCTTTCTTTGT
>LG024059.1 KR 1020150004414-A/2321: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAAGAAAGCCC
>LG024058.1 KR 1020150004414-A/2320: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGGCTTTCTTTG
>LG024057.1 KR 1020150004414-A/2319: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAGAAAGCCCT
>LG024056.1 KR 1020150004414-A/2318: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGGCTTTCTTT
>LG024055.1 KR 1020150004414-A/2317: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGAAAGCCCTC
>LG024054.1 KR 1020150004414-A/2316: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGGGCTTTCTT
>LG024053.1 KR 1020150004414-A/2315: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAAAGCCCTCC
>LG024052.1 KR 1020150004414-A/2314: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAGGGCTTTCT
>LG024051.1 KR 1020150004414-A/2313: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAAGCCCTCCC
>LG024050.1 KR 1020150004414-A/2312: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGGAGGGCTTTC
>LG024049.1 KR 1020150004414-A/2311: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAGCCCTCCCC
>LG024048.1 KR 1020150004414-A/2310: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGGGAGGGCTTT
>LG024047.1 KR 1020150004414-A/2309: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGCCCTCCCCA
>LG024046.1 KR 1020150004414-A/2308: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGGGAGGGCTT
>LG024045.1 KR 1020150004414-A/2307: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCCCTCCCCAG
>LG024044.1 KR 1020150004414-A/2306: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGGGGAGGGCT
>LG024043.1 KR 1020150004414-A/2305: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCCTCCCCAGT
>LG024042.1 KR 1020150004414-A/2304: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTGGGGAGGGC
>LG024041.1 KR 1020150004414-A/2303: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCCTCCCCAGTC
>LG024040.1 KR 1020150004414-A/2302: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACTGGGGAGGG
>LG024039.1 KR 1020150004414-A/2301: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTCCCCAGTCC
>LG024038.1 KR 1020150004414-A/2300: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGACTGGGGAGG
>LG024037.1 KR 1020150004414-A/2299: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCCCCAGTCCT
>LG024036.1 KR 1020150004414-A/2298: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGACTGGGGAG
>LG024035.1 KR 1020150004414-A/2297: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCCCAGTCCTC
>LG024034.1 KR 1020150004414-A/2296: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGGACTGGGGA
>LG024033.1 KR 1020150004414-A/2295: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCCCAGTCCTCA
>LG024032.1 KR 1020150004414-A/2294: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAGGACTGGGG
>LG024031.1 KR 1020150004414-A/2293: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCCAGTCCTCAT
>LG024030.1 KR 1020150004414-A/2292: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGAGGACTGGG
>LG024029.1 KR 1020150004414-A/2291: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCAGTCCTCATG
>LG024028.1 KR 1020150004414-A/2290: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATGAGGACTGG
>LG024027.1 KR 1020150004414-A/2289: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGTCCTCATGT
>LG024026.1 KR 1020150004414-A/2288: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACATGAGGACTG
>LG024025.1 KR 1020150004414-A/2287: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTCCTCATGTA
>LG024024.1 KR 1020150004414-A/2286: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACATGAGGACT
>LG024023.1 KR 1020150004414-A/2285: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCCTCATGTAC
>LG024022.1 KR 1020150004414-A/2284: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTACATGAGGAC
>LG024021.1 KR 1020150004414-A/2283: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTCATGTACT
>LG024020.1 KR 1020150004414-A/2282: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTACATGAGGA
>LG024019.1 KR 1020150004414-A/2281: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTCATGTACTG
>LG024018.1 KR 1020150004414-A/2280: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGTACATGAGG
>LG024017.1 KR 1020150004414-A/2279: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCATGTACTGG
>LG024016.1 KR 1020150004414-A/2278: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCAGTACATGAG
>LG024015.1 KR 1020150004414-A/2277: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCATGTACTGGT
>LG024014.1 KR 1020150004414-A/2276: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCAGTACATGA
>LG024013.1 KR 1020150004414-A/2275: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATGTACTGGTC
>LG024012.1 KR 1020150004414-A/2274: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACCAGTACATG
>LG024011.1 KR 1020150004414-A/2273: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGTACTGGTCC
>LG024010.1 KR 1020150004414-A/2272: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGACCAGTACAT
>LG024009.1 KR 1020150004414-A/2271: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTACTGGTCCC
>LG024008.1 KR 1020150004414-A/2270: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGGACCAGTACA
>LG024007.1 KR 1020150004414-A/2269: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTACTGGTCCCT
>LG024006.1 KR 1020150004414-A/2268: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGGACCAGTAC
>LG024005.1 KR 1020150004414-A/2267: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTGGTCCCTC
>LG024004.1 KR 1020150004414-A/2266: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGGGACCAGTA
>LG024003.1 KR 1020150004414-A/2265: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTGGTCCCTCA
>LG024002.1 KR 1020150004414-A/2264: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAGGGACCAGT
>LG024001.1 KR 1020150004414-A/2263: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGGTCCCTCAT
>LG024000.1 KR 1020150004414-A/2262: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGAGGGACCAG
>LG023999.1 KR 1020150004414-A/2261: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGTCCCTCATT
>LG023998.1 KR 1020150004414-A/2260: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATGAGGGACCA
>LG023997.1 KR 1020150004414-A/2259: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTCCCTCATTG
>LG023996.1 KR 1020150004414-A/2258: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAATGAGGGACC
>LG023995.1 KR 1020150004414-A/2257: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCCCTCATTGC
>LG023994.1 KR 1020150004414-A/2256: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAATGAGGGAC
>LG023993.1 KR 1020150004414-A/2255: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCCTCATTGCA
>LG023992.1 KR 1020150004414-A/2254: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCAATGAGGGA
>LG023991.1 KR 1020150004414-A/2253: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCCTCATTGCAC
>LG023990.1 KR 1020150004414-A/2252: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGCAATGAGGG
>LG023989.1 KR 1020150004414-A/2251: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTCATTGCACT
>LG023988.1 KR 1020150004414-A/2250: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTGCAATGAGG
>LG023987.1 KR 1020150004414-A/2249: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCATTGCACTG
>LG023986.1 KR 1020150004414-A/2248: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGTGCAATGAG
>LG023985.1 KR 1020150004414-A/2247: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCATTGCACTGT
>LG023984.1 KR 1020150004414-A/2246: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGTGCAATGA
>LG023983.1 KR 1020150004414-A/2245: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATTGCACTGTA
>LG023982.1 KR 1020150004414-A/2244: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACAGTGCAATG
>LG023981.1 KR 1020150004414-A/2243: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTGCACTGTAC
>LG023980.1 KR 1020150004414-A/2242: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTACAGTGCAAT
>LG023979.1 KR 1020150004414-A/2241: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCACTGTACT
>LG023978.1 KR 1020150004414-A/2240: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTACAGTGCAA
>LG023977.1 KR 1020150004414-A/2239: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCACTGTACTC
>LG023976.1 KR 1020150004414-A/2238: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGTACAGTGCA
>LG023975.1 KR 1020150004414-A/2237: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCACTGTACTCC
>LG023974.1 KR 1020150004414-A/2236: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAGTACAGTGC
>LG023973.1 KR 1020150004414-A/2235: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACTGTACTCCT
>LG023972.1 KR 1020150004414-A/2234: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGAGTACAGTG
>LG023971.1 KR 1020150004414-A/2233: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTGTACTCCTC
>LG023970.1 KR 1020150004414-A/2232: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGGAGTACAGT
>LG023969.1 KR 1020150004414-A/2231: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTACTCCTCT
>LG023968.1 KR 1020150004414-A/2230: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGGAGTACAG
>LG023967.1 KR 1020150004414-A/2229: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTACTCCTCTT
>LG023966.1 KR 1020150004414-A/2228: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGAGGAGTACA
>LG023965.1 KR 1020150004414-A/2227: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTACTCCTCTTG
>LG023964.1 KR 1020150004414-A/2226: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGAGGAGTAC
>LG023963.1 KR 1020150004414-A/2225: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTCCTCTTGA
>LG023962.1 KR 1020150004414-A/2224: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAAGAGGAGTA
>LG023961.1 KR 1020150004414-A/2223: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTCCTCTTGAC
>LG023960.1 KR 1020150004414-A/2222: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCAAGAGGAGT
>LG023959.1 KR 1020150004414-A/2221: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCCTCTTGACC
>LG023958.1 KR 1020150004414-A/2220: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTCAAGAGGAG
>LG023957.1 KR 1020150004414-A/2219: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTCTTGACCT
>LG023956.1 KR 1020150004414-A/2218: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGTCAAGAGGA
>LG023955.1 KR 1020150004414-A/2217: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTCTTGACCTG
>LG023954.1 KR 1020150004414-A/2216: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGGTCAAGAGG
>LG023953.1 KR 1020150004414-A/2215: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTTGACCTGC
>LG023952.1 KR 1020150004414-A/2214: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAGGTCAAGAG
>LG023951.1 KR 1020150004414-A/2213: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTGACCTGCT
>LG023950.1 KR 1020150004414-A/2212: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCAGGTCAAGA
>LG023949.1 KR 1020150004414-A/2211: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGACCTGCTG
>LG023948.1 KR 1020150004414-A/2210: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGCAGGTCAAG
>LG023947.1 KR 1020150004414-A/2209: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGACCTGCTGT
>LG023946.1 KR 1020150004414-A/2208: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGCAGGTCAA
>LG023945.1 KR 1020150004414-A/2207: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGACCTGCTGTG
>LG023944.1 KR 1020150004414-A/2206: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACAGCAGGTCA
>LG023943.1 KR 1020150004414-A/2205: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACCTGCTGTGT
>LG023942.1 KR 1020150004414-A/2204: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACACAGCAGGTC
>LG023941.1 KR 1020150004414-A/2203: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCTGCTGTGTC
>LG023940.1 KR 1020150004414-A/2202: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACACAGCAGGT
>LG023939.1 KR 1020150004414-A/2201: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTGCTGTGTCG
>LG023938.1 KR 1020150004414-A/2200: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGACACAGCAGG
>LG023937.1 KR 1020150004414-A/2199: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGCTGTGTCGA
>LG023936.1 KR 1020150004414-A/2198: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCGACACAGCAG
>LG023935.1 KR 1020150004414-A/2197: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCTGTGTCGAG
>LG023934.1 KR 1020150004414-A/2196: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCGACACAGCA
>LG023933.1 KR 1020150004414-A/2195: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTGTGTCGAGA
>LG023932.1 KR 1020150004414-A/2194: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTCGACACAGC
>LG023931.1 KR 1020150004414-A/2193: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTGTCGAGAA
>LG023930.1 KR 1020150004414-A/2192: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTCGACACAG
>LG023929.1 KR 1020150004414-A/2191: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTGTCGAGAAT
>LG023928.1 KR 1020150004414-A/2190: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCTCGACACA
>LG023927.1 KR 1020150004414-A/2189: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGTCGAGAATA
>LG023926.1 KR 1020150004414-A/2188: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTCTCGACAC
>LG023925.1 KR 1020150004414-A/2187: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTCGAGAATAT
>LG023924.1 KR 1020150004414-A/2186: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATTCTCGACA
>LG023923.1 KR 1020150004414-A/2185: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCGAGAATATC
>LG023922.1 KR 1020150004414-A/2184: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATATTCTCGAC
>LG023921.1 KR 1020150004414-A/2183: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCGAGAATATCC
>LG023920.1 KR 1020150004414-A/2182: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGATATTCTCGA
>LG023919.1 KR 1020150004414-A/2181: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGAGAATATCCA
>LG023918.1 KR 1020150004414-A/2180: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGATATTCTCG
>LG023917.1 KR 1020150004414-A/2179: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGAATATCCAA
>LG023916.1 KR 1020150004414-A/2178: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGGATATTCTC
>LG023915.1 KR 1020150004414-A/2177: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAATATCCAAG
>LG023914.1 KR 1020150004414-A/2176: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGGATATTCT
>LG023913.1 KR 1020150004414-A/2175: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATATCCAAGA
>LG023912.1 KR 1020150004414-A/2174: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTGGATATTC
>LG023911.1 KR 1020150004414-A/2173: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATATCCAAGAG
>LG023910.1 KR 1020150004414-A/2172: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTTGGATATT
>LG023909.1 KR 1020150004414-A/2171: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATCCAAGAGA
>LG023908.1 KR 1020150004414-A/2170: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTCTTGGATAT
>LG023907.1 KR 1020150004414-A/2169: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATCCAAGAGAC
>LG023906.1 KR 1020150004414-A/2168: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCTCTTGGATA
>LG023905.1 KR 1020150004414-A/2167: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCCAAGAGACA
>LG023904.1 KR 1020150004414-A/2166: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTCTCTTGGAT
>LG023903.1 KR 1020150004414-A/2165: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCAAGAGACAG
>LG023902.1 KR 1020150004414-A/2164: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTCTCTTGGA
>LG023901.1 KR 1020150004414-A/2163: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCAAGAGACAGG
>LG023900.1 KR 1020150004414-A/2162: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTGTCTCTTGG
>LG023899.1 KR 1020150004414-A/2161: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGAGACAGGT
>LG023898.1 KR 1020150004414-A/2160: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCTGTCTCTTG
>LG023897.1 KR 1020150004414-A/2159: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGAGACAGGTT
>LG023896.1 KR 1020150004414-A/2158: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACCTGTCTCTT
>LG023895.1 KR 1020150004414-A/2157: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGACAGGTTT
>LG023894.1 KR 1020150004414-A/2156: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAACCTGTCTCT
>LG023893.1 KR 1020150004414-A/2155: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGACAGGTTTC
>LG023892.1 KR 1020150004414-A/2154: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAACCTGTCTC
>LG023891.1 KR 1020150004414-A/2153: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGACAGGTTTCT
>LG023890.1 KR 1020150004414-A/2152: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAAACCTGTCT
>LG023889.1 KR 1020150004414-A/2151: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACAGGTTTCTC
>LG023888.1 KR 1020150004414-A/2150: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGAAACCTGTC
>LG023887.1 KR 1020150004414-A/2149: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGGTTTCTCC
>LG023886.1 KR 1020150004414-A/2148: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAGAAACCTGT
>LG023885.1 KR 1020150004414-A/2147: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGGTTTCTCCA
>LG023884.1 KR 1020150004414-A/2146: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGAGAAACCTG
>LG023883.1 KR 1020150004414-A/2145: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGTTTCTCCAT
>LG023882.1 KR 1020150004414-A/2144: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGGAGAAACCT
>LG023881.1 KR 1020150004414-A/2143: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTTTCTCCATC
>LG023880.1 KR 1020150004414-A/2142: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATGGAGAAACC
>LG023879.1 KR 1020150004414-A/2141: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTTCTCCATCA
>LG023878.1 KR 1020150004414-A/2140: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGATGGAGAAAC
>LG023877.1 KR 1020150004414-A/2139: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTCTCCATCAA
>LG023876.1 KR 1020150004414-A/2138: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGATGGAGAAA
>LG023875.1 KR 1020150004414-A/2137: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTCCATCAAT
>LG023874.1 KR 1020150004414-A/2136: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTGATGGAGAA
>LG023873.1 KR 1020150004414-A/2135: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTCCATCAATT
>LG023872.1 KR 1020150004414-A/2134: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTGATGGAGA
>LG023871.1 KR 1020150004414-A/2133: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCCATCAATTA
>LG023870.1 KR 1020150004414-A/2132: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAATTGATGGAG
>LG023869.1 KR 1020150004414-A/2131: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCATCAATTAC
>LG023868.1 KR 1020150004414-A/2130: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAATTGATGGA
>LG023867.1 KR 1020150004414-A/2129: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCATCAATTACT
>LG023866.1 KR 1020150004414-A/2128: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTAATTGATGG
>LG023865.1 KR 1020150004414-A/2127: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATCAATTACTA
>LG023864.1 KR 1020150004414-A/2126: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGTAATTGATG
>LG023863.1 KR 1020150004414-A/2125: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCAATTACTAC
>LG023862.1 KR 1020150004414-A/2124: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAGTAATTGAT
>LG023861.1 KR 1020150004414-A/2123: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAATTACTACT
>LG023860.1 KR 1020150004414-A/2122: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTAGTAATTGA
>LG023859.1 KR 1020150004414-A/2121: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAATTACTACTT
>LG023858.1 KR 1020150004414-A/2120: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGTAGTAATTG
>LG023857.1 KR 1020150004414-A/2119: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTACTACTTG
>LG023856.1 KR 1020150004414-A/2118: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGTAGTAATT
>LG023855.1 KR 1020150004414-A/2117: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTACTACTTGC
>LG023854.1 KR 1020150004414-A/2116: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAAGTAGTAAT
>LG023853.1 KR 1020150004414-A/2115: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTACTACTTGCT
>LG023852.1 KR 1020150004414-A/2114: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCAAGTAGTAA
>LG023851.1 KR 1020150004414-A/2113: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTACTTGCTT
>LG023850.1 KR 1020150004414-A/2112: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGCAAGTAGTA
>LG023849.1 KR 1020150004414-A/2111: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTACTTGCTTC
>LG023848.1 KR 1020150004414-A/2110: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAGCAAGTAGT
>LG023847.1 KR 1020150004414-A/2109: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTACTTGCTTCC
>LG023846.1 KR 1020150004414-A/2108: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAAGCAAGTAG
>LG023845.1 KR 1020150004414-A/2107: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTTGCTTCCT
>LG023844.1 KR 1020150004414-A/2106: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGAAGCAAGTA
>LG023843.1 KR 1020150004414-A/2105: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTTGCTTCCTG
>LG023842.1 KR 1020150004414-A/2104: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGGAAGCAAGT
>LG023841.1 KR 1020150004414-A/2103: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGCTTCCTGT
>LG023840.1 KR 1020150004414-A/2102: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGGAAGCAAG
>LG023839.1 KR 1020150004414-A/2101: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCTTCCTGTA
>LG023838.1 KR 1020150004414-A/2100: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACAGGAAGCAA
>LG023837.1 KR 1020150004414-A/2099: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCTTCCTGTAG
>LG023836.1 KR 1020150004414-A/2098: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTACAGGAAGCA
>LG023835.1 KR 1020150004414-A/2097: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTTCCTGTAGG
>LG023834.1 KR 1020150004414-A/2096: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTACAGGAAGC
>LG023833.1 KR 1020150004414-A/2095: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTCCTGTAGGA
>LG023832.1 KR 1020150004414-A/2094: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTACAGGAAG
>LG023831.1 KR 1020150004414-A/2093: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCCTGTAGGAA
>LG023830.1 KR 1020150004414-A/2092: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCCTACAGGAA
>LG023829.1 KR 1020150004414-A/2091: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTGTAGGAAT
>LG023828.1 KR 1020150004414-A/2090: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCCTACAGGA
>LG023827.1 KR 1020150004414-A/2089: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTGTAGGAATC
>LG023826.1 KR 1020150004414-A/2088: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATTCCTACAGG
>LG023825.1 KR 1020150004414-A/2087: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTAGGAATCC
>LG023824.1 KR 1020150004414-A/2086: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGATTCCTACAG
>LG023823.1 KR 1020150004414-A/2085: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTAGGAATCCT
>LG023822.1 KR 1020150004414-A/2084: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGATTCCTACA
>LG023821.1 KR 1020150004414-A/2083: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAGGAATCCTC
>LG023820.1 KR 1020150004414-A/2082: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGGATTCCTAC
>LG023819.1 KR 1020150004414-A/2081: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGGAATCCTCT
>LG023818.1 KR 1020150004414-A/2080: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGGATTCCTA
>LG023817.1 KR 1020150004414-A/2079: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGAATCCTCTA
>LG023816.1 KR 1020150004414-A/2078: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGAGGATTCCT
>LG023815.1 KR 1020150004414-A/2077: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAATCCTCTAT
>LG023814.1 KR 1020150004414-A/2076: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAGAGGATTCC
>LG023813.1 KR 1020150004414-A/2075: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATCCTCTATT
>LG023812.1 KR 1020150004414-A/2074: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATAGAGGATTC
>LG023811.1 KR 1020150004414-A/2073: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATCCTCTATTG
>LG023810.1 KR 1020150004414-A/2072: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAATAGAGGATT
>LG023809.1 KR 1020150004414-A/2071: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCCTCTATTGT
>LG023808.1 KR 1020150004414-A/2070: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAATAGAGGAT
>LG023807.1 KR 1020150004414-A/2069: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTCTATTGTT
>LG023806.1 KR 1020150004414-A/2068: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACAATAGAGGA
>LG023805.1 KR 1020150004414-A/2067: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTCTATTGTTG
>LG023804.1 KR 1020150004414-A/2066: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAACAATAGAGG
>LG023803.1 KR 1020150004414-A/2065: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTATTGTTGG
>LG023802.1 KR 1020150004414-A/2064: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCAACAATAGAG
>LG023801.1 KR 1020150004414-A/2063: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTATTGTTGGA
>LG023800.1 KR 1020150004414-A/2062: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCAACAATAGA
>LG023799.1 KR 1020150004414-A/2061: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTATTGTTGGAT
>LG023798.1 KR 1020150004414-A/2060: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCCAACAATAG
>LG023797.1 KR 1020150004414-A/2059: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTGTTGGATC
>LG023796.1 KR 1020150004414-A/2058: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATCCAACAATA
>LG023795.1 KR 1020150004414-A/2057: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTGTTGGATCA
>LG023794.1 KR 1020150004414-A/2056: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGATCCAACAAT
>LG023793.1 KR 1020150004414-A/2055: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTTGGATCAT
>LG023792.1 KR 1020150004414-A/2054: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGATCCAACAA
>LG023791.1 KR 1020150004414-A/2053: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTTGGATCATA
>LG023790.1 KR 1020150004414-A/2052: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATGATCCAACA
>LG023789.1 KR 1020150004414-A/2051: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTGGATCATAT
>LG023788.1 KR 1020150004414-A/2050: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATGATCCAAC
>LG023787.1 KR 1020150004414-A/2049: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGGATCATATT
>LG023786.1 KR 1020150004414-A/2048: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATATGATCCAA
>LG023785.1 KR 1020150004414-A/2047: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGATCATATTC
>LG023784.1 KR 1020150004414-A/2046: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATATGATCCA
>LG023783.1 KR 1020150004414-A/2045: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGATCATATTCG
>LG023782.1 KR 1020150004414-A/2044: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGAATATGATCC
>LG023781.1 KR 1020150004414-A/2043: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATCATATTCGT
>LG023780.1 KR 1020150004414-A/2042: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACGAATATGATC
>LG023779.1 KR 1020150004414-A/2041: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCATATTCGTC
>LG023778.1 KR 1020150004414-A/2040: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACGAATATGAT
>LG023777.1 KR 1020150004414-A/2039: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCATATTCGTCC
>LG023776.1 KR 1020150004414-A/2038: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGACGAATATGA
>LG023775.1 KR 1020150004414-A/2037: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATATTCGTCCA
>LG023774.1 KR 1020150004414-A/2036: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGACGAATATG
>LG023773.1 KR 1020150004414-A/2035: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATTCGTCCAC
>LG023772.1 KR 1020150004414-A/2034: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGGACGAATAT
>LG023771.1 KR 1020150004414-A/2033: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTCGTCCACA
>LG023770.1 KR 1020150004414-A/2032: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTGGACGAATA
>LG023769.1 KR 1020150004414-A/2031: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCGTCCACAA
>LG023768.1 KR 1020150004414-A/2030: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTGGACGAAT
>LG023767.1 KR 1020150004414-A/2029: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCGTCCACAAA
>LG023766.1 KR 1020150004414-A/2028: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGTGGACGAA
>LG023765.1 KR 1020150004414-A/2027: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCGTCCACAAAA
>LG023764.1 KR 1020150004414-A/2026: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTTGTGGACGA
>LG023763.1 KR 1020150004414-A/2025: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGTCCACAAAAT
>LG023762.1 KR 1020150004414-A/2024: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTTGTGGACG
>LG023761.1 KR 1020150004414-A/2023: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCCACAAAATG
>LG023760.1 KR 1020150004414-A/2022: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATTTTGTGGAC
>LG023759.1 KR 1020150004414-A/2021: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCACAAAATGA
>LG023758.1 KR 1020150004414-A/2020: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCATTTTGTGGA
>LG023757.1 KR 1020150004414-A/2019: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCACAAAATGAT
>LG023756.1 KR 1020150004414-A/2018: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCATTTTGTGG
>LG023755.1 KR 1020150004414-A/2017: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACAAAATGATT
>LG023754.1 KR 1020150004414-A/2016: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATCATTTTGTG
>LG023753.1 KR 1020150004414-A/2015: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAAAATGATTC
>LG023752.1 KR 1020150004414-A/2014: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATCATTTTGT
>LG023751.1 KR 1020150004414-A/2013: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAAATGATTCT
>LG023750.1 KR 1020150004414-A/2012: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAATCATTTTG
>LG023749.1 KR 1020150004414-A/2011: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAATGATTCTG
>LG023748.1 KR 1020150004414-A/2010: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGAATCATTTT
>LG023747.1 KR 1020150004414-A/2009: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATGATTCTGA
>LG023746.1 KR 1020150004414-A/2008: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAGAATCATTT
>LG023745.1 KR 1020150004414-A/2007: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATGATTCTGAA
>LG023744.1 KR 1020150004414-A/2006: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCAGAATCATT
>LG023743.1 KR 1020150004414-A/2005: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGATTCTGAAT
>LG023742.1 KR 1020150004414-A/2004: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCAGAATCAT
>LG023741.1 KR 1020150004414-A/2003: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGATTCTGAATT
>LG023740.1 KR 1020150004414-A/2002: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTCAGAATCA
>LG023739.1 KR 1020150004414-A/2001: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATTCTGAATTA
>LG023738.1 KR 1020150004414-A/2000: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAATTCAGAATC
>LG023737.1 KR 1020150004414-A/1999: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCTGAATTAG
>LG023736.1 KR 1020150004414-A/1998: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAATTCAGAAT
>LG023735.1 KR 1020150004414-A/1997: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTGAATTAGC
>LG023734.1 KR 1020150004414-A/1996: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTAATTCAGAA
>LG023733.1 KR 1020150004414-A/1995: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTGAATTAGCT
>LG023732.1 KR 1020150004414-A/1994: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCTAATTCAGA
>LG023731.1 KR 1020150004414-A/1993: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGAATTAGCTG
>LG023730.1 KR 1020150004414-A/1992: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGCTAATTCAG
>LG023729.1 KR 1020150004414-A/1991: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAATTAGCTGT
>LG023728.1 KR 1020150004414-A/1990: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGCTAATTCA
>LG023727.1 KR 1020150004414-A/1989: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATTAGCTGTA
>LG023726.1 KR 1020150004414-A/1988: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACAGCTAATTC
>LG023725.1 KR 1020150004414-A/1987: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTAGCTGTAT
>LG023724.1 KR 1020150004414-A/1986: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATACAGCTAATT
>LG023723.1 KR 1020150004414-A/1985: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTAGCTGTATC
>LG023722.1 KR 1020150004414-A/1984: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATACAGCTAAT
>LG023721.1 KR 1020150004414-A/1983: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAGCTGTATCG
>LG023720.1 KR 1020150004414-A/1982: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGATACAGCTAA
>LG023719.1 KR 1020150004414-A/1981: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGCTGTATCGT
>LG023718.1 KR 1020150004414-A/1980: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACGATACAGCTA
>LG023717.1 KR 1020150004414-A/1979: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCTGTATCGTC
>LG023716.1 KR 1020150004414-A/1978: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACGATACAGCT
>LG023715.1 KR 1020150004414-A/1977: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTGTATCGTCA
>LG023714.1 KR 1020150004414-A/1976: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGACGATACAGC
>LG023713.1 KR 1020150004414-A/1975: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTATCGTCAA
>LG023712.1 KR 1020150004414-A/1974: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGACGATACAG
>LG023711.1 KR 1020150004414-A/1973: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTATCGTCAAG
>LG023710.1 KR 1020150004414-A/1972: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGACGATACA
>LG023709.1 KR 1020150004414-A/1971: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTATCGTCAAGG
>LG023708.1 KR 1020150004414-A/1970: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTTGACGATAC
>LG023707.1 KR 1020150004414-A/1969: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATCGTCAAGGC
>LG023706.1 KR 1020150004414-A/1968: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCTTGACGATA
>LG023705.1 KR 1020150004414-A/1967: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCGTCAAGGCA
>LG023704.1 KR 1020150004414-A/1966: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCCTTGACGAT
>LG023703.1 KR 1020150004414-A/1965: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCGTCAAGGCAC
>LG023702.1 KR 1020150004414-A/1964: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGCCTTGACGA
>LG023701.1 KR 1020150004414-A/1963: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGTCAAGGCACT
>LG023700.1 KR 1020150004414-A/1962: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTGCCTTGACG
>LG023699.1 KR 1020150004414-A/1961: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCAAGGCACTC
>LG023698.1 KR 1020150004414-A/1960: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGTGCCTTGAC
>LG023697.1 KR 1020150004414-A/1959: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAAGGCACTCT
>LG023696.1 KR 1020150004414-A/1958: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGTGCCTTGA
>LG023695.1 KR 1020150004414-A/1957: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGGCACTCTT
>LG023694.1 KR 1020150004414-A/1956: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGAGTGCCTTG
>LG023693.1 KR 1020150004414-A/1955: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGGCACTCTTG
>LG023692.1 KR 1020150004414-A/1954: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGAGTGCCTT
>LG023691.1 KR 1020150004414-A/1953: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGCACTCTTGC
>LG023690.1 KR 1020150004414-A/1952: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAAGAGTGCCT
>LG023689.1 KR 1020150004414-A/1951: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCACTCTTGCC
>LG023688.1 KR 1020150004414-A/1950: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCAAGAGTGCC
>LG023687.1 KR 1020150004414-A/1949: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCACTCTTGCCT
>LG023686.1 KR 1020150004414-A/1948: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGCAAGAGTGC
>LG023685.1 KR 1020150004414-A/1947: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACTCTTGCCTA
>LG023684.1 KR 1020150004414-A/1946: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGGCAAGAGTG
>LG023683.1 KR 1020150004414-A/1945: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTCTTGCCTAC
>LG023682.1 KR 1020150004414-A/1944: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAGGCAAGAGT
>LG023681.1 KR 1020150004414-A/1943: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTTGCCTACG
>LG023680.1 KR 1020150004414-A/1942: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGTAGGCAAGAG
>LG023679.1 KR 1020150004414-A/1941: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTGCCTACGC
>LG023678.1 KR 1020150004414-A/1940: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCGTAGGCAAGA
>LG023677.1 KR 1020150004414-A/1939: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGCCTACGCC
>LG023676.1 KR 1020150004414-A/1938: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCGTAGGCAAG
>LG023675.1 KR 1020150004414-A/1937: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCCTACGCCA
>LG023674.1 KR 1020150004414-A/1936: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGCGTAGGCAA
>LG023673.1 KR 1020150004414-A/1935: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCCTACGCCAC
>LG023672.1 KR 1020150004414-A/1934: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGGCGTAGGCA
>LG023671.1 KR 1020150004414-A/1933: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCTACGCCACC
>LG023670.1 KR 1020150004414-A/1932: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTGGCGTAGGC
>LG023669.1 KR 1020150004414-A/1931: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTACGCCACCA
>LG023668.1 KR 1020150004414-A/1930: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGTGGCGTAGG
>LG023667.1 KR 1020150004414-A/1929: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTACGCCACCAG
>LG023666.1 KR 1020150004414-A/1928: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGGTGGCGTAG
>LG023665.1 KR 1020150004414-A/1927: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACGCCACCAGC
>LG023664.1 KR 1020150004414-A/1926: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTGGTGGCGTA
>LG023663.1 KR 1020150004414-A/1925: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACGCCACCAGCT
>LG023662.1 KR 1020150004414-A/1924: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCTGGTGGCGT
>LG023661.1 KR 1020150004414-A/1923: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGCCACCAGCTC
>LG023660.1 KR 1020150004414-A/1922: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGCTGGTGGCG
>LG023659.1 KR 1020150004414-A/1921: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCACCAGCTCC
>LG023658.1 KR 1020150004414-A/1920: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAGCTGGTGGC
>LG023657.1 KR 1020150004414-A/1919: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCACCAGCTCCA
>LG023656.1 KR 1020150004414-A/1918: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGAGCTGGTGG
>LG023655.1 KR 1020150004414-A/1917: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACCAGCTCCAA
>LG023654.1 KR 1020150004414-A/1916: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGGAGCTGGTG
>LG023653.1 KR 1020150004414-A/1915: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCAGCTCCAAC
>LG023652.1 KR 1020150004414-A/1914: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTGGAGCTGGT
>LG023651.1 KR 1020150004414-A/1913: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCAGCTCCAACT
>LG023650.1 KR 1020150004414-A/1912: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTTGGAGCTGG
>LG023649.1 KR 1020150004414-A/1911: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGCTCCAACTA
>LG023648.1 KR 1020150004414-A/1910: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGTTGGAGCTG
>LG023647.1 KR 1020150004414-A/1909: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCTCCAACTAC
>LG023646.1 KR 1020150004414-A/1908: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAGTTGGAGCT
>LG023645.1 KR 1020150004414-A/1907: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTCCAACTACC
>LG023644.1 KR 1020150004414-A/1906: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTAGTTGGAGC
>LG023643.1 KR 1020150004414-A/1905: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCCAACTACCA
>LG023642.1 KR 1020150004414-A/1904: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGTAGTTGGAG
>LG023641.1 KR 1020150004414-A/1903: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCAACTACCAC
>LG023640.1 KR 1020150004414-A/1902: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGGTAGTTGGA
>LG023639.1 KR 1020150004414-A/1901: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCAACTACCACA
>LG023638.1 KR 1020150004414-A/1900: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTGGTAGTTGG
>LG023637.1 KR 1020150004414-A/1899: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAACTACCACAA
>LG023636.1 KR 1020150004414-A/1898: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTGGTAGTTG
>LG023635.1 KR 1020150004414-A/1897: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACTACCACAAG
>LG023634.1 KR 1020150004414-A/1896: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGTGGTAGTT
>LG023633.1 KR 1020150004414-A/1895: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTACCACAAGT
>LG023632.1 KR 1020150004414-A/1894: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTTGTGGTAGT
>LG023631.1 KR 1020150004414-A/1893: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTACCACAAGTT
>LG023630.1 KR 1020150004414-A/1892: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACTTGTGGTAG
>LG023629.1 KR 1020150004414-A/1891: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACCACAAGTTT
>LG023628.1 KR 1020150004414-A/1890: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAACTTGTGGTA
>LG023627.1 KR 1020150004414-A/1889: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCACAAGTTTA
>LG023626.1 KR 1020150004414-A/1888: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAACTTGTGGT
>LG023625.1 KR 1020150004414-A/1887: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCACAAGTTTAT
>LG023624.1 KR 1020150004414-A/1886: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAAACTTGTGG
>LG023623.1 KR 1020150004414-A/1885: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACAAGTTTATA
>LG023622.1 KR 1020150004414-A/1884: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATAAACTTGTG
>LG023621.1 KR 1020150004414-A/1883: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAAGTTTATAT
>LG023620.1 KR 1020150004414-A/1882: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATAAACTTGT
>LG023619.1 KR 1020150004414-A/1881: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGTTTATATT
>LG023618.1 KR 1020150004414-A/1880: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATATAAACTTG
>LG023617.1 KR 1020150004414-A/1879: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGTTTATATTC
>LG023616.1 KR 1020150004414-A/1878: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATATAAACTT
>LG023615.1 KR 1020150004414-A/1877: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTTTATATTCA
>LG023614.1 KR 1020150004414-A/1876: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAATATAAACT
>LG023613.1 KR 1020150004414-A/1875: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTTATATTCAG
>LG023612.1 KR 1020150004414-A/1874: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGAATATAAAC
>LG023611.1 KR 1020150004414-A/1873: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTATATTCAGT
>LG023610.1 KR 1020150004414-A/1872: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTGAATATAAA
>LG023609.1 KR 1020150004414-A/1871: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATATTCAGTC
>LG023608.1 KR 1020150004414-A/1870: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACTGAATATAA
>LG023607.1 KR 1020150004414-A/1869: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATATTCAGTCA
>LG023606.1 KR 1020150004414-A/1868: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGACTGAATATA
>LG001626.1 KR 1020140138995-A/37: Boronic acid conjugates of oligonucleotide analogues
CAGGCAGGCAGG
>LG001620.1 KR 1020140138995-A/31: Boronic acid conjugates of oligonucleotide analogues
GCAGCAGCAGCA
>LG001616.1 KR 1020140138995-A/27: Boronic acid conjugates of oligonucleotide analogues
AGCAGCAGCAGC
>LG001612.1 KR 1020140138995-A/23: Boronic acid conjugates of oligonucleotide analogues
CAGCAGCAGCAG
>LG001477.1 KR 1020140146105-A/70: METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS
AGGCGGAGACGC
>LG001476.1 KR 1020140146105-A/69: METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS
AGGAGACGGCGC
>LG001450.1 KR 1020140146105-A/40: METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS
TTCTTTTTCTTC
>LG001449.1 KR 1020140146105-A/39: METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS
TTCTTCTTTTTC
>LG001448.1 KR 1020140146105-A/38: METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS
TTCTTCTTCTTT
>LG001434.1 KR 1020140146105-A/24: METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS
GAAGAGGAAGAA
>LG001433.1 KR 1020140146105-A/23: METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS
GAAGAAGAGGAA
>LG001432.1 KR 1020140146105-A/22: METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS
GAAGAAGAAGAG
>LG064025.1 KR 1020150056647-A/2: OLGIONUCLEOTIDE AND ARTIFICIAL NUCLEOSIDE HAVING GUANIDINE BRIDGE
AGCAAAAAACGC
>LG064024.1 KR 1020150056647-A/1: OLGIONUCLEOTIDE AND ARTIFICIAL NUCLEOSIDE HAVING GUANIDINE BRIDGE
GCGTTTTTTGCT
>LG042696.1 KR 1020150033620-A/55: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>LG042694.1 KR 1020150033620-A/53: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>LG042693.1 KR 1020150033620-A/52: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>LG042682.1 KR 1020150033620-A/41: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>LG042679.1 KR 1020150033620-A/38: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>LG042676.1 KR 1020150033620-A/35: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>LG042673.1 KR 1020150033620-A/32: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>LG042650.1 KR 1020150033620-A/9: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
AACGTTCGAGAT
>LG042643.1 KR 1020150033620-A/2: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>LG042461.1 KR 1020150016364-A/130: OPTIMIZED NON-CANONICAL ZINC FINGER PROTEINS
ATGGCCCCACAG
>LG042454.1 KR 1020150016364-A/8: OPTIMIZED NON-CANONICAL ZINC FINGER PROTEINS
CTGTGGGGCCAT
>LG042078.1 KR 1020150016588-A/679: METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
GTTTTAGAGCTA
>LG020730.1 KR 1020150004882-A/32: ANTI-GCC ANTIBODY MOLECULES AND USE OF SAME TO TEST FOR SUSCEPTIBILITY TO GCC-TARGETED THERAPY
AGTCCTAACTTG
>LG020534.1 KR 1020150003846-A/51: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
ATCTAATAAGCT
>LG020533.1 KR 1020150003846-A/50: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
AATCTAATAAGC
>LG020527.1 KR 1020150003846-A/44: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
TCTAATAAGCTA
>LG020520.1 KR 1020150003846-A/37: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
GTCTGATAAGCT
>LG020519.1 KR 1020150003846-A/36: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
AGTCTGATAAGC
>LG020505.1 KR 1020150003846-A/22: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
TCTGATAAGCTA
>LG040647.1 KR 1020150013804-A/42: Enzymatic synthesis of L-nucleic acids
ACGACGGCCAGT
>LG040627.1 KR 1020150013804-A/13: Enzymatic synthesis of L-nucleic acids
ACGACGGCCAGT
>LG018125.1 KR 1020150016941-A/26: MULTIPLEX IMMUNO SCREENING ASSAY
GGTGGCGGATCT
>DI495249.1 KR 1020150055676-A/27: Method for preparing the plant producing bispecific antibody
AAAGATGAACTT
>DI495248.1 KR 1020150055676-A/26: Method for preparing the plant producing bispecific antibody
AAGGACGAACTT
>DI493595.1 KR 1020150045592-A/1: Development of radioisotope labeled nucleotide structure and its labeling method to various aptamers
TGTGGTGGTCGG
>DI493035.1 KR 1020150041982-A/1: Method for Detecting Theophylline Using Silver Nanoclusters Formation
TGGTGGGGCAGC
>LG056034.1 KR 1020150036814-A/290: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TTTCACCTGGGT
>LG056033.1 KR 1020150036814-A/289: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TTTTCACCTGGG
>LG056032.1 KR 1020150036814-A/288: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CTTTTCACCTGG
>LG056029.1 KR 1020150036814-A/285: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
ACTTTTCACCTG
>LG056026.1 KR 1020150036814-A/282: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TTCACCTGGGTC
>LG056018.1 KR 1020150036814-A/274: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TCCTAGAAAGAS
>LG056017.1 KR 1020150036814-A/273: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
GTCCTAGAAAGA
>LG056016.1 KR 1020150036814-A/272: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
AGTCCTAGAAAG
>LG056013.1 KR 1020150036814-A/269: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CAGTCCTAGAAS
>LG056010.1 KR 1020150036814-A/266: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CCTAGAAAGAAS
>LG056002.1 KR 1020150036814-A/257: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CACAATCAGTCC
>LG056000.1 KR 1020150036814-A/255: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CCACAATCAGTC
>LG055997.1 KR 1020150036814-A/252: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
AATCAGTCCTAG
>LG055991.1 KR 1020150036814-A/246: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
ACAATCAGTCCT
>LG055917.1 KR 1020150036814-A/172: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TTTCACCTGGGT
>LG055916.1 KR 1020150036814-A/170: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CTTTTCACCTGG
>LG055913.1 KR 1020150036814-A/167: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
ACTTTTCACCTG
>LG055910.1 KR 1020150036814-A/164: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TTCACCTGGGTC
>LG055902.1 KR 1020150036814-A/156: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TCCTAGAAAGAS
>LG055901.1 KR 1020150036814-A/155: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
GTCCTAGAAAGA
>LG055900.1 KR 1020150036814-A/154: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
AGTCCTAGAAAG
>LG055897.1 KR 1020150036814-A/151: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CAGTCCTAGAAS
>LG055894.1 KR 1020150036814-A/148: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CCTAGAAAGAAS
>LG055886.1 KR 1020150036814-A/139: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
ACAATCAGTCCT
>LG055885.1 KR 1020150036814-A/138: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CACAATCAGTCC
>LG055882.1 KR 1020150036814-A/135: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CCACAATCAGTC
>LG055879.1 KR 1020150036814-A/132: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
AATCAGTCCTAG
>LG055666.1 KR 1020150041657-A/3: CYCLOPENTANE-PEPTIDE NUCLEIC ACIDS FOR QUALITATIVE AND QUANTITATIVE DETECTION OF NUCLEIC ACIDS
TAACAATAATCC
>LG055567.1 KR 1020150028856-A/14: NUCLEIC ACID NANOPARTICLES AND USES THEREFOR
CATGACGTTCCT
>DI487489.1 KR 1020100056492-A/325: HUMAN C-FMS ANTIGEN BINDING PROTEINS
GGGAAAGGGAAA
>HZ375683.1 JP 2015165804-A/118: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
AAACTGCAAAAG
>HZ375682.1 JP 2015165804-A/117: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
GATGAGGATGAC
>HZ375676.1 JP 2015165804-A/111: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
AATGCTCAGGTA
>HZ375675.1 JP 2015165804-A/110: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
GGAAGGTCTCCG
>HZ375660.1 JP 2015165804-A/95: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
AACTCGGATAAT
>HZ375659.1 JP 2015165804-A/94: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
AACTCGGATAAT
>HZ375653.1 JP 2015165804-A/88: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
GAAGTCTGCCGT
>HZ375639.1 JP 2015165804-A/74: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
AAAGCGGCTCCG
>HZ375638.1 JP 2015165804-A/73: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
ACTCTGTGGAAG
>HZ375620.1 JP 2015165804-A/55: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
ACTCTGTGGAAG
>HZ375607.1 JP 2015165804-A/42: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
AACTCGGATAAT
>HZ375600.1 JP 2015165804-A/35: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
AAGGTGAACGTG
>HZ375599.1 JP 2015165804-A/34: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
GGGCAGTAACGG
>HZ375591.1 JP 2015165804-A/26: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
TACAAGAACTCG
>HZ375589.1 JP 2015165804-A/24: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
AACTCGGATAAT
>HZ375582.1 JP 2015165804-A/17: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
GCGGCGCCGGCG
>HZ375581.1 JP 2015165804-A/16: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
CATGGGGTTCCT
>HZ373361.1 JP 2015167478-A/7: MANDELONITRILE OXIDASE
GTACAAGAGCTG
>HZ390709.1 JP 2015523087-A/1: SINGLE CELL ANALYSIS USING SEQUENCE TAGS
GCANNNNNNTGC
>HZ390583.1 JP 2015522292-A/52: COOPERATIVE PRIMERS, PROBES, AND APPLICATIONS THEREOF
GAGGCGATCACA
>HZ390557.1 JP 2015522292-A/26: COOPERATIVE PRIMERS, PROBES, AND APPLICATIONS THEREOF
CTGGAACGGTGA
>HZ390510.1 JP 2015524264-A/3: NUCLEIC ACIDS FOR DOWN-REGULATION OF GENE EXPRESSION
TCAGCAGTGCCT
>HZ390508.1 JP 2015524264-A/1: NUCLEIC ACIDS FOR DOWN-REGULATION OF GENE EXPRESSION
GGTGATAGCAAT
>HZ385547.1 JP 2015523856-A/403: METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
GTTTTAGAGCTA
>HZ385089.1 JP 2015521993-A/21: USE OF AN INHIBITOR OF IRS-1 FOR TREATING SKIN DISORDERS
CGCCATGCTGCT
>HZ384793.1 JP 2015523060-A/99: TREATMENT OF AMD USING AAV SFLT-1
CCGGTCGCCACC
>HZ186141.1 JP 2015146808-A/25: IDENTIFICATION OF NUCLEIC ACID SEQUENCES
NCTCCGTAGGAA
>HZ254293.1 JP 2015518816-A/14597: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
ATGGCCCTGTAG
>HZ350847.1 JP 2015518714-A/1272: COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION
AAAGCCCGCCAA
>HZ185410.1 JP 2015145369-A/14: AFFINITY MATURED CRIG VARIANTS
GTCACCTGGNNN
>HZ184777.1 JP 2015142558-A/24: HYDROXYMETHYL SUBSTITUTED RNA OLIGONUCLEOTIDES AND RNA COMPLEXES
GCCACAAGTTCT
>HZ312649.1 JP 2015518704-A/38551: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGACCACCTAG
>HZ273942.1 JP 2015518485-A/612: MIRNA MODULATORS OF THERMOGENESIS
GCAGGTTCTCAC
>HZ273929.1 JP 2015518485-A/599: MIRNA MODULATORS OF THERMOGENESIS
TGATTGGTACGT
>HZ312137.1 JP 2015518704-A/38039: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGGTGCTGTAG
>HZ273572.1 JP 2015518485-A/242: MIRNA MODULATORS OF THERMOGENESIS
CTAACATATGAA
>HZ273472.1 JP 2015518485-A/142: MIRNA MODULATORS OF THERMOGENESIS
TGCCTACTGGCC
>HZ273349.1 JP 2015518485-A/19: MIRNA MODULATORS OF THERMOGENESIS
GATTGGCAGCTT
>HZ292195.1 JP 2015518704-A/18097: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGGATCCGTAG
>HZ249805.1 JP 2015518816-A/10109: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
ATGGCCCTGTAG
>HZ345545.1 JP 2015519662-A/91: SYSTEM AND METHOD FOR GENERATION AND USE OF OPTIMAL NUCLEOTIDE FLOW ORDERS
TACGTACGTACG
>HZ345464.1 JP 2015519662-A/10: SYSTEM AND METHOD FOR GENERATION AND USE OF OPTIMAL NUCLEOTIDE FLOW ORDERS
TACGTACGTACG
>HZ345455.1 JP 2015519662-A/1: SYSTEM AND METHOD FOR GENERATION AND USE OF OPTIMAL NUCLEOTIDE FLOW ORDERS
TCGTGACGTCTA
>HZ304661.1 JP 2015518704-A/30563: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGACCACCTAG
>HZ284207.1 JP 2015518704-A/10109: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGGACCCCTAG
>HZ304149.1 JP 2015518704-A/30051: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGGTGCTGTAG
>HZ263269.1 JP 2015518816-A/23573: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
ATGGCCCTTTAG
>HZ320637.1 JP 2015518704-A/46539: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGACAACCTAG
>HZ320125.1 JP 2015518704-A/46027: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGGTCCTGTAG
>HZ300183.1 JP 2015518704-A/26085: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGGACCCCTAG
>HZ258781.1 JP 2015518816-A/19085: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
ATGGCCCTGTAG
>HZ189543.1 WO 2015125783-A/1: Bridged nucleoside and nucleotide
AGCAAAAAACGC
>HZ188951.1 WO 2015115610-A/24: Expression cassette
CCCCGCCCATAC
>HZ353500.1 JP 2015519081-A/5: METHOD OF SEQUENCE DETERMINATION USING SEQUENCE TAGS
GTATTTTTTTCT
>HZ316159.1 JP 2015518704-A/42061: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGGACCCCTAG
>HZ296673.1 JP 2015518704-A/22575: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGACAACCTAG
>HZ187116.1 JP 2015147778-A/120: ANTIBODIES TO IL-6 AND USE THEREOF
GCCTATGACTTG
>HZ351942.1 JP 2015519373-A/55: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>HZ351940.1 JP 2015519373-A/53: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>HZ351939.1 JP 2015519373-A/52: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>HZ351928.1 JP 2015519373-A/41: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>HZ351925.1 JP 2015519373-A/38: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>HZ351922.1 JP 2015519373-A/35: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>HZ351919.1 JP 2015519373-A/32: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>HZ351896.1 JP 2015519373-A/9: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
AACGTTCGAGAT
>HZ351889.1 JP 2015519373-A/2: COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST
CGTAGAGCATCA
>HZ296161.1 JP 2015518704-A/22063: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGGTGCTGTAG
>HZ308171.1 JP 2015518704-A/34073: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGGACCCCTAG
>HZ288685.1 JP 2015518704-A/14587: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGACCACCTAG
>HZ288173.1 JP 2015518704-A/14075: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
ATGGTGCTGTAG
>HZ343519.1 JP 2015519891-A/51: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
ATCTAATAAGCT
>HZ343518.1 JP 2015519891-A/50: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
AATCTAATAAGC
>HZ343512.1 JP 2015519891-A/44: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
TCTAATAAGCTA
>HZ343505.1 JP 2015519891-A/37: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
GTCTGATAAGCT
>HZ343504.1 JP 2015519891-A/36: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
AGTCTGATAAGC
>HZ343490.1 JP 2015519891-A/22: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
TCTGATAAGCTA
>HZ245317.1 JP 2015518816-A/5621: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
ATGGCCCTGTAG
>HZ165131.1 WO 2015099167-A/8: Vaccine targeting IL-17A
TCAGATTACTAC
>HZ164362.1 JP 2015131828-A/23: COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
ATTCACTTTCAT
>HZ164361.1 JP 2015131828-A/22: COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
TTCACTTTCATA
>HZ164360.1 JP 2015131828-A/21: COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
TCACTTTCATAA
>HZ164358.1 JP 2015131828-A/19: COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
CACTTTCATAAT
>HZ164356.1 JP 2015131828-A/17: COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
ACTTTCATAATG
>HZ164354.1 JP 2015131828-A/15: COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
CTTTCATAATGC
>HZ164352.1 JP 2015131828-A/13: COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
TTTCATAATGCT
>HZ164350.1 JP 2015131828-A/11: COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
TTCATAATGCTG
>HZ164348.1 JP 2015131828-A/9: COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
TCATAATGCTGG
>HZ157187.1 JP 2015130862-A/11: Micromirs
GTCTGATAAGCT
>HZ156602.1 JP 2015120714-A/659: Albumin Fusion Proteins
GGGGACTTTCCC
>HZ148030.1 JP 2015513912-A/48530: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
ATGGAGGGCTAG
>HZ182077.1 JP 2015517466-A/2459: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTCTTTTAATT
>HZ182076.1 JP 2015517466-A/2458: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTAAAAGAGT
>HZ182075.1 JP 2015517466-A/2457: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTTTTAATTT
>HZ182074.1 JP 2015517466-A/2456: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATTAAAAGAG
>HZ182073.1 JP 2015517466-A/2455: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTTTAATTTG
>HZ182072.1 JP 2015517466-A/2454: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAATTAAAAGA
>HZ182071.1 JP 2015517466-A/2453: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTTTAATTTGT
>HZ182070.1 JP 2015517466-A/2452: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAAATTAAAAG
>HZ182069.1 JP 2015517466-A/2451: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTTAATTTGTT
>HZ182068.1 JP 2015517466-A/2450: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACAAATTAAAA
>HZ182067.1 JP 2015517466-A/2449: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTAATTTGTTC
>HZ182066.1 JP 2015517466-A/2448: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAACAAATTAAA
>HZ182065.1 JP 2015517466-A/2447: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAATTTGTTCT
>HZ182064.1 JP 2015517466-A/2446: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAACAAATTAA
>HZ182063.1 JP 2015517466-A/2445: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAATTTGTTCTC
>HZ182062.1 JP 2015517466-A/2444: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGAACAAATTA
>HZ182061.1 JP 2015517466-A/2443: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTTGTTCTCT
>HZ182060.1 JP 2015517466-A/2442: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGAACAAATT
>HZ182059.1 JP 2015517466-A/2441: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTGTTCTCTA
>HZ182058.1 JP 2015517466-A/2440: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGAGAACAAAT
>HZ182057.1 JP 2015517466-A/2439: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGTTCTCTAT
>HZ182056.1 JP 2015517466-A/2438: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAGAGAACAAA
>HZ182055.1 JP 2015517466-A/2437: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTTCTCTATA
>HZ182054.1 JP 2015517466-A/2436: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATAGAGAACAA
>HZ182053.1 JP 2015517466-A/2435: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTTCTCTATAA
>HZ182052.1 JP 2015517466-A/2434: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATAGAGAACA
>HZ182051.1 JP 2015517466-A/2433: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTCTCTATAAT
>HZ182050.1 JP 2015517466-A/2432: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTATAGAGAAC
>HZ182049.1 JP 2015517466-A/2431: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTCTATAATG
>HZ182048.1 JP 2015517466-A/2430: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATTATAGAGAA
>HZ182047.1 JP 2015517466-A/2429: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTCTATAATGG
>HZ182046.1 JP 2015517466-A/2428: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCATTATAGAGA
>HZ182045.1 JP 2015517466-A/2427: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTATAATGGT
>HZ182044.1 JP 2015517466-A/2426: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCATTATAGAG
>HZ182043.1 JP 2015517466-A/2425: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTATAATGGTG
>HZ182042.1 JP 2015517466-A/2424: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACCATTATAGA
>HZ182041.1 JP 2015517466-A/2423: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTATAATGGTGA
>HZ182040.1 JP 2015517466-A/2422: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCACCATTATAG
>HZ182039.1 JP 2015517466-A/2421: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATAATGGTGAA
>HZ182038.1 JP 2015517466-A/2420: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCACCATTATA
>HZ182037.1 JP 2015517466-A/2419: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAATGGTGAAT
>HZ182036.1 JP 2015517466-A/2418: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCACCATTAT
>HZ182035.1 JP 2015517466-A/2417: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAATGGTGAATA
>HZ182034.1 JP 2015517466-A/2416: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTCACCATTA
>HZ182033.1 JP 2015517466-A/2415: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATGGTGAATAT
>HZ182032.1 JP 2015517466-A/2414: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATTCACCATT
>HZ182031.1 JP 2015517466-A/2413: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGGTGAATATC
>HZ182030.1 JP 2015517466-A/2412: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATATTCACCAT
>HZ182029.1 JP 2015517466-A/2411: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGTGAATATCT
>HZ182028.1 JP 2015517466-A/2410: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGATATTCACCA
>HZ182027.1 JP 2015517466-A/2409: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTGAATATCTT
>HZ182026.1 JP 2015517466-A/2408: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGATATTCACC
>HZ182025.1 JP 2015517466-A/2407: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGAATATCTTC
>HZ182024.1 JP 2015517466-A/2406: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAGATATTCAC
>HZ182023.1 JP 2015517466-A/2405: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAATATCTTCA
>HZ182022.1 JP 2015517466-A/2404: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAAGATATTCA
>HZ182021.1 JP 2015517466-A/2403: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATATCTTCAA
>HZ182020.1 JP 2015517466-A/2402: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGAAGATATTC
>HZ182019.1 JP 2015517466-A/2401: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATATCTTCAAA
>HZ182018.1 JP 2015517466-A/2400: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGAAGATATT
>HZ182017.1 JP 2015517466-A/2399: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATCTTCAAAT
>HZ182016.1 JP 2015517466-A/2398: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTGAAGATAT
>HZ182015.1 JP 2015517466-A/2397: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATCTTCAAATG
>HZ182014.1 JP 2015517466-A/2396: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATTTGAAGATA
>HZ182013.1 JP 2015517466-A/2395: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCTTCAAATGA
>HZ182012.1 JP 2015517466-A/2394: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCATTTGAAGAT
>HZ182011.1 JP 2015517466-A/2393: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTCAAATGAT
>HZ182010.1 JP 2015517466-A/2392: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCATTTGAAGA
>HZ182009.1 JP 2015517466-A/2391: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTCAAATGATT
>HZ182008.1 JP 2015517466-A/2390: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATCATTTGAAG
>HZ182007.1 JP 2015517466-A/2389: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCAAATGATTT
>HZ182006.1 JP 2015517466-A/2388: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATCATTTGAA
>HZ182005.1 JP 2015517466-A/2387: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAAATGATTTA
>HZ182004.1 JP 2015517466-A/2386: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAATCATTTGA
>HZ182003.1 JP 2015517466-A/2385: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAATGATTTAG
>HZ182002.1 JP 2015517466-A/2384: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAAATCATTTG
>HZ182001.1 JP 2015517466-A/2383: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATGATTTAGT
>HZ182000.1 JP 2015517466-A/2382: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTAAATCATTT
>HZ181999.1 JP 2015517466-A/2381: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATGATTTAGTA
>HZ181998.1 JP 2015517466-A/2380: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTAAATCATT
>HZ181997.1 JP 2015517466-A/2379: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGATTTAGTAT
>HZ181996.1 JP 2015517466-A/2378: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATACTAAATCAT
>HZ181995.1 JP 2015517466-A/2377: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGATTTAGTATT
>HZ181994.1 JP 2015517466-A/2376: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATACTAAATCA
>HZ181993.1 JP 2015517466-A/2375: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATTTAGTATTA
>HZ181992.1 JP 2015517466-A/2374: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAATACTAAATC
>HZ181991.1 JP 2015517466-A/2373: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTAGTATTAT
>HZ181990.1 JP 2015517466-A/2372: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAATACTAAAT
>HZ181989.1 JP 2015517466-A/2371: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTAGTATTATT
>HZ181988.1 JP 2015517466-A/2370: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATAATACTAAA
>HZ181987.1 JP 2015517466-A/2369: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAGTATTATTT
>HZ181986.1 JP 2015517466-A/2368: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATAATACTAA
>HZ181985.1 JP 2015517466-A/2367: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGTATTATTTA
>HZ181984.1 JP 2015517466-A/2366: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAATAATACTA
>HZ181983.1 JP 2015517466-A/2365: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTATTATTTAT
>HZ181982.1 JP 2015517466-A/2364: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAAATAATACT
>HZ181981.1 JP 2015517466-A/2363: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTATTATTTATG
>HZ181980.1 JP 2015517466-A/2362: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATAAATAATAC
>HZ181979.1 JP 2015517466-A/2361: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTATTTATGG
>HZ181978.1 JP 2015517466-A/2360: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCATAAATAATA
>HZ181977.1 JP 2015517466-A/2359: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTATTTATGGC
>HZ181976.1 JP 2015517466-A/2358: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCATAAATAAT
>HZ181975.1 JP 2015517466-A/2357: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATTTATGGCA
>HZ181974.1 JP 2015517466-A/2356: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCCATAAATAA
>HZ181973.1 JP 2015517466-A/2355: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTTATGGCAA
>HZ181972.1 JP 2015517466-A/2354: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCCATAAATA
>HZ181971.1 JP 2015517466-A/2353: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTATGGCAAA
>HZ181970.1 JP 2015517466-A/2352: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGCCATAAAT
>HZ181969.1 JP 2015517466-A/2351: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTATGGCAAAT
>HZ181968.1 JP 2015517466-A/2350: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTGCCATAAA
>HZ181967.1 JP 2015517466-A/2349: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATGGCAAATA
>HZ181966.1 JP 2015517466-A/2348: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTTGCCATAA
>HZ181965.1 JP 2015517466-A/2347: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATGGCAAATAC
>HZ181964.1 JP 2015517466-A/2346: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTATTTGCCATA
>HZ181963.1 JP 2015517466-A/2345: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGGCAAATACA
>HZ181962.1 JP 2015517466-A/2344: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTATTTGCCAT
>HZ181961.1 JP 2015517466-A/2343: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGCAAATACAC
>HZ181960.1 JP 2015517466-A/2342: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGTATTTGCCA
>HZ181959.1 JP 2015517466-A/2341: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCAAATACACA
>HZ181958.1 JP 2015517466-A/2340: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTGTATTTGCC
>HZ181957.1 JP 2015517466-A/2339: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAAATACACAA
>HZ181956.1 JP 2015517466-A/2338: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTGTATTTGC
>HZ181955.1 JP 2015517466-A/2337: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAATACACAAA
>HZ181954.1 JP 2015517466-A/2336: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGTGTATTTG
>HZ181953.1 JP 2015517466-A/2335: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATACACAAAG
>HZ181952.1 JP 2015517466-A/2334: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTTGTGTATTT
>HZ181951.1 JP 2015517466-A/2333: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATACACAAAGA
>HZ181950.1 JP 2015517466-A/2332: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTTGTGTATT
>HZ181949.1 JP 2015517466-A/2331: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATACACAAAGAA
>HZ181948.1 JP 2015517466-A/2330: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTTTGTGTAT
>HZ181947.1 JP 2015517466-A/2329: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACACAAAGAAA
>HZ181946.1 JP 2015517466-A/2328: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTCTTTGTGTA
>HZ181945.1 JP 2015517466-A/2327: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACACAAAGAAAG
>HZ181944.1 JP 2015517466-A/2326: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTTCTTTGTGT
>HZ181943.1 JP 2015517466-A/2325: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACAAAGAAAGC
>HZ181942.1 JP 2015517466-A/2324: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTTTCTTTGTG
>HZ181941.1 JP 2015517466-A/2323: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAAAGAAAGCC
>HZ181892.1 JP 2015517466-A/2274: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACCAGTACATG
>HZ181891.1 JP 2015517466-A/2273: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGTACTGGTCC
>HZ181890.1 JP 2015517466-A/2272: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGACCAGTACAT
>HZ181889.1 JP 2015517466-A/2271: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTACTGGTCCC
>HZ181888.1 JP 2015517466-A/2270: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGGACCAGTACA
>HZ181887.1 JP 2015517466-A/2269: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTACTGGTCCCT
>HZ181886.1 JP 2015517466-A/2268: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGGACCAGTAC
>HZ181885.1 JP 2015517466-A/2267: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTGGTCCCTC
>HZ181884.1 JP 2015517466-A/2266: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGGGACCAGTA
>HZ181883.1 JP 2015517466-A/2265: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTGGTCCCTCA
>HZ181882.1 JP 2015517466-A/2264: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAGGGACCAGT
>HZ181881.1 JP 2015517466-A/2263: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGGTCCCTCAT
>HZ181880.1 JP 2015517466-A/2262: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGAGGGACCAG
>HZ181879.1 JP 2015517466-A/2261: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGTCCCTCATT
>HZ181878.1 JP 2015517466-A/2260: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATGAGGGACCA
>HZ181877.1 JP 2015517466-A/2259: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTCCCTCATTG
>HZ181876.1 JP 2015517466-A/2258: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAATGAGGGACC
>HZ181875.1 JP 2015517466-A/2257: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCCCTCATTGC
>HZ181874.1 JP 2015517466-A/2256: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAATGAGGGAC
>HZ181873.1 JP 2015517466-A/2255: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCCTCATTGCA
>HZ181872.1 JP 2015517466-A/2254: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCAATGAGGGA
>HZ181871.1 JP 2015517466-A/2253: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCCTCATTGCAC
>HZ181870.1 JP 2015517466-A/2252: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGCAATGAGGG
>HZ181869.1 JP 2015517466-A/2251: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTCATTGCACT
>HZ181868.1 JP 2015517466-A/2250: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTGCAATGAGG
>HZ181867.1 JP 2015517466-A/2249: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCATTGCACTG
>HZ181866.1 JP 2015517466-A/2248: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGTGCAATGAG
>HZ181865.1 JP 2015517466-A/2247: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCATTGCACTGT
>HZ181864.1 JP 2015517466-A/2246: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGTGCAATGA
>HZ181863.1 JP 2015517466-A/2245: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATTGCACTGTA
>HZ181862.1 JP 2015517466-A/2244: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACAGTGCAATG
>HZ181861.1 JP 2015517466-A/2243: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTGCACTGTAC
>HZ181860.1 JP 2015517466-A/2242: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTACAGTGCAAT
>HZ181859.1 JP 2015517466-A/2241: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCACTGTACT
>HZ181858.1 JP 2015517466-A/2240: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTACAGTGCAA
>HZ181857.1 JP 2015517466-A/2239: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCACTGTACTC
>HZ181856.1 JP 2015517466-A/2238: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGTACAGTGCA
>HZ181855.1 JP 2015517466-A/2237: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCACTGTACTCC
>HZ181854.1 JP 2015517466-A/2236: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAGTACAGTGC
>HZ181853.1 JP 2015517466-A/2235: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACTGTACTCCT
>HZ181852.1 JP 2015517466-A/2234: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGAGTACAGTG
>HZ181851.1 JP 2015517466-A/2233: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTGTACTCCTC
>HZ181850.1 JP 2015517466-A/2232: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGGAGTACAGT
>HZ181849.1 JP 2015517466-A/2231: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTACTCCTCT
>HZ181848.1 JP 2015517466-A/2230: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGGAGTACAG
>HZ181847.1 JP 2015517466-A/2229: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTACTCCTCTT
>HZ181846.1 JP 2015517466-A/2228: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGAGGAGTACA
>HZ181845.1 JP 2015517466-A/2227: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTACTCCTCTTG
>HZ181844.1 JP 2015517466-A/2226: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGAGGAGTAC
>HZ181843.1 JP 2015517466-A/2225: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTCCTCTTGA
>HZ181842.1 JP 2015517466-A/2224: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAAGAGGAGTA
>HZ181841.1 JP 2015517466-A/2223: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTCCTCTTGAC
>HZ181840.1 JP 2015517466-A/2222: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCAAGAGGAGT
>HZ181839.1 JP 2015517466-A/2221: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCCTCTTGACC
>HZ181838.1 JP 2015517466-A/2220: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTCAAGAGGAG
>HZ181837.1 JP 2015517466-A/2219: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTCTTGACCT
>HZ181836.1 JP 2015517466-A/2218: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGTCAAGAGGA
>HZ181835.1 JP 2015517466-A/2217: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTCTTGACCTG
>HZ181834.1 JP 2015517466-A/2216: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGGTCAAGAGG
>HZ181833.1 JP 2015517466-A/2215: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTTGACCTGC
>HZ181832.1 JP 2015517466-A/2214: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAGGTCAAGAG
>HZ181831.1 JP 2015517466-A/2213: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTGACCTGCT
>HZ181830.1 JP 2015517466-A/2212: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCAGGTCAAGA
>HZ181829.1 JP 2015517466-A/2211: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGACCTGCTG
>HZ181828.1 JP 2015517466-A/2210: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGCAGGTCAAG
>HZ181827.1 JP 2015517466-A/2209: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGACCTGCTGT
>HZ181826.1 JP 2015517466-A/2208: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGCAGGTCAA
>HZ181825.1 JP 2015517466-A/2207: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGACCTGCTGTG
>HZ181824.1 JP 2015517466-A/2206: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACAGCAGGTCA
>HZ181823.1 JP 2015517466-A/2205: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACCTGCTGTGT
>HZ181822.1 JP 2015517466-A/2204: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACACAGCAGGTC
>HZ181821.1 JP 2015517466-A/2203: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCTGCTGTGTC
>HZ181820.1 JP 2015517466-A/2202: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACACAGCAGGT
>HZ181819.1 JP 2015517466-A/2201: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTGCTGTGTCG
>HZ181818.1 JP 2015517466-A/2200: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGACACAGCAGG
>HZ181817.1 JP 2015517466-A/2199: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGCTGTGTCGA
>HZ181816.1 JP 2015517466-A/2198: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCGACACAGCAG
>HZ181815.1 JP 2015517466-A/2197: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCTGTGTCGAG
>HZ181814.1 JP 2015517466-A/2196: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCGACACAGCA
>HZ181813.1 JP 2015517466-A/2195: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTGTGTCGAGA
>HZ181812.1 JP 2015517466-A/2194: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTCGACACAGC
>HZ181811.1 JP 2015517466-A/2193: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTGTCGAGAA
>HZ181810.1 JP 2015517466-A/2192: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTCGACACAG
>HZ181809.1 JP 2015517466-A/2191: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTGTCGAGAAT
>HZ181808.1 JP 2015517466-A/2190: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCTCGACACA
>HZ181807.1 JP 2015517466-A/2189: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGTCGAGAATA
>HZ181806.1 JP 2015517466-A/2188: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTCTCGACAC
>HZ181805.1 JP 2015517466-A/2187: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTCGAGAATAT
>HZ181804.1 JP 2015517466-A/2186: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATTCTCGACA
>HZ181803.1 JP 2015517466-A/2185: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCGAGAATATC
>HZ181802.1 JP 2015517466-A/2184: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATATTCTCGAC
>HZ181801.1 JP 2015517466-A/2183: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCGAGAATATCC
>HZ181800.1 JP 2015517466-A/2182: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGATATTCTCGA
>HZ181799.1 JP 2015517466-A/2181: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGAGAATATCCA
>HZ181798.1 JP 2015517466-A/2180: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGATATTCTCG
>HZ181797.1 JP 2015517466-A/2179: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGAATATCCAA
>HZ181796.1 JP 2015517466-A/2178: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGGATATTCTC
>HZ181795.1 JP 2015517466-A/2177: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAATATCCAAG
>HZ181794.1 JP 2015517466-A/2176: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGGATATTCT
>HZ181793.1 JP 2015517466-A/2175: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATATCCAAGA
>HZ181792.1 JP 2015517466-A/2174: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTGGATATTC
>HZ181791.1 JP 2015517466-A/2173: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATATCCAAGAG
>HZ181790.1 JP 2015517466-A/2172: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTTGGATATT
>HZ181789.1 JP 2015517466-A/2171: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATCCAAGAGA
>HZ181788.1 JP 2015517466-A/2170: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTCTTGGATAT
>HZ181787.1 JP 2015517466-A/2169: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATCCAAGAGAC
>HZ181786.1 JP 2015517466-A/2168: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCTCTTGGATA
>HZ181785.1 JP 2015517466-A/2167: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCCAAGAGACA
>HZ181784.1 JP 2015517466-A/2166: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTCTCTTGGAT
>HZ181783.1 JP 2015517466-A/2165: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCAAGAGACAG
>HZ181782.1 JP 2015517466-A/2164: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTCTCTTGGA
>HZ181781.1 JP 2015517466-A/2163: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCAAGAGACAGG
>HZ181780.1 JP 2015517466-A/2162: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTGTCTCTTGG
>HZ181779.1 JP 2015517466-A/2161: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGAGACAGGT
>HZ181778.1 JP 2015517466-A/2160: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCTGTCTCTTG
>HZ181777.1 JP 2015517466-A/2159: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGAGACAGGTT
>HZ181776.1 JP 2015517466-A/2158: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACCTGTCTCTT
>HZ181775.1 JP 2015517466-A/2157: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGACAGGTTT
>HZ181774.1 JP 2015517466-A/2156: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAACCTGTCTCT
>HZ181773.1 JP 2015517466-A/2155: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGACAGGTTTC
>HZ181772.1 JP 2015517466-A/2154: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAACCTGTCTC
>HZ181771.1 JP 2015517466-A/2153: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGACAGGTTTCT
>HZ181770.1 JP 2015517466-A/2152: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAAACCTGTCT
>HZ181769.1 JP 2015517466-A/2151: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACAGGTTTCTC
>HZ181768.1 JP 2015517466-A/2150: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGAAACCTGTC
>HZ181767.1 JP 2015517466-A/2149: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGGTTTCTCC
>HZ181766.1 JP 2015517466-A/2148: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAGAAACCTGT
>HZ181765.1 JP 2015517466-A/2147: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGGTTTCTCCA
>HZ181764.1 JP 2015517466-A/2146: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGAGAAACCTG
>HZ181763.1 JP 2015517466-A/2145: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGTTTCTCCAT
>HZ181762.1 JP 2015517466-A/2144: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGGAGAAACCT
>HZ181761.1 JP 2015517466-A/2143: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTTTCTCCATC
>HZ181760.1 JP 2015517466-A/2142: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATGGAGAAACC
>HZ181759.1 JP 2015517466-A/2141: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTTCTCCATCA
>HZ181758.1 JP 2015517466-A/2140: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGATGGAGAAAC
>HZ181757.1 JP 2015517466-A/2139: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTCTCCATCAA
>HZ181756.1 JP 2015517466-A/2138: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGATGGAGAAA
>HZ181755.1 JP 2015517466-A/2137: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTCCATCAAT
>HZ181754.1 JP 2015517466-A/2136: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTGATGGAGAA
>HZ181753.1 JP 2015517466-A/2135: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTCCATCAATT
>HZ181752.1 JP 2015517466-A/2134: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTGATGGAGA
>HZ181751.1 JP 2015517466-A/2133: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCCATCAATTA
>HZ181750.1 JP 2015517466-A/2132: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAATTGATGGAG
>HZ181749.1 JP 2015517466-A/2131: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCATCAATTAC
>HZ181748.1 JP 2015517466-A/2130: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAATTGATGGA
>HZ181747.1 JP 2015517466-A/2129: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCATCAATTACT
>HZ181746.1 JP 2015517466-A/2128: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTAATTGATGG
>HZ181745.1 JP 2015517466-A/2127: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATCAATTACTA
>HZ181744.1 JP 2015517466-A/2126: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGTAATTGATG
>HZ181743.1 JP 2015517466-A/2125: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCAATTACTAC
>HZ181742.1 JP 2015517466-A/2124: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAGTAATTGAT
>HZ181741.1 JP 2015517466-A/2123: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAATTACTACT
>HZ181740.1 JP 2015517466-A/2122: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTAGTAATTGA
>HZ181739.1 JP 2015517466-A/2121: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAATTACTACTT
>HZ181738.1 JP 2015517466-A/2120: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGTAGTAATTG
>HZ181737.1 JP 2015517466-A/2119: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTACTACTTG
>HZ181736.1 JP 2015517466-A/2118: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGTAGTAATT
>HZ181735.1 JP 2015517466-A/2117: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTACTACTTGC
>HZ181734.1 JP 2015517466-A/2116: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAAGTAGTAAT
>HZ181733.1 JP 2015517466-A/2115: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTACTACTTGCT
>HZ181732.1 JP 2015517466-A/2114: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCAAGTAGTAA
>HZ181731.1 JP 2015517466-A/2113: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTACTTGCTT
>HZ181730.1 JP 2015517466-A/2112: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGCAAGTAGTA
>HZ181729.1 JP 2015517466-A/2111: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTACTTGCTTC
>HZ181728.1 JP 2015517466-A/2110: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAGCAAGTAGT
>HZ181727.1 JP 2015517466-A/2109: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTACTTGCTTCC
>HZ181726.1 JP 2015517466-A/2108: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAAGCAAGTAG
>HZ181725.1 JP 2015517466-A/2107: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTTGCTTCCT
>HZ181724.1 JP 2015517466-A/2106: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGAAGCAAGTA
>HZ181723.1 JP 2015517466-A/2105: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTTGCTTCCTG
>HZ181722.1 JP 2015517466-A/2104: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGGAAGCAAGT
>HZ181721.1 JP 2015517466-A/2103: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGCTTCCTGT
>HZ181720.1 JP 2015517466-A/2102: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGGAAGCAAG
>HZ181719.1 JP 2015517466-A/2101: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCTTCCTGTA
>HZ181718.1 JP 2015517466-A/2100: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACAGGAAGCAA
>HZ181717.1 JP 2015517466-A/2099: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCTTCCTGTAG
>HZ181716.1 JP 2015517466-A/2098: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTACAGGAAGCA
>HZ181715.1 JP 2015517466-A/2097: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTTCCTGTAGG
>HZ181714.1 JP 2015517466-A/2096: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTACAGGAAGC
>HZ181713.1 JP 2015517466-A/2095: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTCCTGTAGGA
>HZ181712.1 JP 2015517466-A/2094: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTACAGGAAG
>HZ181711.1 JP 2015517466-A/2093: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCCTGTAGGAA
>HZ181710.1 JP 2015517466-A/2092: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCCTACAGGAA
>HZ181709.1 JP 2015517466-A/2091: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTGTAGGAAT
>HZ181708.1 JP 2015517466-A/2090: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCCTACAGGA
>HZ181707.1 JP 2015517466-A/2089: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTGTAGGAATC
>HZ181706.1 JP 2015517466-A/2088: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATTCCTACAGG
>HZ181705.1 JP 2015517466-A/2087: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTAGGAATCC
>HZ181704.1 JP 2015517466-A/2086: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGATTCCTACAG
>HZ181703.1 JP 2015517466-A/2085: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTAGGAATCCT
>HZ181702.1 JP 2015517466-A/2084: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGATTCCTACA
>HZ181701.1 JP 2015517466-A/2083: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAGGAATCCTC
>HZ181700.1 JP 2015517466-A/2082: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGGATTCCTAC
>HZ181699.1 JP 2015517466-A/2081: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGGAATCCTCT
>HZ181698.1 JP 2015517466-A/2080: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGGATTCCTA
>HZ181697.1 JP 2015517466-A/2079: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGAATCCTCTA
>HZ181696.1 JP 2015517466-A/2078: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGAGGATTCCT
>HZ181695.1 JP 2015517466-A/2077: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAATCCTCTAT
>HZ181694.1 JP 2015517466-A/2076: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAGAGGATTCC
>HZ181693.1 JP 2015517466-A/2075: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATCCTCTATT
>HZ181692.1 JP 2015517466-A/2074: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATAGAGGATTC
>HZ139264.1 JP 2015513912-A/39764: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
ATGGAGGGCTAG
>HZ130498.1 JP 2015513912-A/30998: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
ATGGAGGGCTAG
>HZ121732.1 JP 2015513912-A/22232: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
ATGGAAGGATAG
>HZ112966.1 JP 2015513912-A/13466: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
ATGGAGGGCTAG
>HZ098953.1 JP 2015514418-A/148: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NNCNNCNNCNNC
>HZ098952.1 JP 2015514418-A/147: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
TTNTTNTTNTTN
>HZ098939.1 JP 2015514418-A/134: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
CNGCNGCNGCNG
>HZ098938.1 JP 2015514418-A/133: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NNGNNGNNGNNG
>HZ098925.1 JP 2015514418-A/120: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NGCNGCNGCNGC
>HZ098924.1 JP 2015514418-A/119: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NGNNGNNGNNGN
>HZ098868.1 JP 2015514418-A/63: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NNGGNNGGNNGG
>HZ098854.1 JP 2015514418-A/49: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NGGNGGNGGNGG
>HZ098845.1 JP 2015514418-A/40: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
GGNGGNGGNGGN
>HZ098827.1 JP 2015514418-A/22: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NNGNNGNNGNNG
>HZ098818.1 JP 2015514418-A/13: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NGNNGNNGNNGN
>HZ098809.1 JP 2015514418-A/4: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NNGNNGNNGNNG
>HZ098746.1 JP 2015514406-A/67: Method for the expression of polypeptides using modified nucleic acids
AGGCGGAGACGC
>HZ098745.1 JP 2015514406-A/66: Method for the expression of polypeptides using modified nucleic acids
AGGAGACGGCGC
>HZ098719.1 JP 2015514406-A/40: Method for the expression of polypeptides using modified nucleic acids
TTCTTTTTCTTC
>HZ098718.1 JP 2015514406-A/39: Method for the expression of polypeptides using modified nucleic acids
TTCTTCTTTTTC
>HZ098717.1 JP 2015514406-A/38: Method for the expression of polypeptides using modified nucleic acids
TTCTTCTTCTTT
>HZ098703.1 JP 2015514406-A/24: Method for the expression of polypeptides using modified nucleic acids
GAAGAGGAAGAA
>HZ098702.1 JP 2015514406-A/23: Method for the expression of polypeptides using modified nucleic acids
GAAGAAGAGGAA
>HZ098701.1 JP 2015514406-A/22: Method for the expression of polypeptides using modified nucleic acids
GAAGAAGAAGAG
>HZ096777.1 JP 2015513914-A/13070: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
ATGTGGACATAG
>HZ095138.1 JP 2015513914-A/11431: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
ATGTGGACATAG
>HZ093498.1 JP 2015513914-A/9791: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
ATGTGGACATAG
>HZ091827.1 JP 2015513914-A/8120: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
ATGTGGACCTAG
>HZ090156.1 JP 2015513914-A/6449: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
ATGTGGACCTAG
>HZ088485.1 JP 2015513914-A/4778: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
ATGTGGACCTAG
>HZ082148.1 JP 2015514397-A/8: Methods and Compositions for Discrimination Between Cytosine and Modifications Thereof, and for Methylome Analysis
GGGTTGGATTGC
>HZ082147.1 JP 2015514397-A/7: Methods and Compositions for Discrimination Between Cytosine and Modifications Thereof, and for Methylome Analysis
GGGTCGGATTGC
>HZ082146.1 JP 2015514397-A/6: Methods and Compositions for Discrimination Between Cytosine and Modifications Thereof, and for Methylome Analysis
GGGTCGGATTGC
>HZ082145.1 JP 2015514397-A/5: Methods and Compositions for Discrimination Between Cytosine and Modifications Thereof, and for Methylome Analysis
GGGTTGGATTGC
>HZ082144.1 JP 2015514397-A/4: Methods and Compositions for Discrimination Between Cytosine and Modifications Thereof, and for Methylome Analysis
GGGTCGGATTGC
>HZ082143.1 JP 2015514397-A/3: Methods and Compositions for Discrimination Between Cytosine and Modifications Thereof, and for Methylome Analysis
GGGTCGGACCGC
>HZ183825.1 JP 2015516165-A/28: Enzymatic synthesis of L-nucleic acids
ACGACGGCCAGT
>HZ183805.1 JP 2015516165-A/8: Enzymatic synthesis of L-nucleic acids
ACGACGGCCAGT
>HZ182359.1 JP 2015517466-A/2741: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTCTTGTCTTT
>HZ182358.1 JP 2015517466-A/2740: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAGACAAGACA
>HZ182357.1 JP 2015517466-A/2739: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCTTGTCTTTG
>HZ182356.1 JP 2015517466-A/2738: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAAGACAAGAC
>HZ182355.1 JP 2015517466-A/2737: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTGTCTTTGC
>HZ182354.1 JP 2015517466-A/2736: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAAAGACAAGA
>HZ182353.1 JP 2015517466-A/2735: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGTCTTTGCT
>HZ182352.1 JP 2015517466-A/2734: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCAAAGACAAG
>HZ182351.1 JP 2015517466-A/2733: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTCTTTGCTG
>HZ182350.1 JP 2015517466-A/2732: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGCAAAGACAA
>HZ182349.1 JP 2015517466-A/2731: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTCTTTGCTGA
>HZ182348.1 JP 2015517466-A/2730: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAGCAAAGACA
>HZ182347.1 JP 2015517466-A/2729: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCTTTGCTGAT
>HZ182346.1 JP 2015517466-A/2728: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCAGCAAAGAC
>HZ182345.1 JP 2015517466-A/2727: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTTGCTGATG
>HZ182344.1 JP 2015517466-A/2726: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATCAGCAAAGA
>HZ182343.1 JP 2015517466-A/2725: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTTGCTGATGT
>HZ182342.1 JP 2015517466-A/2724: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACATCAGCAAAG
>HZ182341.1 JP 2015517466-A/2723: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGCTGATGTT
>HZ182340.1 JP 2015517466-A/2722: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACATCAGCAAA
>HZ182339.1 JP 2015517466-A/2721: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCTGATGTTT
>HZ182338.1 JP 2015517466-A/2720: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAACATCAGCAA
>HZ182337.1 JP 2015517466-A/2719: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCTGATGTTTC
>HZ182336.1 JP 2015517466-A/2718: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAACATCAGCA
>HZ182335.1 JP 2015517466-A/2717: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTGATGTTTCA
>HZ182334.1 JP 2015517466-A/2716: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAAACATCAGC
>HZ182333.1 JP 2015517466-A/2715: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGATGTTTCAA
>HZ182332.1 JP 2015517466-A/2714: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGAAACATCAG
>HZ182331.1 JP 2015517466-A/2713: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGATGTTTCAAT
>HZ182330.1 JP 2015517466-A/2712: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTGAAACATCA
>HZ182329.1 JP 2015517466-A/2711: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATGTTTCAATA
>HZ182328.1 JP 2015517466-A/2710: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTGAAACATC
>HZ182327.1 JP 2015517466-A/2709: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGTTTCAATAA
>HZ182326.1 JP 2015517466-A/2708: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATTGAAACAT
>HZ182325.1 JP 2015517466-A/2707: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTTTCAATAAA
>HZ182324.1 JP 2015517466-A/2706: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTATTGAAACA
>HZ182323.1 JP 2015517466-A/2705: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTTCAATAAAA
>HZ182322.1 JP 2015517466-A/2704: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTTATTGAAAC
>HZ182321.1 JP 2015517466-A/2703: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTCAATAAAAG
>HZ182320.1 JP 2015517466-A/2702: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTTTATTGAAA
>HZ182319.1 JP 2015517466-A/2701: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCAATAAAAGG
>HZ182318.1 JP 2015517466-A/2700: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTTTTATTGAA
>HZ182317.1 JP 2015517466-A/2699: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAATAAAAGGA
>HZ182316.1 JP 2015517466-A/2698: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTTTTATTGA
>HZ182315.1 JP 2015517466-A/2697: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAATAAAAGGAA
>HZ182314.1 JP 2015517466-A/2696: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCCTTTTATTG
>HZ182313.1 JP 2015517466-A/2695: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATAAAAGGAAT
>HZ182312.1 JP 2015517466-A/2694: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCCTTTTATT
>HZ182311.1 JP 2015517466-A/2693: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAAAAGGAATT
>HZ182310.1 JP 2015517466-A/2692: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTCCTTTTAT
>HZ182309.1 JP 2015517466-A/2691: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAAAGGAATTC
>HZ182308.1 JP 2015517466-A/2690: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATTCCTTTTA
>HZ182307.1 JP 2015517466-A/2689: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAAGGAATTCC
>HZ182306.1 JP 2015517466-A/2688: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAATTCCTTTT
>HZ182305.1 JP 2015517466-A/2687: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAGGAATTCCA
>HZ182304.1 JP 2015517466-A/2686: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGAATTCCTTT
>HZ182303.1 JP 2015517466-A/2685: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGGAATTCCAT
>HZ182302.1 JP 2015517466-A/2684: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGGAATTCCTT
>HZ182301.1 JP 2015517466-A/2683: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGAATTCCATA
>HZ182300.1 JP 2015517466-A/2682: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATGGAATTCCT
>HZ182299.1 JP 2015517466-A/2681: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAATTCCATAA
>HZ182298.1 JP 2015517466-A/2680: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATGGAATTCC
>HZ182297.1 JP 2015517466-A/2679: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATTCCATAAC
>HZ182296.1 JP 2015517466-A/2678: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTATGGAATTC
>HZ182295.1 JP 2015517466-A/2677: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTCCATAACT
>HZ182294.1 JP 2015517466-A/2676: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTTATGGAATT
>HZ182293.1 JP 2015517466-A/2675: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCCATAACTT
>HZ182292.1 JP 2015517466-A/2674: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGTTATGGAAT
>HZ182291.1 JP 2015517466-A/2673: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCCATAACTTC
>HZ182290.1 JP 2015517466-A/2672: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAGTTATGGAA
>HZ182289.1 JP 2015517466-A/2671: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCATAACTTCT
>HZ182288.1 JP 2015517466-A/2670: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAAGTTATGGA
>HZ182287.1 JP 2015517466-A/2669: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCATAACTTCTT
>HZ182286.1 JP 2015517466-A/2668: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGAAGTTATGG
>HZ182285.1 JP 2015517466-A/2667: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATAACTTCTTG
>HZ182284.1 JP 2015517466-A/2666: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGAAGTTATG
>HZ182283.1 JP 2015517466-A/2665: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAACTTCTTGC
>HZ182282.1 JP 2015517466-A/2664: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAAGAAGTTAT
>HZ182281.1 JP 2015517466-A/2663: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAACTTCTTGCT
>HZ182280.1 JP 2015517466-A/2662: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCAAGAAGTTA
>HZ182279.1 JP 2015517466-A/2661: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACTTCTTGCTA
>HZ182278.1 JP 2015517466-A/2660: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGCAAGAAGTT
>HZ182277.1 JP 2015517466-A/2659: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTTCTTGCTAA
>HZ182276.1 JP 2015517466-A/2658: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAGCAAGAAGT
>HZ182275.1 JP 2015517466-A/2657: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTCTTGCTAAG
>HZ182274.1 JP 2015517466-A/2656: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTAGCAAGAAG
>HZ182273.1 JP 2015517466-A/2655: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTTGCTAAGT
>HZ182272.1 JP 2015517466-A/2654: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTTAGCAAGAA
>HZ182271.1 JP 2015517466-A/2653: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTGCTAAGTC
>HZ182270.1 JP 2015517466-A/2652: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACTTAGCAAGA
>HZ182269.1 JP 2015517466-A/2651: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGCTAAGTCC
>HZ182268.1 JP 2015517466-A/2650: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGACTTAGCAAG
>HZ182267.1 JP 2015517466-A/2649: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCTAAGTCCT
>HZ182266.1 JP 2015517466-A/2648: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGACTTAGCAA
>HZ182265.1 JP 2015517466-A/2647: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCTAAGTCCTG
>HZ182264.1 JP 2015517466-A/2646: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGGACTTAGCA
>HZ182263.1 JP 2015517466-A/2645: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTAAGTCCTGA
>HZ182262.1 JP 2015517466-A/2644: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAGGACTTAGC
>HZ182261.1 JP 2015517466-A/2643: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAAGTCCTGAG
>HZ182260.1 JP 2015517466-A/2642: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCAGGACTTAG
>HZ182259.1 JP 2015517466-A/2641: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAGTCCTGAGC
>HZ182258.1 JP 2015517466-A/2640: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTCAGGACTTA
>HZ182257.1 JP 2015517466-A/2639: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGTCCTGAGCC
>HZ182256.1 JP 2015517466-A/2638: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCTCAGGACTT
>HZ182255.1 JP 2015517466-A/2637: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTCCTGAGCCT
>HZ182254.1 JP 2015517466-A/2636: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGCTCAGGACT
>HZ182253.1 JP 2015517466-A/2635: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCCTGAGCCTG
>HZ182252.1 JP 2015517466-A/2634: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGGCTCAGGAC
>HZ182251.1 JP 2015517466-A/2633: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTGAGCCTGT
>HZ182250.1 JP 2015517466-A/2632: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGGCTCAGGA
>HZ182249.1 JP 2015517466-A/2631: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTGAGCCTGTT
>HZ182248.1 JP 2015517466-A/2630: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACAGGCTCAGG
>HZ182247.1 JP 2015517466-A/2629: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGAGCCTGTTT
>HZ182246.1 JP 2015517466-A/2628: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAACAGGCTCAG
>HZ182245.1 JP 2015517466-A/2627: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAGCCTGTTTT
>HZ182244.1 JP 2015517466-A/2626: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAACAGGCTCA
>HZ182243.1 JP 2015517466-A/2625: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGCCTGTTTTG
>HZ182242.1 JP 2015517466-A/2624: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAAACAGGCTC
>HZ182241.1 JP 2015517466-A/2623: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCCTGTTTTGT
>HZ182240.1 JP 2015517466-A/2622: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAAAACAGGCT
>HZ182239.1 JP 2015517466-A/2621: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCTGTTTTGTG
>HZ182238.1 JP 2015517466-A/2620: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACAAAACAGGC
>HZ182237.1 JP 2015517466-A/2619: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTGTTTTGTGT
>HZ182236.1 JP 2015517466-A/2618: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACACAAAACAGG
>HZ182235.1 JP 2015517466-A/2617: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTTTTGTGTC
>HZ182234.1 JP 2015517466-A/2616: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACACAAAACAG
>HZ182233.1 JP 2015517466-A/2615: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTTTTGTGTCT
>HZ182232.1 JP 2015517466-A/2614: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGACACAAAACA
>HZ182231.1 JP 2015517466-A/2613: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTTTGTGTCTA
>HZ182230.1 JP 2015517466-A/2612: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGACACAAAAC
>HZ182229.1 JP 2015517466-A/2611: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTTGTGTCTAC
>HZ182228.1 JP 2015517466-A/2610: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAGACACAAAA
>HZ181940.1 JP 2015517466-A/2322: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCTTTCTTTGT
>HZ181939.1 JP 2015517466-A/2321: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAAGAAAGCCC
>HZ181938.1 JP 2015517466-A/2320: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGGCTTTCTTTG
>HZ181937.1 JP 2015517466-A/2319: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAGAAAGCCCT
>HZ181936.1 JP 2015517466-A/2318: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGGCTTTCTTT
>HZ181935.1 JP 2015517466-A/2317: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGAAAGCCCTC
>HZ181934.1 JP 2015517466-A/2316: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGGGCTTTCTT
>HZ181933.1 JP 2015517466-A/2315: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAAAGCCCTCC
>HZ181932.1 JP 2015517466-A/2314: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAGGGCTTTCT
>HZ181931.1 JP 2015517466-A/2313: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAAGCCCTCCC
>HZ181930.1 JP 2015517466-A/2312: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGGAGGGCTTTC
>HZ181929.1 JP 2015517466-A/2311: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAGCCCTCCCC
>HZ181928.1 JP 2015517466-A/2310: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGGGAGGGCTTT
>HZ181927.1 JP 2015517466-A/2309: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGCCCTCCCCA
>HZ181926.1 JP 2015517466-A/2308: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGGGAGGGCTT
>HZ181925.1 JP 2015517466-A/2307: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCCCTCCCCAG
>HZ181924.1 JP 2015517466-A/2306: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGGGGAGGGCT
>HZ181923.1 JP 2015517466-A/2305: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCCTCCCCAGT
>HZ181922.1 JP 2015517466-A/2304: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTGGGGAGGGC
>HZ181921.1 JP 2015517466-A/2303: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCCTCCCCAGTC
>HZ181920.1 JP 2015517466-A/2302: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACTGGGGAGGG
>HZ181919.1 JP 2015517466-A/2301: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTCCCCAGTCC
>HZ181918.1 JP 2015517466-A/2300: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGACTGGGGAGG
>HZ181917.1 JP 2015517466-A/2299: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCCCCAGTCCT
>HZ181916.1 JP 2015517466-A/2298: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGACTGGGGAG
>HZ181915.1 JP 2015517466-A/2297: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCCCAGTCCTC
>HZ181914.1 JP 2015517466-A/2296: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGGACTGGGGA
>HZ181913.1 JP 2015517466-A/2295: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCCCAGTCCTCA
>HZ181912.1 JP 2015517466-A/2294: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAGGACTGGGG
>HZ181911.1 JP 2015517466-A/2293: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCCAGTCCTCAT
>HZ181910.1 JP 2015517466-A/2292: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGAGGACTGGG
>HZ181909.1 JP 2015517466-A/2291: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCAGTCCTCATG
>HZ181908.1 JP 2015517466-A/2290: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATGAGGACTGG
>HZ181907.1 JP 2015517466-A/2289: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGTCCTCATGT
>HZ181906.1 JP 2015517466-A/2288: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACATGAGGACTG
>HZ181905.1 JP 2015517466-A/2287: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTCCTCATGTA
>HZ181904.1 JP 2015517466-A/2286: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACATGAGGACT
>HZ181903.1 JP 2015517466-A/2285: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCCTCATGTAC
>HZ181902.1 JP 2015517466-A/2284: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTACATGAGGAC
>HZ181901.1 JP 2015517466-A/2283: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTCATGTACT
>HZ181900.1 JP 2015517466-A/2282: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTACATGAGGA
>HZ181899.1 JP 2015517466-A/2281: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTCATGTACTG
>HZ181898.1 JP 2015517466-A/2280: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGTACATGAGG
>HZ181897.1 JP 2015517466-A/2279: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCATGTACTGG
>HZ181896.1 JP 2015517466-A/2278: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCAGTACATGAG
>HZ181895.1 JP 2015517466-A/2277: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCATGTACTGGT
>HZ181894.1 JP 2015517466-A/2276: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCAGTACATGA
>HZ181893.1 JP 2015517466-A/2275: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATGTACTGGTC
>HZ181691.1 JP 2015517466-A/2073: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATCCTCTATTG
>HZ181690.1 JP 2015517466-A/2072: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAATAGAGGATT
>HZ181689.1 JP 2015517466-A/2071: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCCTCTATTGT
>HZ181688.1 JP 2015517466-A/2070: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAATAGAGGAT
>HZ181687.1 JP 2015517466-A/2069: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTCTATTGTT
>HZ181686.1 JP 2015517466-A/2068: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACAATAGAGGA
>HZ181685.1 JP 2015517466-A/2067: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTCTATTGTTG
>HZ181684.1 JP 2015517466-A/2066: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAACAATAGAGG
>HZ181683.1 JP 2015517466-A/2065: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTATTGTTGG
>HZ181682.1 JP 2015517466-A/2064: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCAACAATAGAG
>HZ181681.1 JP 2015517466-A/2063: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTATTGTTGGA
>HZ181680.1 JP 2015517466-A/2062: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCAACAATAGA
>HZ181679.1 JP 2015517466-A/2061: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTATTGTTGGAT
>HZ181678.1 JP 2015517466-A/2060: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCCAACAATAG
>HZ181677.1 JP 2015517466-A/2059: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTGTTGGATC
>HZ181676.1 JP 2015517466-A/2058: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATCCAACAATA
>HZ181630.1 JP 2015517466-A/2012: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAATCATTTTG
>HZ181629.1 JP 2015517466-A/2011: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAATGATTCTG
>HZ181628.1 JP 2015517466-A/2010: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGAATCATTTT
>HZ181627.1 JP 2015517466-A/2009: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATGATTCTGA
>HZ181626.1 JP 2015517466-A/2008: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAGAATCATTT
>HZ181625.1 JP 2015517466-A/2007: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATGATTCTGAA
>HZ181624.1 JP 2015517466-A/2006: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCAGAATCATT
>HZ181623.1 JP 2015517466-A/2005: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGATTCTGAAT
>HZ181622.1 JP 2015517466-A/2004: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCAGAATCAT
>HZ181621.1 JP 2015517466-A/2003: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGATTCTGAATT
>HZ181620.1 JP 2015517466-A/2002: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTCAGAATCA
>HZ181619.1 JP 2015517466-A/2001: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATTCTGAATTA
>HZ181618.1 JP 2015517466-A/2000: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAATTCAGAATC
>HZ181617.1 JP 2015517466-A/1999: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCTGAATTAG
>HZ181616.1 JP 2015517466-A/1998: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAATTCAGAAT
>HZ181615.1 JP 2015517466-A/1997: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTGAATTAGC
>HZ181614.1 JP 2015517466-A/1996: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTAATTCAGAA
>HZ181613.1 JP 2015517466-A/1995: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTGAATTAGCT
>HZ181612.1 JP 2015517466-A/1994: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCTAATTCAGA
>HZ181611.1 JP 2015517466-A/1993: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGAATTAGCTG
>HZ181610.1 JP 2015517466-A/1992: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGCTAATTCAG
>HZ181609.1 JP 2015517466-A/1991: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAATTAGCTGT
>HZ181608.1 JP 2015517466-A/1990: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGCTAATTCA
>HZ181607.1 JP 2015517466-A/1989: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATTAGCTGTA
>HZ181606.1 JP 2015517466-A/1988: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACAGCTAATTC
>HZ181605.1 JP 2015517466-A/1987: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATTAGCTGTAT
>HZ181604.1 JP 2015517466-A/1986: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATACAGCTAATT
>HZ181603.1 JP 2015517466-A/1985: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTAGCTGTATC
>HZ181602.1 JP 2015517466-A/1984: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATACAGCTAAT
>HZ181601.1 JP 2015517466-A/1983: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAGCTGTATCG
>HZ181600.1 JP 2015517466-A/1982: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGATACAGCTAA
>HZ181599.1 JP 2015517466-A/1981: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGCTGTATCGT
>HZ181598.1 JP 2015517466-A/1980: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACGATACAGCTA
>HZ181597.1 JP 2015517466-A/1979: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCTGTATCGTC
>HZ181596.1 JP 2015517466-A/1978: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACGATACAGCT
>HZ181595.1 JP 2015517466-A/1977: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTGTATCGTCA
>HZ181594.1 JP 2015517466-A/1976: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGACGATACAGC
>HZ181593.1 JP 2015517466-A/1975: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTATCGTCAA
>HZ181592.1 JP 2015517466-A/1974: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGACGATACAG
>HZ181591.1 JP 2015517466-A/1973: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTATCGTCAAG
>HZ181590.1 JP 2015517466-A/1972: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGACGATACA
>HZ181589.1 JP 2015517466-A/1971: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTATCGTCAAGG
>HZ181588.1 JP 2015517466-A/1970: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTTGACGATAC
>HZ181587.1 JP 2015517466-A/1969: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATCGTCAAGGC
>HZ181586.1 JP 2015517466-A/1968: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCTTGACGATA
>HZ181585.1 JP 2015517466-A/1967: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCGTCAAGGCA
>HZ181584.1 JP 2015517466-A/1966: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCCTTGACGAT
>HZ181583.1 JP 2015517466-A/1965: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCGTCAAGGCAC
>HZ181582.1 JP 2015517466-A/1964: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGCCTTGACGA
>HZ181581.1 JP 2015517466-A/1963: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGTCAAGGCACT
>HZ181580.1 JP 2015517466-A/1962: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTGCCTTGACG
>HZ181579.1 JP 2015517466-A/1961: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCAAGGCACTC
>HZ181578.1 JP 2015517466-A/1960: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGTGCCTTGAC
>HZ181577.1 JP 2015517466-A/1959: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAAGGCACTCT
>HZ181576.1 JP 2015517466-A/1958: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGTGCCTTGA
>HZ181575.1 JP 2015517466-A/1957: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGGCACTCTT
>HZ181574.1 JP 2015517466-A/1956: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGAGTGCCTTG
>HZ181573.1 JP 2015517466-A/1955: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGGCACTCTTG
>HZ181572.1 JP 2015517466-A/1954: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGAGTGCCTT
>HZ181571.1 JP 2015517466-A/1953: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGCACTCTTGC
>HZ181570.1 JP 2015517466-A/1952: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAAGAGTGCCT
>HZ181569.1 JP 2015517466-A/1951: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCACTCTTGCC
>HZ181568.1 JP 2015517466-A/1950: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCAAGAGTGCC
>HZ181567.1 JP 2015517466-A/1949: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCACTCTTGCCT
>HZ181566.1 JP 2015517466-A/1948: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGCAAGAGTGC
>HZ181565.1 JP 2015517466-A/1947: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACTCTTGCCTA
>HZ181564.1 JP 2015517466-A/1946: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGGCAAGAGTG
>HZ181563.1 JP 2015517466-A/1945: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTCTTGCCTAC
>HZ181562.1 JP 2015517466-A/1944: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAGGCAAGAGT
>HZ181561.1 JP 2015517466-A/1943: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTTGCCTACG
>HZ181560.1 JP 2015517466-A/1942: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGTAGGCAAGAG
>HZ181559.1 JP 2015517466-A/1941: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTGCCTACGC
>HZ181558.1 JP 2015517466-A/1940: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCGTAGGCAAGA
>HZ181557.1 JP 2015517466-A/1939: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGCCTACGCC
>HZ181556.1 JP 2015517466-A/1938: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCGTAGGCAAG
>HZ181555.1 JP 2015517466-A/1937: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCCTACGCCA
>HZ181554.1 JP 2015517466-A/1936: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGCGTAGGCAA
>HZ181553.1 JP 2015517466-A/1935: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCCTACGCCAC
>HZ181552.1 JP 2015517466-A/1934: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGGCGTAGGCA
>HZ181551.1 JP 2015517466-A/1933: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCTACGCCACC
>HZ181550.1 JP 2015517466-A/1932: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTGGCGTAGGC
>HZ181549.1 JP 2015517466-A/1931: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTACGCCACCA
>HZ181548.1 JP 2015517466-A/1930: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGTGGCGTAGG
>HZ181547.1 JP 2015517466-A/1929: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTACGCCACCAG
>HZ181546.1 JP 2015517466-A/1928: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGGTGGCGTAG
>HZ181545.1 JP 2015517466-A/1927: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACGCCACCAGC
>HZ181544.1 JP 2015517466-A/1926: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTGGTGGCGTA
>HZ181543.1 JP 2015517466-A/1925: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACGCCACCAGCT
>HZ181542.1 JP 2015517466-A/1924: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCTGGTGGCGT
>HZ181541.1 JP 2015517466-A/1923: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGCCACCAGCTC
>HZ181540.1 JP 2015517466-A/1922: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGCTGGTGGCG
>HZ181539.1 JP 2015517466-A/1921: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCACCAGCTCC
>HZ181538.1 JP 2015517466-A/1920: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAGCTGGTGGC
>HZ181537.1 JP 2015517466-A/1919: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCACCAGCTCCA
>HZ181536.1 JP 2015517466-A/1918: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGAGCTGGTGG
>HZ181535.1 JP 2015517466-A/1917: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACCAGCTCCAA
>HZ181534.1 JP 2015517466-A/1916: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGGAGCTGGTG
>HZ181533.1 JP 2015517466-A/1915: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCAGCTCCAAC
>HZ181532.1 JP 2015517466-A/1914: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTGGAGCTGGT
>HZ181531.1 JP 2015517466-A/1913: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCAGCTCCAACT
>HZ181530.1 JP 2015517466-A/1912: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTTGGAGCTGG
>HZ181529.1 JP 2015517466-A/1911: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGCTCCAACTA
>HZ181528.1 JP 2015517466-A/1910: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGTTGGAGCTG
>HZ181527.1 JP 2015517466-A/1909: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGCTCCAACTAC
>HZ181526.1 JP 2015517466-A/1908: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAGTTGGAGCT
>HZ181525.1 JP 2015517466-A/1907: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCTCCAACTACC
>HZ181524.1 JP 2015517466-A/1906: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTAGTTGGAGC
>HZ181523.1 JP 2015517466-A/1905: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCCAACTACCA
>HZ181522.1 JP 2015517466-A/1904: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGTAGTTGGAG
>HZ181521.1 JP 2015517466-A/1903: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCAACTACCAC
>HZ181520.1 JP 2015517466-A/1902: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGGTAGTTGGA
>HZ181519.1 JP 2015517466-A/1901: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCAACTACCACA
>HZ181518.1 JP 2015517466-A/1900: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTGGTAGTTGG
>HZ181517.1 JP 2015517466-A/1899: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAACTACCACAA
>HZ181516.1 JP 2015517466-A/1898: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTGGTAGTTG
>HZ181515.1 JP 2015517466-A/1897: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACTACCACAAG
>HZ181514.1 JP 2015517466-A/1896: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTGTGGTAGTT
>HZ181513.1 JP 2015517466-A/1895: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTACCACAAGT
>HZ181512.1 JP 2015517466-A/1894: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTTGTGGTAGT
>HZ181511.1 JP 2015517466-A/1893: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTACCACAAGTT
>HZ181510.1 JP 2015517466-A/1892: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACTTGTGGTAG
>HZ181509.1 JP 2015517466-A/1891: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACCACAAGTTT
>HZ181508.1 JP 2015517466-A/1890: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAACTTGTGGTA
>HZ181507.1 JP 2015517466-A/1889: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCACAAGTTTA
>HZ181506.1 JP 2015517466-A/1888: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAACTTGTGGT
>HZ181505.1 JP 2015517466-A/1887: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCACAAGTTTAT
>HZ181504.1 JP 2015517466-A/1886: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAAACTTGTGG
>HZ181503.1 JP 2015517466-A/1885: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACAAGTTTATA
>HZ181502.1 JP 2015517466-A/1884: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATAAACTTGTG
>HZ181501.1 JP 2015517466-A/1883: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAAGTTTATAT
>HZ181500.1 JP 2015517466-A/1882: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATAAACTTGT
>HZ182227.1 JP 2015517466-A/2609: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGTGTCTACT
>HZ182226.1 JP 2015517466-A/2608: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTAGACACAAA
>HZ182225.1 JP 2015517466-A/2607: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTGTCTACTG
>HZ182224.1 JP 2015517466-A/2606: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGTAGACACAA
>HZ182223.1 JP 2015517466-A/2605: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTGTCTACTGT
>HZ182222.1 JP 2015517466-A/2604: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAGTAGACACA
>HZ182221.1 JP 2015517466-A/2603: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGTCTACTGTT
>HZ182220.1 JP 2015517466-A/2602: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACAGTAGACAC
>HZ182219.1 JP 2015517466-A/2601: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTCTACTGTTC
>HZ182218.1 JP 2015517466-A/2600: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAACAGTAGACA
>HZ182217.1 JP 2015517466-A/2599: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCTACTGTTCT
>HZ182216.1 JP 2015517466-A/2598: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAACAGTAGAC
>HZ182215.1 JP 2015517466-A/2597: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTACTGTTCTA
>HZ182214.1 JP 2015517466-A/2596: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGAACAGTAGA
>HZ182213.1 JP 2015517466-A/2595: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTACTGTTCTAG
>HZ182212.1 JP 2015517466-A/2594: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAGAACAGTAG
>HZ182211.1 JP 2015517466-A/2593: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTGTTCTAGA
>HZ182210.1 JP 2015517466-A/2592: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTAGAACAGTA
>HZ182209.1 JP 2015517466-A/2591: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTGTTCTAGAA
>HZ182208.1 JP 2015517466-A/2590: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTAGAACAGT
>HZ182207.1 JP 2015517466-A/2589: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGTTCTAGAAG
>HZ182206.1 JP 2015517466-A/2588: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTCTAGAACAG
>HZ182205.1 JP 2015517466-A/2587: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTTCTAGAAGG
>HZ182204.1 JP 2015517466-A/2586: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTTCTAGAACA
>HZ182203.1 JP 2015517466-A/2585: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTCTAGAAGGC
>HZ182202.1 JP 2015517466-A/2584: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCCTTCTAGAAC
>HZ182201.1 JP 2015517466-A/2583: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCTAGAAGGCA
>HZ182200.1 JP 2015517466-A/2582: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGCCTTCTAGAA
>HZ182199.1 JP 2015517466-A/2581: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTAGAAGGCAA
>HZ182198.1 JP 2015517466-A/2580: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGCCTTCTAGA
>HZ182197.1 JP 2015517466-A/2579: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAGAAGGCAAA
>HZ182196.1 JP 2015517466-A/2578: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGCCTTCTAG
>HZ182195.1 JP 2015517466-A/2577: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGAAGGCAAAT
>HZ182194.1 JP 2015517466-A/2576: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTGCCTTCTA
>HZ182193.1 JP 2015517466-A/2575: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAAGGCAAATC
>HZ182192.1 JP 2015517466-A/2574: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATTTGCCTTCT
>HZ182191.1 JP 2015517466-A/2573: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAGGCAAATCA
>HZ182190.1 JP 2015517466-A/2572: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGATTTGCCTTC
>HZ182189.1 JP 2015517466-A/2571: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGGCAAATCAC
>HZ182188.1 JP 2015517466-A/2570: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGATTTGCCTT
>HZ182187.1 JP 2015517466-A/2569: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGCAAATCACA
>HZ182186.1 JP 2015517466-A/2568: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTGATTTGCCT
>HZ182185.1 JP 2015517466-A/2567: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGCAAATCACAT
>HZ182184.1 JP 2015517466-A/2566: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGTGATTTGCC
>HZ182183.1 JP 2015517466-A/2565: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GCAAATCACATT
>HZ182182.1 JP 2015517466-A/2564: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATGTGATTTGC
>HZ182181.1 JP 2015517466-A/2563: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAATCACATTT
>HZ182180.1 JP 2015517466-A/2562: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATGTGATTTG
>HZ182179.1 JP 2015517466-A/2561: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATCACATTTA
>HZ182178.1 JP 2015517466-A/2560: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAATGTGATTT
>HZ182177.1 JP 2015517466-A/2559: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATCACATTTAT
>HZ182176.1 JP 2015517466-A/2558: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAAATGTGATT
>HZ182175.1 JP 2015517466-A/2557: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCACATTTATT
>HZ182174.1 JP 2015517466-A/2556: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATAAATGTGAT
>HZ182173.1 JP 2015517466-A/2555: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCACATTTATTT
>HZ182172.1 JP 2015517466-A/2554: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAATAAATGTGA
>HZ182171.1 JP 2015517466-A/2553: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACATTTATTTC
>HZ182170.1 JP 2015517466-A/2552: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAATAAATGTG
>HZ182169.1 JP 2015517466-A/2551: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACATTTATTTCC
>HZ182168.1 JP 2015517466-A/2550: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGAAATAAATGT
>HZ182167.1 JP 2015517466-A/2549: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATTTATTTCCT
>HZ182166.1 JP 2015517466-A/2548: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGAAATAAATG
>HZ182165.1 JP 2015517466-A/2547: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTATTTCCTA
>HZ182164.1 JP 2015517466-A/2546: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGGAAATAAAT
>HZ182163.1 JP 2015517466-A/2545: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTATTTCCTAC
>HZ182162.1 JP 2015517466-A/2544: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTAGGAAATAAA
>HZ182161.1 JP 2015517466-A/2543: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATTTCCTACT
>HZ182160.1 JP 2015517466-A/2542: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTAGGAAATAA
>HZ182159.1 JP 2015517466-A/2541: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTTCCTACTA
>HZ182158.1 JP 2015517466-A/2540: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGTAGGAAATA
>HZ182157.1 JP 2015517466-A/2539: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTCCTACTAG
>HZ182156.1 JP 2015517466-A/2538: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAGTAGGAAAT
>HZ182155.1 JP 2015517466-A/2537: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTCCTACTAGG
>HZ182154.1 JP 2015517466-A/2536: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTAGTAGGAAA
>HZ182153.1 JP 2015517466-A/2535: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCCTACTAGGA
>HZ182152.1 JP 2015517466-A/2534: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTAGTAGGAA
>HZ182151.1 JP 2015517466-A/2533: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTACTAGGAC
>HZ182150.1 JP 2015517466-A/2532: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCCTAGTAGGA
>HZ182149.1 JP 2015517466-A/2531: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTACTAGGACC
>HZ182148.1 JP 2015517466-A/2530: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTCCTAGTAGG
>HZ182147.1 JP 2015517466-A/2529: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTACTAGGACCA
>HZ182146.1 JP 2015517466-A/2528: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGTCCTAGTAG
>HZ182145.1 JP 2015517466-A/2527: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACTAGGACCAT
>HZ182144.1 JP 2015517466-A/2526: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGGTCCTAGTA
>HZ182143.1 JP 2015517466-A/2525: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTAGGACCATA
>HZ182142.1 JP 2015517466-A/2524: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATGGTCCTAGT
>HZ182141.1 JP 2015517466-A/2523: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTAGGACCATAG
>HZ182140.1 JP 2015517466-A/2522: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTATGGTCCTAG
>HZ182139.1 JP 2015517466-A/2521: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGGACCATAGG
>HZ182138.1 JP 2015517466-A/2520: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTATGGTCCTA
>HZ182137.1 JP 2015517466-A/2519: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGACCATAGGT
>HZ182136.1 JP 2015517466-A/2518: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCTATGGTCCT
>HZ182135.1 JP 2015517466-A/2517: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGACCATAGGTA
>HZ182134.1 JP 2015517466-A/2516: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACCTATGGTCC
>HZ182133.1 JP 2015517466-A/2515: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACCATAGGTAC
>HZ182132.1 JP 2015517466-A/2514: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTACCTATGGTC
>HZ182131.1 JP 2015517466-A/2513: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACCATAGGTACA
>HZ182130.1 JP 2015517466-A/2512: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTACCTATGGT
>HZ182129.1 JP 2015517466-A/2511: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCATAGGTACAT
>HZ182128.1 JP 2015517466-A/2510: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGTACCTATGG
>HZ182127.1 JP 2015517466-A/2509: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATAGGTACATC
>HZ182126.1 JP 2015517466-A/2508: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATGTACCTATG
>HZ182125.1 JP 2015517466-A/2507: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATAGGTACATCT
>HZ182124.1 JP 2015517466-A/2506: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGATGTACCTAT
>HZ182123.1 JP 2015517466-A/2505: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAGGTACATCTT
>HZ182122.1 JP 2015517466-A/2504: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGATGTACCTA
>HZ179394.1 JP 2015516985-A/18: ANTI-GCC ANTIBODY MOLECULES AND USE OF SAME TO TEST FOR SUSCEPTIBILITY TO GCC-TARGETED THERAPY
AGTCCTAACTTG
>HZ171517.1 JP 2015516146-A/40: COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
GGACGAAACACC
>HZ182121.1 JP 2015517466-A/2503: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGTACATCTTC
>HZ182120.1 JP 2015517466-A/2502: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAAGATGTACCT
>HZ182119.1 JP 2015517466-A/2501: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGTACATCTTCA
>HZ182118.1 JP 2015517466-A/2500: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAAGATGTACC
>HZ182117.1 JP 2015517466-A/2499: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTACATCTTCAG
>HZ182116.1 JP 2015517466-A/2498: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGAAGATGTAC
>HZ182115.1 JP 2015517466-A/2497: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TACATCTTCAGA
>HZ182114.1 JP 2015517466-A/2496: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTGAAGATGTA
>HZ182113.1 JP 2015517466-A/2495: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACATCTTCAGAG
>HZ182112.1 JP 2015517466-A/2494: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTCTGAAGATGT
>HZ182111.1 JP 2015517466-A/2493: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATCTTCAGAGT
>HZ182110.1 JP 2015517466-A/2492: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTCTGAAGATG
>HZ182109.1 JP 2015517466-A/2491: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCTTCAGAGTC
>HZ182108.1 JP 2015517466-A/2490: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACTCTGAAGAT
>HZ182107.1 JP 2015517466-A/2489: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCTTCAGAGTCC
>HZ182106.1 JP 2015517466-A/2488: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGACTCTGAAGA
>HZ182105.1 JP 2015517466-A/2487: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTCAGAGTCCT
>HZ182104.1 JP 2015517466-A/2486: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGGACTCTGAAG
>HZ182103.1 JP 2015517466-A/2485: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCAGAGTCCTT
>HZ182102.1 JP 2015517466-A/2484: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGGACTCTGAA
>HZ182101.1 JP 2015517466-A/2483: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCAGAGTCCTTA
>HZ182100.1 JP 2015517466-A/2482: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAGGACTCTGA
>HZ182099.1 JP 2015517466-A/2481: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAGAGTCCTTAA
>HZ182098.1 JP 2015517466-A/2480: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAAGGACTCTG
>HZ182097.1 JP 2015517466-A/2479: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGTCCTTAAC
>HZ182096.1 JP 2015517466-A/2478: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTAAGGACTCT
>HZ182095.1 JP 2015517466-A/2477: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGTCCTTAACT
>HZ182094.1 JP 2015517466-A/2476: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTTAAGGACTC
>HZ182093.1 JP 2015517466-A/2475: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTCCTTAACTC
>HZ182092.1 JP 2015517466-A/2474: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAGTTAAGGACT
>HZ182091.1 JP 2015517466-A/2473: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCCTTAACTCT
>HZ182090.1 JP 2015517466-A/2472: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGAGTTAAGGAC
>HZ182089.1 JP 2015517466-A/2471: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCTTAACTCTT
>HZ182088.1 JP 2015517466-A/2470: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGAGTTAAGGA
>HZ182087.1 JP 2015517466-A/2469: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCTTAACTCTTT
>HZ182086.1 JP 2015517466-A/2468: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAGAGTTAAGG
>HZ182085.1 JP 2015517466-A/2467: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTTAACTCTTTT
>HZ182084.1 JP 2015517466-A/2466: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAAAGAGTTAAG
>HZ182083.1 JP 2015517466-A/2465: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAACTCTTTTA
>HZ182082.1 JP 2015517466-A/2464: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAAAAGAGTTAA
>HZ182081.1 JP 2015517466-A/2463: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TAACTCTTTTAA
>HZ182080.1 JP 2015517466-A/2462: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTAAAAGAGTTA
>HZ182079.1 JP 2015517466-A/2461: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AACTCTTTTAAT
>HZ182078.1 JP 2015517466-A/2460: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTAAAAGAGTT
>HZ181675.1 JP 2015517466-A/2057: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTGTTGGATCA
>HZ181674.1 JP 2015517466-A/2056: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGATCCAACAAT
>HZ181673.1 JP 2015517466-A/2055: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTTGGATCAT
>HZ181672.1 JP 2015517466-A/2054: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATGATCCAACAA
>HZ181671.1 JP 2015517466-A/2053: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTTGGATCATA
>HZ181670.1 JP 2015517466-A/2052: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATGATCCAACA
>HZ181669.1 JP 2015517466-A/2051: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTGGATCATAT
>HZ181668.1 JP 2015517466-A/2050: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATGATCCAAC
>HZ181667.1 JP 2015517466-A/2049: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGGATCATATT
>HZ181666.1 JP 2015517466-A/2048: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATATGATCCAA
>HZ181665.1 JP 2015517466-A/2047: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGATCATATTC
>HZ181664.1 JP 2015517466-A/2046: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATATGATCCA
>HZ181663.1 JP 2015517466-A/2045: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGATCATATTCG
>HZ181662.1 JP 2015517466-A/2044: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGAATATGATCC
>HZ181661.1 JP 2015517466-A/2043: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GATCATATTCGT
>HZ181660.1 JP 2015517466-A/2042: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACGAATATGATC
>HZ181659.1 JP 2015517466-A/2041: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCATATTCGTC
>HZ181658.1 JP 2015517466-A/2040: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACGAATATGAT
>HZ181657.1 JP 2015517466-A/2039: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCATATTCGTCC
>HZ181656.1 JP 2015517466-A/2038: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GGACGAATATGA
>HZ181655.1 JP 2015517466-A/2037: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATATTCGTCCA
>HZ181654.1 JP 2015517466-A/2036: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGGACGAATATG
>HZ181653.1 JP 2015517466-A/2035: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATATTCGTCCAC
>HZ181652.1 JP 2015517466-A/2034: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTGGACGAATAT
>HZ181651.1 JP 2015517466-A/2033: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATTCGTCCACA
>HZ181650.1 JP 2015517466-A/2032: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGTGGACGAATA
>HZ181649.1 JP 2015517466-A/2031: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTCGTCCACAA
>HZ181648.1 JP 2015517466-A/2030: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTGTGGACGAAT
>HZ181647.1 JP 2015517466-A/2029: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTCGTCCACAAA
>HZ181646.1 JP 2015517466-A/2028: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTGTGGACGAA
>HZ181645.1 JP 2015517466-A/2027: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCGTCCACAAAA
>HZ181644.1 JP 2015517466-A/2026: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTTGTGGACGA
>HZ181643.1 JP 2015517466-A/2025: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CGTCCACAAAAT
>HZ181642.1 JP 2015517466-A/2024: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATTTTGTGGACG
>HZ181641.1 JP 2015517466-A/2023: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTCCACAAAATG
>HZ181640.1 JP 2015517466-A/2022: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CATTTTGTGGAC
>HZ181639.1 JP 2015517466-A/2021: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCCACAAAATGA
>HZ181638.1 JP 2015517466-A/2020: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TCATTTTGTGGA
>HZ181637.1 JP 2015517466-A/2019: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CCACAAAATGAT
>HZ181636.1 JP 2015517466-A/2018: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ATCATTTTGTGG
>HZ181635.1 JP 2015517466-A/2017: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CACAAAATGATT
>HZ181634.1 JP 2015517466-A/2016: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATCATTTTGTG
>HZ181633.1 JP 2015517466-A/2015: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACAAAATGATTC
>HZ181632.1 JP 2015517466-A/2014: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATCATTTTGT
>HZ181631.1 JP 2015517466-A/2013: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAAATGATTCT
>HZ181499.1 JP 2015517466-A/1881: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CAAGTTTATATT
>HZ181498.1 JP 2015517466-A/1880: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AATATAAACTTG
>HZ181497.1 JP 2015517466-A/1879: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AAGTTTATATTC
>HZ181496.1 JP 2015517466-A/1878: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GAATATAAACTT
>HZ181495.1 JP 2015517466-A/1877: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
AGTTTATATTCA
>HZ181494.1 JP 2015517466-A/1876: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGAATATAAACT
>HZ181493.1 JP 2015517466-A/1875: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GTTTATATTCAG
>HZ181492.1 JP 2015517466-A/1874: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
CTGAATATAAAC
>HZ181491.1 JP 2015517466-A/1873: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTTATATTCAGT
>HZ181490.1 JP 2015517466-A/1872: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
ACTGAATATAAA
>HZ181489.1 JP 2015517466-A/1871: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TTATATTCAGTC
>HZ181488.1 JP 2015517466-A/1870: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
GACTGAATATAA
>HZ181487.1 JP 2015517466-A/1869: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TATATTCAGTCA
>HZ181486.1 JP 2015517466-A/1868: ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
TGACTGAATATA
>HZ165704.1 WO 2015108000-A/20: METHOD OF DETERMINING RESISTANCE OF TABACCO TO ERYSIPHE CICHORACEARUM AND USE THEREOF
AAAAATTAAATA
>HZ083395.1 JP 2015513906-A/752: Stem Cell Microparticles
GTGCCCTTCTTC
>HZ083390.1 JP 2015513906-A/747: Stem Cell Microparticles
GGGTCCGGTGCG
>HZ098999.1 JP 2015514418-A/194: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
CNGGCNGGCNGG
>HZ098983.1 JP 2015514418-A/178: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NGGNGGNGGNGG
>HZ098998.1 JP 2015514418-A/193: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NAGGNAGGNAGG
>HZ098973.1 JP 2015514418-A/168: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
GGNGGNGGNGGN
>HZ086814.1 JP 2015513914-A/3107: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
ATGTGGACCTAG
>JE996754.1 Sequence 30 from Patent WO2015113725
TGCGTCAGTTCA
>JE996736.1 Sequence 12 from Patent WO2015113725
TGCGTCAGTTCA
>JE956328.1 Sequence 752 from Patent WO2015052527
GTGCCCTTCTTC
>JE956323.1 Sequence 747 from Patent WO2015052527
GGGTCCGGTGCG
>JE993792.1 Sequence 41 from Patent EP2821487
TCCCACCCCACC
>JE993791.1 Sequence 40 from Patent EP2821487
TCCCACCCCGCC
>JE987959.1 Sequence 22 from Patent WO2015061573
ACCCATGCCCGA
>JE987958.1 Sequence 21 from Patent WO2015061573
ACGGGCATGGGA
>JE987932.1 Sequence 51 from Patent WO2015061536
ATCTAATAAGCT
>JE987931.1 Sequence 50 from Patent WO2015061536
AATCTAATAAGC
>JE987925.1 Sequence 44 from Patent WO2015061536
TCTAATAAGCTA
>JE987918.1 Sequence 37 from Patent WO2015061536
GTCTGATAAGCT
>JE987917.1 Sequence 36 from Patent WO2015061536
AGTCTGATAAGC
>JE987903.1 Sequence 22 from Patent WO2015061536
TCTGATAAGCTA
>JE986491.1 Sequence 6 from Patent WO2015061103
TGGATAGATGAA
>HZ072577.1 JP 2014057596-A/43: MN/CA9 Splice Variants
TCGCAGGTGACA
>HZ070931.1 JP 2014043448-A/659: Albumin Fusion Proteins
GGGGACTTTCCC
>HZ066440.1 JP 2013208118-A/659: Albumin Fusion Proteins
GGGGACTTTCCC
>HZ062557.1 JP 2013172734-A/659: Albumin Fusion Proteins
GGGGACTTTCCC
>HZ061821.1 JP 2015156805-A/6: Measuring method of inhibitory activity of polymerase inhibitor
CCCCCCCCCCCC
>HZ059985.1 JP 2015512254-A/37: BORONIC ACID CONJUGATES OF OLIGONUCLEOTIDE ANALOGUES
CAGGCAGGCAGG
>HZ059979.1 JP 2015512254-A/31: BORONIC ACID CONJUGATES OF OLIGONUCLEOTIDE ANALOGUES
GCAGCAGCAGCA
>HZ059975.1 JP 2015512254-A/27: BORONIC ACID CONJUGATES OF OLIGONUCLEOTIDE ANALOGUES
AGCAGCAGCAGC
>HZ059971.1 JP 2015512254-A/23: BORONIC ACID CONJUGATES OF OLIGONUCLEOTIDE ANALOGUES
CAGCAGCAGCAG
>HZ047010.1 JP 2015107118-A/61: HUMAN C-FMS ANTIGEN BINDING PROTEINS
GGGAAAGGGAAA
>HZ046340.1 JP 2015112062-A/23: A method to render nuclease resistance to a RNA molecule, and a chimeric RNA molecule having nuclease resistance
GGTTAGGGTTAG
>HZ046323.1 JP 2015112062-A/6: A method to render nuclease resistance to a RNA molecule, and a chimeric RNA molecule having nuclease resistance
NNNNNNNNNNAG
>JE982171.1 Sequence 17 from Patent EP2865766
ACATTAACGGAC
>JE980148.1 Sequence 27 from Patent WO2015110813
TTTTTTTTTTTT
>JE977545.1 Sequence 31 from Patent EP2896696
ANTCGTTGCTNA
>JE977542.1 Sequence 28 from Patent EP2896696
ANTCGTTGCTNA
>JE977539.1 Sequence 25 from Patent EP2896696
ATCGTNNTGCTA
>JE977538.1 Sequence 24 from Patent EP2896696
ATCGNNTTGCTA
>JE977536.1 Sequence 22 from Patent EP2896696
ATCNGTTNGCTA
>JE977535.1 Sequence 21 from Patent EP2896696
ATCNNGTTGCTA
>JE977251.1 Sequence 9 from Patent WO2015058097
GGATCGAAATGG
>JE966906.1 Sequence 5 from Patent EP2861738
CAANNNNNGTGG
>JE966904.1 Sequence 3 from Patent EP2861738
CGANNNNNNTGC
>JE966946.1 Sequence 5 from Patent EP2864345
GCSTSACSSSAT
>JE964794.1 Sequence 12 from Patent EP2863956
TGCCGTGCTGCT
>JE964793.1 Sequence 11 from Patent EP2863956
TGCTGTGCTGCT
>JE964792.1 Sequence 10 from Patent EP2863956
TGACGTGCTGCT
>JE964791.1 Sequence 9 from Patent EP2863956
TGATGTGCTGCT
>JE964790.1 Sequence 8 from Patent EP2863956
TTCCGTGCTGCT
>JE964789.1 Sequence 7 from Patent EP2863956
TTCTGTGCTGCT
>JE964788.1 Sequence 6 from Patent EP2863956
TTACGTGCTGCT
>JE964787.1 Sequence 5 from Patent EP2863956
TTATGTGCTGCT
>JE999640.1 Sequence 8 from Patent EP2905621
TCACTGCTCCAG
>JE999639.1 Sequence 7 from Patent EP2905621
GTCCCTCCCACA
>JE999638.1 Sequence 6 from Patent EP2905621
GAGAGTGAAGGG
>JE999637.1 Sequence 5 from Patent EP2905621
TTCTGCAGGCTG
>JE999622.1 Sequence 28 from Patent EP2905332
TTTTTTTTTTTT
>JE962982.1 Sequence 2 from Patent EP2899197
AGCAAAAAACGC
>JE962981.1 Sequence 1 from Patent EP2899197
GCGTTTTTTGCT
>JE962736.1 Sequence 78 from Patent EP2819703
GTGAAGCAGATG
>JE852429.1 Sequence 38 from Patent EP2910568
CGTCTGGACAAG
>JE852415.1 Sequence 24 from Patent EP2910568
GTGGCGGCCCTG
>JE852413.1 Sequence 22 from Patent EP2910568
GATCCAGACAAG
>JE852412.1 Sequence 21 from Patent EP2910568
CAGGGTGGCTGG
>JE954575.1 Sequence 752 from Patent WO2015052526
GTGCCCTTCTTC
>JE954570.1 Sequence 747 from Patent WO2015052526
GGGTCCGGTGCG
>JE844413.1 Sequence 16 from Patent WO2015092440
CAGCCACCATGG
>JE840533.1 Sequence 22 from Patent EP2898887
CGCCCTTCTCAG
>JE840532.1 Sequence 21 from Patent EP2898887
CCCTTCTCAGTT
>JE840525.1 Sequence 14 from Patent EP2898887
TAGGGTTAGACA
>JE867192.1 Sequence 346 from Patent WO2015128509
CTRAYYNNCAGG
>JE837179.1 Sequence 42 from Patent WO2015074756
ACGACGGCCAGT
>JE837150.1 Sequence 13 from Patent WO2015074756
ACGACGGCCAGT
>JE866232.1 Sequence 208 from Patent EP2915542
GACAAAACTCAC
>JE836493.1 Sequence 140 from Patent EP2909321
GGACAAAAACGA
>JE862820.1 Sequence 14 from Patent EP2910646
CCGCAGCATACG
>HZ044229.1 JP 2015509958-A/61: METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE
CTGCTGCTGCTG
>HZ044225.1 JP 2015509958-A/57: METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE
GCAGCAGCAGCA
>HZ042212.1 JP 2015509922-A/169: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
AGGACATTGGCA
>HZ042196.1 JP 2015509922-A/153: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
AGGAAGATGGCA
>HZ042191.1 JP 2015509922-A/148: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
ACAGATCTGTCA
>HZ042132.1 JP 2015509922-A/89: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
NGGNNNNNGGNN
>HZ042116.1 JP 2015509922-A/73: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
NGGNNGNNGGNN
>HZ042111.1 JP 2015509922-A/68: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
NNNGNNNNGNNN
>HZ040720.1 JP 2015510504-A/70: Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
GGGTTTTTTGGG
>HZ040709.1 JP 2015510504-A/59: Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
GGTTTTTTTTGG
>HZ038786.1 WO 2015064718-A/2: Method of Inhibitiion of Photo-crosslinking, and Self-crosslinking Inhibitory Type Photo-responsive Nucleic Acid
GNANAGAGNGNA
>HZ038785.1 WO 2015064718-A/1: Method of Inhibitiion of Photo-crosslinking, and Self-crosslinking Inhibitory Type Photo-responsive Nucleic Acid
GTANAGAGTGTA
>HZ037974.1 JP 2015091834-A/17: Treatment for alpha-Galactosidase A Deficiency
CTAGTCCTAGGA
>HZ035822.1 JP 2015091796-A/47: Method for diagnosing or treating of cancer using anti-EREG antibody
GTTATGGCCTAC
>HZ035274.1 JP 2015093853-A/3: Boranophosphate compound and nucleic acid oligomer
GCATTGGTATTC
>HZ035273.1 JP 2015093853-A/2: Boranophosphate compound and nucleic acid oligomer
CGTAACCATAAG
>HZ035272.1 JP 2015093853-A/1: Boranophosphate compound and nucleic acid oligomer
CGTAACCATAAG
>DI483194.1 KR 1020140130699-A/29: ANTI-LIPOARABINOMANNAN ANTIBODY AND IMMUNOASSAY FOR ACID-FAST BACILLARY INFECTION USING THE ANTIBODY
ACCTGCGGCCGC
>HW832646.1 JP 2015053935-A/102: The detection and use of genetic polymorphism of Monkeys CYP2C and CYP2D genes
GACATAATCCAT
>HW832642.1 JP 2015053935-A/98: The detection and use of genetic polymorphism of Monkeys CYP2C and CYP2D genes
AACCAGTCTCTC
>HW767301.1 JP 2014527396-A/41: ANTI-HXCR1 ANTIBODY
ACATCACTCCGT
>HW832754.1 JP 2015053935-A/210: The detection and use of genetic polymorphism of Monkeys CYP2C and CYP2D genes
CCGGATGGCCCC
>HW832738.1 JP 2015053935-A/194: The detection and use of genetic polymorphism of Monkeys CYP2C and CYP2D genes
ACCTGTGCATAG
>HW832188.1 JP 2015039365-A/4: Kit and method for detection of prostate cancer
TGGGGGAGAGGC
>HW662034.1 JP 2013172750-A/154: Compositions and methods for detection of hepatitis A virus nucleic acid
GAAACACTGGTC
>HW645692.1 JP 2014196306-A/70: Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
GGGTTTTTTGGG
>HW645681.1 JP 2014196306-A/59: Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
GGTTTTTTTTGG
>HW943423.1 JP 2015508661-A/2315: MULTIMODAL PCR TARGET DETECTION
GTACGTTCGCTA
>HW817861.1 WO 2015025864-A/13: Methods of measuring modified nucleobases with absorbent polynucleotide and kits therefor
CCCCCCCCCCCC
>HW766512.1 JP 2014528698-A/175: COMPOSITIONS AND METHOD FOR DETECTING HUMAN PARVOVIRUS NUCLEIC ACID AND FOR DETECTING HEPATITIS A VIRUS NUCLEIC ACIDS IN SINGLE-PLEX OR MULTIPLEX ASSAYS
GGAAAATTAATC
>HW766510.1 JP 2014528698-A/173: COMPOSITIONS AND METHOD FOR DETECTING HUMAN PARVOVIRUS NUCLEIC ACID AND FOR DETECTING HEPATITIS A VIRUS NUCLEIC ACIDS IN SINGLE-PLEX OR MULTIPLEX ASSAYS
GAATWATGAAAG
>DI482226.1 KR 1020140120933-A/84: Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
GGGTTTTTTGGG
>DI482215.1 KR 1020140120933-A/73: Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
GGTTTTTTTTGG
>DI445471.1 KR 1020140102677-A/25: ANTI-HUMAN TROP-2 ANTIBODY HAVING AN ANTITUMOR ACTIVITY IN VIVO
GCTGTCCTGATC
>DI445470.1 KR 1020140102677-A/24: ANTI-HUMAN TROP-2 ANTIBODY HAVING AN ANTITUMOR ACTIVITY IN VIVO
TCCAKAGTTCCA
>HW943114.1 JP 2015508661-A/2006: MULTIMODAL PCR TARGET DETECTION
CGGTTTATACAT
>HW943006.1 JP 2015508661-A/1898: MULTIMODAL PCR TARGET DETECTION
AACTTGTATCGT
>HW660942.1 JP 2014523748-A/18: METHODS AND COMPOSITIONS FOR ALTERATION OF A CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE
TTATAGTAACCA
>DI445266.1 KR 1020140091587-A/112: COMPOUNDS FOR THE MODULATION OF SMN2 SPLICING
AACAAAGTCACA
>DI445264.1 KR 1020140091587-A/110: COMPOUNDS FOR THE MODULATION OF SMN2 SPLICING
CAAAGTCACATA
>HW942852.1 JP 2015508661-A/1744: MULTIMODAL PCR TARGET DETECTION
CTTTGTACTAGA
>DI445262.1 KR 1020140091587-A/108: COMPOUNDS FOR THE MODULATION OF SMN2 SPLICING
AAGTCACATAAC
>DI445260.1 KR 1020140091587-A/106: COMPOUNDS FOR THE MODULATION OF SMN2 SPLICING
GTCACATAACTA
>DI445258.1 KR 1020140091587-A/104: COMPOUNDS FOR THE MODULATION OF SMN2 SPLICING
CACATAACTACA
>DI445183.1 KR 1020140091587-A/29: COMPOUNDS FOR THE MODULATION OF SMN2 SPLICING
AACAAAGTCACA
>DI445181.1 KR 1020140091587-A/27: COMPOUNDS FOR THE MODULATION OF SMN2 SPLICING
CAAAGTCACATA
>DI445179.1 KR 1020140091587-A/25: COMPOUNDS FOR THE MODULATION OF SMN2 SPLICING
AAGTCACATAAC
>DI445177.1 KR 1020140091587-A/23: COMPOUNDS FOR THE MODULATION OF SMN2 SPLICING
GTCACATAACTA
>DI445175.1 KR 1020140091587-A/21: COMPOUNDS FOR THE MODULATION OF SMN2 SPLICING
CACATAACTACA
>HW915718.1 JP 2015503351-A/276: GENETIC SWITCHES FOR BUTANOL PRODUCTION
YYYATTGTTCTC
>HW763641.1 JP 2014528900-A/14: NANOPARTICLE COMPOSITIONS
CATGACGTTCCT
>HW913133.1 JP 2015505665-A/61: TDP-43 SPECIFIC BINDING MOLECULES
TTTTTTTTTTTT
>HW913132.1 JP 2015505665-A/60: TDP-43 SPECIFIC BINDING MOLECULES
TGTGTGTGTGTG
>HW828855.1 JP 2014502163-A/11: MGMT-based method for obtaining high yield of recombinant protein expression
GGTGGCGGATCT
>HW827892.1 JP 2013539360-A/70: Complexation of nucleic acids with disulfide-linked cationic polymers for transfection and immunostimulation
GGGTTTTTTGGG
>HW827881.1 JP 2013539360-A/59: Complexation of nucleic acids with disulfide-linked cationic polymers for transfection and immunostimulation
GGTTTTTTTTGG
>HW827789.1 JP 2014055983-A/13: Compositions and Methods Related to Protein Displacement Therapy for Myotonic Dystrophy
CAGCAGCAGCAG
>HW911323.1 JP 2015503608-A/4108: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAAAGTTTAATT
>HW911322.1 JP 2015503608-A/4107: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAAGTTTAATTC
>HW911321.1 JP 2015503608-A/4106: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAGTTTAATTCT
>HW911320.1 JP 2015503608-A/4105: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGTTTAATTCTG
>HW911319.1 JP 2015503608-A/4104: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTTTAATTCTGA
>HW911318.1 JP 2015503608-A/4103: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTTAATTCTGAA
>HW911317.1 JP 2015503608-A/4102: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTAATTCTGAAC
>HW911316.1 JP 2015503608-A/4101: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAATTCTGAACC
>HW911315.1 JP 2015503608-A/4100: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AATTCTGAACCA
>HW911314.1 JP 2015503608-A/4099: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTCTGAACCAT
>HW911313.1 JP 2015503608-A/4098: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTCTGAACCATT
>HW911312.1 JP 2015503608-A/4097: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATAACCGCATTT
>HW911311.1 JP 2015503608-A/4096: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAACCGCATTTT
>HW911310.1 JP 2015503608-A/4095: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AACCGCATTTTC
>HW911309.1 JP 2015503608-A/4094: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACCGCATTTTCT
>HW911308.1 JP 2015503608-A/4093: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCGCATTTTCTC
>HW911307.1 JP 2015503608-A/4092: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CGCATTTTCTCT
>HW911306.1 JP 2015503608-A/4091: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GCATTTTCTCTT
>HW911305.1 JP 2015503608-A/4090: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CATTTTCTCTTG
>HW911304.1 JP 2015503608-A/4089: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TATCACAGCAGG
>HW911303.1 JP 2015503608-A/4088: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATCACAGCAGGT
>HW911302.1 JP 2015503608-A/4087: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCACAGCAGGTT
>HW911301.1 JP 2015503608-A/4086: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CACAGCAGGTTA
>HW911300.1 JP 2015503608-A/4085: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACAGCAGGTTAC
>HW911299.1 JP 2015503608-A/4084: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAGCAGGTTACA
>HW911298.1 JP 2015503608-A/4083: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGCAGGTTACAA
>HW911297.1 JP 2015503608-A/4082: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GCAGGTTACAAC
>HW911296.1 JP 2015503608-A/4081: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAGGTTACAACA
>HW911295.1 JP 2015503608-A/4080: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGGTTACAACAA
>HW911294.1 JP 2015503608-A/4079: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GGTTACAACAAC
>HW911293.1 JP 2015503608-A/4078: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTTACAACAACT
>HW911292.1 JP 2015503608-A/4077: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTACAACAACTT
>HW911291.1 JP 2015503608-A/4076: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TACAACAACTTT
>HW911290.1 JP 2015503608-A/4075: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACAACAACTTTG
>HW911289.1 JP 2015503608-A/4074: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAACAACTTTGG
>HW911288.1 JP 2015503608-A/4073: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AACAACTTTGGG
>HW911287.1 JP 2015503608-A/4072: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACAACTTTGGGA
>HW911286.1 JP 2015503608-A/4071: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAACTTTGGGAT
>HW911285.1 JP 2015503608-A/4070: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AACTTTGGGATA
>HW911284.1 JP 2015503608-A/4069: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACTTTGGGATAA
>HW911283.1 JP 2015503608-A/4068: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTTTGGGATAAA
>HW911282.1 JP 2015503608-A/4067: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTTGGGATAAAA
>HW911281.1 JP 2015503608-A/4066: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTGGGATAAAAG
>HW911280.1 JP 2015503608-A/4065: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGGGATAAAAGG
>HW911279.1 JP 2015503608-A/4064: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GGGATAAAAGGC
>HW911278.1 JP 2015503608-A/4063: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GGATAAAAGGCA
>HW911277.1 JP 2015503608-A/4062: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GATAAAAGGCAA
>HW911276.1 JP 2015503608-A/4061: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATAAAAGGCAAC
>HW911275.1 JP 2015503608-A/4060: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAAAAGGCAACT
>HW911274.1 JP 2015503608-A/4059: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAAAGGCAACTG
>HW911273.1 JP 2015503608-A/4058: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAAGGCAACTGG
>HW911272.1 JP 2015503608-A/4057: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAGGCAACTGGT
>HW911271.1 JP 2015503608-A/4056: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AACTGGTAAACT
>HW911270.1 JP 2015503608-A/4055: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACTGGTAAACTG
>HW911269.1 JP 2015503608-A/4054: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTGGTAAACTGT
>HW911268.1 JP 2015503608-A/4053: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGGTAAACTGTC
>HW911267.1 JP 2015503608-A/4052: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GGTAAACTGTCC
>HW911266.1 JP 2015503608-A/4051: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTAAACTGTCCA
>HW911265.1 JP 2015503608-A/4050: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAAACTGTCCAA
>HW911264.1 JP 2015503608-A/4049: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAACTGTCCAAA
>HW911263.1 JP 2015503608-A/4048: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AACTGTCCAAAA
>HW911262.1 JP 2015503608-A/4047: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACTGTCCAAAAC
>HW911261.1 JP 2015503608-A/4046: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTGTCCAAAACA
>HW911260.1 JP 2015503608-A/4045: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGTCCAAAACAA
>HW911259.1 JP 2015503608-A/4044: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTCCAAAACAAG
>HW911258.1 JP 2015503608-A/4043: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCCAAAACAAGG
>HW911257.1 JP 2015503608-A/4042: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCAAAACAAGGT
>HW911256.1 JP 2015503608-A/4041: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAAAACAAGGTT
>HW911255.1 JP 2015503608-A/4040: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAAACAAGGTTC
>HW911254.1 JP 2015503608-A/4039: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAACAAGGTTCC
>HW911253.1 JP 2015503608-A/4038: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GGTTCCAAATAA
>HW911252.1 JP 2015503608-A/4037: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTTCCAAATAAC
>HW911251.1 JP 2015503608-A/4036: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTCCAAATAACA
>HW911250.1 JP 2015503608-A/4035: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCCAAATAACAC
>HW911249.1 JP 2015503608-A/4034: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCAAATAACACC
>HW911248.1 JP 2015503608-A/4033: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAAATAACACCT
>HW911247.1 JP 2015503608-A/4032: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAATAACACCTC
>HW911246.1 JP 2015503608-A/4031: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AATAACACCTCT
>HW911245.1 JP 2015503608-A/4030: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATAACACCTCTT
>HW911244.1 JP 2015503608-A/4029: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAACACCTCTTA
>HW911243.1 JP 2015503608-A/4028: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AACACCTCTTAC
>HW911242.1 JP 2015503608-A/4027: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACACCTCTTACT
>HW911241.1 JP 2015503608-A/4026: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CACCTCTTACTG
>HW911240.1 JP 2015503608-A/4025: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACCTCTTACTGA
>HW911239.1 JP 2015503608-A/4024: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCTCTTACTGAT
>HW911238.1 JP 2015503608-A/4023: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTCTTACTGATT
>HW911237.1 JP 2015503608-A/4022: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCTTACTGATTT
>HW911236.1 JP 2015503608-A/4021: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTTACTGATTTA
>HW911235.1 JP 2015503608-A/4020: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTACTGATTTAC
>HW911234.1 JP 2015503608-A/4019: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TACTGATTTACC
>HW911233.1 JP 2015503608-A/4018: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACTGATTTACCC
>HW911232.1 JP 2015503608-A/4017: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTGATTTACCCT
>HW911231.1 JP 2015503608-A/4016: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGATTTACCCTA
>HW911230.1 JP 2015503608-A/4015: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GATTTACCCTAC
>HW911229.1 JP 2015503608-A/4014: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTTACCCTACC
>HW911228.1 JP 2015503608-A/4013: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACCCTACCCATA
>HW911227.1 JP 2015503608-A/4012: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCCTACCCATAC
>HW911226.1 JP 2015503608-A/4011: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCTACCCATACA
>HW911225.1 JP 2015503608-A/4010: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTACCCATACAT
>HW911224.1 JP 2015503608-A/4009: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TACCCATACATA
>HW911223.1 JP 2015503608-A/4008: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACCCATACATAT
>HW911222.1 JP 2015503608-A/4007: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCCATACATATC
>HW911221.1 JP 2015503608-A/4006: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCATACATATCC
>HW911220.1 JP 2015503608-A/4005: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CATACATATCCC
>HW911219.1 JP 2015503608-A/4004: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATACATATCCCA
>HW911218.1 JP 2015503608-A/4003: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TACATATCCCAA
>HW911217.1 JP 2015503608-A/4002: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACATATCCCAAA
>HW911216.1 JP 2015503608-A/4001: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CATATCCCAAAT
>HW911215.1 JP 2015503608-A/4000: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CATGAAATAGAT
>HW911214.1 JP 2015503608-A/3999: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATGAAATAGATC
>HW911213.1 JP 2015503608-A/3998: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGAAATAGATCC
>HW911212.1 JP 2015503608-A/3997: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GAAATAGATCCA
>HW911211.1 JP 2015503608-A/3996: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAATAGATCCAC
>HW911210.1 JP 2015503608-A/3995: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AATAGATCCACC
>HW911209.1 JP 2015503608-A/3994: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATAGATCCACCT
>HW911208.1 JP 2015503608-A/3993: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAGATCCACCTG
>HW911207.1 JP 2015503608-A/3992: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGATCCACCTGC
>HW911206.1 JP 2015503608-A/3991: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GATCCACCTGCT
>HW827208.1 JP 2014050400-A/284: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
TTTCACCTGGGT
>HW827207.1 JP 2014050400-A/283: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
TTTTCACCTGGG
>HW827206.1 JP 2014050400-A/282: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
CTTTTCACCTGG
>HW827203.1 JP 2014050400-A/279: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
ACTTTTCACCTG
>HW827200.1 JP 2014050400-A/276: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
TTCACCTGGGTC
>HW827192.1 JP 2014050400-A/268: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
TCCTAGAAAGAS
>HW827191.1 JP 2014050400-A/267: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
GTCCTAGAAAGA
>HW827190.1 JP 2014050400-A/266: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
AGTCCTAGAAAG
>HW827187.1 JP 2014050400-A/263: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
CAGTCCTAGAAS
>HW827184.1 JP 2014050400-A/260: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
CCTAGAAAGAAS
>HW827176.1 JP 2014050400-A/252: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
CAATCAGTCCTN
>HW827175.1 JP 2014050400-A/251: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
CACAATCAGTCC
>HW827173.1 JP 2014050400-A/249: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
CCACAATCAGTC
>HW827170.1 JP 2014050400-A/246: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
AATCAGTCCTAG
>HW827164.1 JP 2014050400-A/240: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
ACAATCAGTCCT
>HW911205.1 JP 2015503608-A/3990: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATCCACCTGCTT
>HW911204.1 JP 2015503608-A/3989: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCCACCTGCTTA
>HW911203.1 JP 2015503608-A/3988: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCACCTGCTTAT
>HW911202.1 JP 2015503608-A/3987: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CACCTGCTTATT
>HW911201.1 JP 2015503608-A/3986: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACCTGCTTATTT
>HW911200.1 JP 2015503608-A/3985: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCTGCTTATTTT
>HW911199.1 JP 2015503608-A/3984: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTGCTTATTTTA
>HW911198.1 JP 2015503608-A/3983: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGCTTATTTTAA
>HW911197.1 JP 2015503608-A/3982: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GCTTATTTTAAG
>HW911196.1 JP 2015503608-A/3981: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTTATTTTAAGC
>HW911195.1 JP 2015503608-A/3980: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTATTTTAAGCA
>HW911194.1 JP 2015503608-A/3979: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TATTTTAAGCAT
>HW911193.1 JP 2015503608-A/3978: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTAATTGGACCA
>HW911192.1 JP 2015503608-A/3977: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAATTGGACCAT
>HW911191.1 JP 2015503608-A/3976: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AATTGGACCATT
>HW911190.1 JP 2015503608-A/3975: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTGGACCATTT
>HW911189.1 JP 2015503608-A/3974: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTGGACCATTTT
>HW911188.1 JP 2015503608-A/3973: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGGACCATTTTC
>HW911187.1 JP 2015503608-A/3972: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GGACCATTTTCT
>HW911186.1 JP 2015503608-A/3971: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GACCATTTTCTA
>HW911185.1 JP 2015503608-A/3970: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACCATTTTCTAT
>HW911184.1 JP 2015503608-A/3969: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCATTTTCTATT
>HW911183.1 JP 2015503608-A/3968: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CATTTTCTATTT
>HW911182.1 JP 2015503608-A/3967: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTTTCTATTTG
>HW911181.1 JP 2015503608-A/3966: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTTTCTATTTGT
>HW911180.1 JP 2015503608-A/3965: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTTCTATTTGTC
>HW911179.1 JP 2015503608-A/3964: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTCTATTTGTCT
>HW911178.1 JP 2015503608-A/3963: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCTATTTGTCTA
>HW911177.1 JP 2015503608-A/3962: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTATTTGTCTAT
>HW911176.1 JP 2015503608-A/3961: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TATTTGTCTATT
>HW911175.1 JP 2015503608-A/3960: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTTGTCTATTT
>HW911174.1 JP 2015503608-A/3959: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTTGTCTATTTT
>HW911173.1 JP 2015503608-A/3958: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTGTCTATTTTA
>HW911172.1 JP 2015503608-A/3957: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGTCTATTTTAT
>HW911171.1 JP 2015503608-A/3956: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTCTATTTTATA
>HW911170.1 JP 2015503608-A/3955: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCTATTTTATAC
>HW911169.1 JP 2015503608-A/3954: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTATTTTATACA
>HW911168.1 JP 2015503608-A/3953: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TATTTTATACAA
>HW911167.1 JP 2015503608-A/3952: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CACTTTATTCAG
>HW911166.1 JP 2015503608-A/3951: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACTTTATTCAGA
>HW911165.1 JP 2015503608-A/3950: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTTTATTCAGAT
>HW911164.1 JP 2015503608-A/3949: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTTATTCAGATT
>HW911163.1 JP 2015503608-A/3948: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTATTCAGATTA
>HW911162.1 JP 2015503608-A/3947: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TATTCAGATTAC
>HW911161.1 JP 2015503608-A/3946: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTCAGATTACA
>HW911160.1 JP 2015503608-A/3945: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTCAGATTACAA
>HW911159.1 JP 2015503608-A/3944: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCAGATTACAAT
>HW911158.1 JP 2015503608-A/3943: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAGATTACAATT
>HW911157.1 JP 2015503608-A/3942: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTAGAGTGATTA
>HW911156.1 JP 2015503608-A/3941: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAGAGTGATTAT
>HW911155.1 JP 2015503608-A/3940: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGAGTGATTATG
>HW911154.1 JP 2015503608-A/3939: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GAGTGATTATGA
>HW911153.1 JP 2015503608-A/3938: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGTGATTATGAA
>HW911152.1 JP 2015503608-A/3937: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTGATTATGAAT
>HW911151.1 JP 2015503608-A/3936: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGATTATGAATT
>HW911150.1 JP 2015503608-A/3935: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GATTATGAATTA
>HW911149.1 JP 2015503608-A/3934: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTATGAATTAG
>HW911148.1 JP 2015503608-A/3933: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTATGAATTAGT
>HW911147.1 JP 2015503608-A/3932: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TATGAATTAGTG
>HW911146.1 JP 2015503608-A/3931: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATGAATTAGTGT
>HW911145.1 JP 2015503608-A/3930: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGAATTAGTGTT
>HW911144.1 JP 2015503608-A/3929: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GAATTAGTGTTC
>HW911143.1 JP 2015503608-A/3928: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AATTAGTGTTCT
>HW911142.1 JP 2015503608-A/3927: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTAGTGTTCTA
>HW911141.1 JP 2015503608-A/3926: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTAGTGTTCTAC
>HW911140.1 JP 2015503608-A/3925: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAGTGTTCTACA
>HW911139.1 JP 2015503608-A/3924: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGTGTTCTACAC
>HW911138.1 JP 2015503608-A/3923: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTGTTCTACACC
>HW911137.1 JP 2015503608-A/3922: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGTTCTACACCA
>HW911136.1 JP 2015503608-A/3921: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTTCTACACCAT
>HW911135.1 JP 2015503608-A/3920: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTCTACACCATT
>HW911134.1 JP 2015503608-A/3919: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCTACACCATTA
>HW911133.1 JP 2015503608-A/3918: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAATTAGAAATT
>HW911132.1 JP 2015503608-A/3917: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AATTAGAAATTG
>HW911131.1 JP 2015503608-A/3916: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTAGAAATTGC
>HW911130.1 JP 2015503608-A/3915: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTAGAAATTGCT
>HW911129.1 JP 2015503608-A/3914: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAGAAATTGCTG
>HW911128.1 JP 2015503608-A/3913: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGAAATTGCTGT
>HW911127.1 JP 2015503608-A/3912: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GAAATTGCTGTA
>HW911126.1 JP 2015503608-A/3911: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTCACTATAACT
>HW911125.1 JP 2015503608-A/3910: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCACTATAACTT
>HW911124.1 JP 2015503608-A/3909: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CACTATAACTTA
>HW911123.1 JP 2015503608-A/3908: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACTATAACTTAA
>HW911122.1 JP 2015503608-A/3907: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTATAACTTAAC
>HW911121.1 JP 2015503608-A/3906: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TATAACTTAACA
>HW911120.1 JP 2015503608-A/3905: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATAACTTAACAC
>HW911119.1 JP 2015503608-A/3904: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAACTTAACACT
>HW911118.1 JP 2015503608-A/3903: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AACTTAACACTA
>HW911117.1 JP 2015503608-A/3902: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACTTAACACTAC
>HW911116.1 JP 2015503608-A/3901: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTTAACACTACG
>HW911115.1 JP 2015503608-A/3900: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTAACACTACGA
>HW911114.1 JP 2015503608-A/3899: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAACACTACGAG
>HW911113.1 JP 2015503608-A/3898: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AACACTACGAGA
>HW911112.1 JP 2015503608-A/3897: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACACTACGAGAG
>HW911111.1 JP 2015503608-A/3896: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CACTACGAGAGA
>HW911110.1 JP 2015503608-A/3895: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACTACGAGAGAC
>HW911109.1 JP 2015503608-A/3894: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTACGAGAGACT
>HW911108.1 JP 2015503608-A/3893: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TACGAGAGACTT
>HW911107.1 JP 2015503608-A/3892: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACGAGAGACTTA
>HW911106.1 JP 2015503608-A/3891: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CGAGAGACTTAA
>HW911105.1 JP 2015503608-A/3890: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GAGAGACTTAAA
>HW911104.1 JP 2015503608-A/3889: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAGTACCATTAC
>HW911103.1 JP 2015503608-A/3888: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGTACCATTACA
>HW911102.1 JP 2015503608-A/3887: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTACCATTACAG
>HW911101.1 JP 2015503608-A/3886: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TACCATTACAGA
>HW911100.1 JP 2015503608-A/3885: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACCATTACAGAT
>HW911099.1 JP 2015503608-A/3884: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCATTACAGATA
>HW911098.1 JP 2015503608-A/3883: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CATTACAGATAT
>HW911097.1 JP 2015503608-A/3882: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTACAGATATT
>HW911096.1 JP 2015503608-A/3881: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTACAGATATTC
>HW911095.1 JP 2015503608-A/3880: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AATTTAACAAGC
>HW911094.1 JP 2015503608-A/3879: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTTAACAAGCA
>HW911093.1 JP 2015503608-A/3878: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTTAACAAGCAA
>HW911092.1 JP 2015503608-A/3877: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTAACAAGCAAG
>HW911091.1 JP 2015503608-A/3876: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAACAAGCAAGG
>HW911090.1 JP 2015503608-A/3875: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AACAAGCAAGGC
>HW911089.1 JP 2015503608-A/3874: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACAAGCAAGGCT
>HW911088.1 JP 2015503608-A/3873: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAAGCAAGGCTA
>HW911087.1 JP 2015503608-A/3872: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAGCAAGGCTAG
>HW911086.1 JP 2015503608-A/3871: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGCAAGGCTAGG
>HW911085.1 JP 2015503608-A/3870: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GCAAGGCTAGGG
>HW911084.1 JP 2015503608-A/3869: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAAGGCTAGGGT
>HW911083.1 JP 2015503608-A/3868: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAGGCTAGGGTT
>HW911082.1 JP 2015503608-A/3867: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGGCTAGGGTTT
>HW911081.1 JP 2015503608-A/3866: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GGCTAGGGTTTG
>HW911080.1 JP 2015503608-A/3865: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GCTAGGGTTTGA
>HW911079.1 JP 2015503608-A/3864: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTAGGGTTTGAT
>HW911078.1 JP 2015503608-A/3863: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAGGGTTTGATA
>HW911077.1 JP 2015503608-A/3862: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGGGTTTGATAA
>HW911076.1 JP 2015503608-A/3861: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GGGTTTGATAAA
>HW911075.1 JP 2015503608-A/3860: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GGTTTGATAAAT
>HW911074.1 JP 2015503608-A/3859: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTTTGATAAATT
>HW911073.1 JP 2015503608-A/3858: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTTGATAAATTC
>HW911072.1 JP 2015503608-A/3857: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTGATAAATTCC
>HW911071.1 JP 2015503608-A/3856: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGATAAATTCCA
>HW911070.1 JP 2015503608-A/3855: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GATAAATTCCAT
>HW911069.1 JP 2015503608-A/3854: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATAAATTCCATC
>HW911068.1 JP 2015503608-A/3853: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TAAATTCCATCT
>HW911067.1 JP 2015503608-A/3852: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAATTCCATCTT
>HW911066.1 JP 2015503608-A/3851: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AATTCCATCTTG
>HW911065.1 JP 2015503608-A/3850: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTCCATCTTGT
>HW911064.1 JP 2015503608-A/3849: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTCCATCTTGTG
>HW911063.1 JP 2015503608-A/3848: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCCATCTTGTGA
>HW911062.1 JP 2015503608-A/3847: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCATCTTGTGAT
>HW911061.1 JP 2015503608-A/3846: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CATCTTGTGATC
>HW911060.1 JP 2015503608-A/3845: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATCTTGTGATCC
>HW911059.1 JP 2015503608-A/3844: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCTTGTGATCCA
>HW911058.1 JP 2015503608-A/3843: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTTGTGATCCAT
>HW911057.1 JP 2015503608-A/3842: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCTTGTGCATTC
>HW911056.1 JP 2015503608-A/3841: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTTGTGCATTCT
>HW911055.1 JP 2015503608-A/3840: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTGTGCATTCTT
>HW911054.1 JP 2015503608-A/3839: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGTGCATTCTTC
>HW911053.1 JP 2015503608-A/3838: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTGCATTCTTCA
>HW911052.1 JP 2015503608-A/3837: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGCATTCTTCAC
>HW911051.1 JP 2015503608-A/3836: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GCATTCTTCACT
>HW911050.1 JP 2015503608-A/3835: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CATTCTTCACTT
>HW911049.1 JP 2015503608-A/3834: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTTCTTGAGTCA
>HW911048.1 JP 2015503608-A/3833: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTCTTGAGTCAC
>HW911047.1 JP 2015503608-A/3832: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCTTGAGTCACT
>HW911046.1 JP 2015503608-A/3831: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CTTGAGTCACTC
>HW911045.1 JP 2015503608-A/3830: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTGAGTCACTCC
>HW911044.1 JP 2015503608-A/3829: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGAGTCACTCCC
>HW911043.1 JP 2015503608-A/3828: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GAGTCACTCCCA
>HW911042.1 JP 2015503608-A/3827: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAAAATCCATTT
>HW911041.1 JP 2015503608-A/3826: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAAATCCATTTG
>HW911040.1 JP 2015503608-A/3825: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAATCCATTTGT
>HW911039.1 JP 2015503608-A/3824: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AATCCATTTGTA
>HW911038.1 JP 2015503608-A/3823: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATCCATTTGTAT
>HW911037.1 JP 2015503608-A/3822: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCCATTTGTATT
>HW911036.1 JP 2015503608-A/3821: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCATTTGTATTG
>HW911035.1 JP 2015503608-A/3820: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CATTTGTATTGT
>HW911034.1 JP 2015503608-A/3819: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTTGTATTGTT
>HW911033.1 JP 2015503608-A/3818: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTTGTATTGTTA
>HW911032.1 JP 2015503608-A/3817: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTGTATTGTTAC
>HW911031.1 JP 2015503608-A/3816: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAAGGATGATTT
>HW911030.1 JP 2015503608-A/3815: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAGGATGATTTA
>HW911029.1 JP 2015503608-A/3814: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGGATGATTTAC
>HW911028.1 JP 2015503608-A/3813: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GGATGATTTACA
>HW911027.1 JP 2015503608-A/3812: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GATGATTTACAG
>HW911026.1 JP 2015503608-A/3811: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATGATTTACAGG
>HW911025.1 JP 2015503608-A/3810: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TGATTTACAGGT
>HW911024.1 JP 2015503608-A/3809: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GATTTACAGGTC
>HW911023.1 JP 2015503608-A/3808: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATTTACAGGTCA
>HW911022.1 JP 2015503608-A/3807: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTTACAGGTCAG
>HW911021.1 JP 2015503608-A/3806: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TTACAGGTCAGT
>HW911020.1 JP 2015503608-A/3805: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TACAGGTCAGTA
>HW911019.1 JP 2015503608-A/3804: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACAGGTCAGTAT
>HW911018.1 JP 2015503608-A/3803: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAGGTCAGTATC
>HW911017.1 JP 2015503608-A/3802: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGGTCAGTATCA
>HW911016.1 JP 2015503608-A/3801: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GGTCAGTATCAA
>HW911015.1 JP 2015503608-A/3800: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTCAGTATCAAA
>HW911014.1 JP 2015503608-A/3799: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCAGTATCAAAC
>HW911013.1 JP 2015503608-A/3798: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAGTATCAAACC
>HW911012.1 JP 2015503608-A/3797: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGTATCAAACCA
>HW911011.1 JP 2015503608-A/3796: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GTATCAAACCAG
>HW911010.1 JP 2015503608-A/3795: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TATCAAACCAGG
>HW911009.1 JP 2015503608-A/3794: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ATCAAACCAGGC
>HW911008.1 JP 2015503608-A/3793: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
TCAAACCAGGCC
>HW911007.1 JP 2015503608-A/3792: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAAACCAGGCCA
>HW827090.1 JP 2014050400-A/166: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
TTTCACCTGGGT
>HW827089.1 JP 2014050400-A/165: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
TTTTCACCTGGG
>HW827088.1 JP 2014050400-A/164: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
CTTTTCACCTGG
>HW827085.1 JP 2014050400-A/161: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
ACTTTTCACCTG
>HW827082.1 JP 2014050400-A/158: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
TTCACCTGGGTC
>HW827074.1 JP 2014050400-A/150: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
TCCTAGAAAGAS
>HW827073.1 JP 2014050400-A/149: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
GTCCTAGAAAGA
>HW827072.1 JP 2014050400-A/148: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
AGTCCTAGAAAG
>HW827069.1 JP 2014050400-A/145: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
CAGTCCTAGAAS
>HW827066.1 JP 2014050400-A/142: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
CCTAGAAAGAAS
>HW827058.1 JP 2014050400-A/134: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
CAATCAGTCCTN
>HW827057.1 JP 2014050400-A/133: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
ACAATCAGTCCT
>HW827056.1 JP 2014050400-A/132: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
CACAATCAGTCC
>HW827053.1 JP 2014050400-A/129: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
CCACAATCAGTC
>HW827050.1 JP 2014050400-A/126: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS
AATCAGTCCTAG
>HW911006.1 JP 2015503608-A/3791: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AAACCAGGCCAG
>HW826623.1 JP 2014027947-A/12: Compositions and Methods for Inhibiting Endogenous Immunoglobulin Genes and Producing Transgenic Human Idiotype Antibodies
GTTCTGGTAGTT
>HW800320.1 JP 2014531196-A/5: Hairpin Loop Method
TTTNTTNNTTTN
>HW800319.1 JP 2014531196-A/4: Hairpin Loop Method
AAAAAAAAAAAA
>HW911004.1 JP 2015503608-A/3789: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
ACCAGGCCAGCT
>HW911003.1 JP 2015503608-A/3788: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CCAGGCCAGCTG
>HW911002.1 JP 2015503608-A/3787: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
CAGGCCAGCTGA
>HW911001.1 JP 2015503608-A/3786: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
AGGCCAGCTGAT
>HW911000.1 JP 2015503608-A/3785: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GGCCAGCTGATT
>HW910999.1 JP 2015503608-A/3784: ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
GCCAGCTGATTG
